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Alzheimer’s Disease and related dementias (ADRD) and depression are two 
conditions that often result in significant functional impairment and are widespread in 
prevalence, globally affecting 35.6 million and 264 million people, respectively. There is 
evidence for a connection between ADRD and depression, such that those with a history 
of depression are more likely to develop ADRD in late life. However, extant literature 
has yet to examine genetic and psychosocial factors that contribute to earlier or later 
onset of depression between males and females and how these factors in turn may confer 
risk for ADRD in a single sample. The present study utilized extant data from the Cache 
County Study on Memory In Aging (CCSMA). Participants underwent clinical 
assessments, repeated triennially over the course of 12 years. Participants were further 
linked to data from the Utah Population Database (UPDB) and Medicare claims data. 
Results from Study 1 showed that in early life, death of a spouse, possession of the minor 
allele for BDNF gene Rs2072446 (NGF/BDNF receptor p 75NTR) (males only) and 
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corticosteroid use (females only) were associated with higher odds of early life 
depression. In late life, death of a mother (males only), death of a spouse, death of a 
child, hospitalizations of self and family and corticosteroid use (females only) were 
associated with higher odds of late life depression. Chronic pain conditions and number 
of vascular health conditions were associated with reduced odds of late life depression for 
both males and females. Further, some BDNF-related genes modified the association 
between stressful life events and depression in both males and females. Results from 
Study 2 showed that late life depression was associated with increased risk of dementia 
only in males, and that chronic depression was associated with reduced odds of dementia 
among females. The present study identified several risk factors that contribute to a 
comprehensive model of risk for depression across the lifespan. Further, our results 
support depression as a risk factor for dementia in late life amongst males. Implications 
from this work suggest early intervention with depression is important to reduce future 









Risk Factors for Early and Late Onset Depression and Subsequent Risk for Alzheimer’s 




 The Cach County Study on Memory in Aging (CCSMA) was a research study 
that followed 5092 participants aged 65 or older over the course of 12 years, examining 
risk and protective factors for dementia.  One of these factors was depression history, 
which has evidence for a connection with dementia, such that those with a history of 
depression are more likely to develop dementia later in life. However, the existing 
literature has yet to examine sex differences, genetic and psychosocial factors that 
contribute to earlier or later onset of depression and how these factors in turn might later 
increase risk for dementia. 
 The current research contained two related studies. The fist study looked at how 
several life events, such as death of a spouse, chronic conditions, such as having diabetes, 
and genetic factors, such as the presence and of certain genes related to brain derived 
neurotrophic factor (BDNF), related to depression in early life and late life. The second 
study looked at how depression in early life and late life related to risk for dementia.  The 
results of these studies showed that certain life events reliably led to depression in early 
life and late life for males and females, specifically death of a spouse. In late life 
depression, death of a mother (males only), death of a spouse, death of a child, 
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hospitalizations of self and family and corticosteroid use (females only) were associated 
with increased risk of late life depression. Chronic pain conditions and number of 
vascular health conditions were associated with reduced likelihood of having late life 
depression for both males and females. Further, the presence of some BDNF-related 
genes changed the relationship of stressful life events and depression. Finally, late life 
depression was associated with increased risk of dementia only in males and having both 
early and late life depression was associated with reduced likelihood of having dementia 
among females. These results provide evidence that early identification of depression and 
awareness of risk factors for depression is important, particularly as history of depression 
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Dementia and depression are two conditions that may result in significant 
functional impairment; both are widespread with high prevalence, globally affecting 35.6 
million and 264 million people, respectively (World Health Organization, 2017). 
Dementia most commonly occurs in late life (i.e., after age 60) and refers to a 
constellation of symptoms that negatively impacts cognitive functioning and results in 
significant functional impairment (American Psychiatric Association [APA], 2013). 
Alzheimer’s Disease (AD), a degenerative brain disorder, is the leading cause of 
dementia and is estimated to account for up to 60-80% of all dementia cases in the United 
States alone (Reitz et al., 2011; Mayeux & Stern, 2011). Due to the aging of large birth 
cohorts and medical advances that prolong life, the number of people likely to be affected 
by AD and related dementias (ADRD) is expected to increase drastically in the 
approaching decades (Prince et al., 2013). As such, a large body of research has been 
devoted to understanding the risk factors and etiology of ADRD (Braak et al., 2011; 
Breteler, 2000; Toshitake et al., 1995).  
In contrast to ADRD, depression occurs throughout the lifespan, and is 
characterized by a persistent low affect or mood, lack of pleasure in daily experiences 
and frequent thoughts of hopelessness (APA, 2013). The highest prevalence rates of 
depression are observed in early life (i.e., before age 50) and late life (i.e., after age 60; 
National Institute of Mental Health [NIMH], 2018; Gatz et al., 1993; Djernes, 2006). 
Unlike ADRD, there are several effective treatments for depression, however many 
individuals do not receive these treatments (Mitchell et al., 2010; Djernes, 2006; 
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González et al., 2010).  Some instances of depression are also resistant to treatment 
(Nemeroff, 2007; Thomas et al., 2013). Untreated, depression may result in significant 
functional impairment and poor health outcomes, including mortality (Lépine & Briley, 
2011; Rodda et al., 2011). Further, depression has been characterized by the World 
Health Organization (WHO) as the leading cause of disability and the leader among all 
mental health conditions in the global burden of disease (WHO, 2017). Researchers have 
posited that an interaction of biological vulnerabilities and environmental stressors, such 
as traumatic life events and chronic health conditions often result in depression (Colodro-
Conde et al., 2018), though risk factors may differ for the occurrence of depression at 
various points in the lifespan (Baldwin & Tomenson, 1995).  
There is evidence for a connection between ADRD and depression in longitudinal 
studies, such that those with a history depression are more likely to develop ADRD in 
late life (see review: Bennett & Thomas, 2014; Geerlings et al., 2008). A number of 
studies have explored the relationship between depression and ADRD, with three 
hypotheses typically emerging: 1) Depression is an independent risk factor for ADRD, 2) 
Depression is a prodromal feature of ADRD and 3) Depression is a coincidental finding 
resulting from the loss of functioning associated with ADRD (Bennett & Thomas, 2014). 
While the majority of research featuring longitudinal samples supports depression as an 
independent risk factor for ADRD (Blazer, 2003; Ownby et al., 2006; Wilson et al., 
2008), few studies have considered the potential differences in risk for those by age of 
depression onset.  
Differences in symptom presentation have been observed for early onset 
depression (Manepalli et al., 2011) and late onset depression (Hegeman et al., 2012). This 
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observation may suggest that depression in early life is experienced differently than 
depression occurring in late life. Further, risk factors also differ (Baldwin & Tomenson, 
1995), with evidence suggesting inherited biological vulnerabilities, such as family 
history of psychiatric illness (Klein et al., 2001), combined with acute stressors (Riso et 
al., 2002), increase an individual’s risk for early onset depression. Comparatively, studies 
that explored risk factors for late onset depression suggest that chronic stressors, such as 
poor cardiovascular health, low socioeconomic status, and others are related to increased 
risk for the condition (Valkonova & Ebmeier, 2013). Interestingly, research has also 
found that acute stressors appear to be less robustly related to late life depression in 
comparison to early life depression (Kraaij, et al., 2002). However, differences in risk 
factors by depression onset has not been examined in a single sample. 
Biological alterations in brain structures, such as the hippocampus, have been 
observed in the aftermath of depressive episodes (Ding et al., 2015; Lee & Kim, 2010; 
Rapp et al., 2006; Warner, et al., 2006). Studies have found evidence of reduced neuronal 
(brain cell) health and functioning, as well as reduced hippocampal volumes in 
individuals following a depressive episode (Lee & Kim, 2010; Warner et al., 2006). 
Further, several studies have observed that neurotrophin levels (which are proteins that 
promote neuronal survival and differentiation) are significantly lower in those with 
depression compared to that of healthy controls (Karege et al., 2002; Sen et al., 2008). 
Interestingly, similar changes have been observed in persons with ADRD (Vijayakumar 
& Vijayakumar, 2012). Indeed, hippocampal atrophy is considered a reliable biomarker 
of the neurodegeneration associated with ADRD (Vijayakumar & Vijayakumar, 2012; 
Schuff et al., 2009) and decreased neurotrophin levels have been associated with 
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increased risk for ADRD (Lin et al., 2014; Wenzler et al., 2017). These studies suggest 
that depression and ADRD may share a similar pathophysiology (Lewis, 2002; Treadway 
et al., 2015).  
Underscoring the link between depression and ADRD are a number of risk factors 
that are shared between these conditions. In particular, poor cardiovascular health 
(Frasure-Smith et al., 1993; Lewis, 2002; Treadway et al., 2015;), exposure to traumatic 
or stressful life events (Riso et al., 2002; Tschanz et al., 2013) family history (Green et 
al., 2002; Klein et al., 2001; Loy et al., 2014) and genetic polymorphisms related to Brain 
Derived Neurotrophic Factor (BDNF; Matyi et al., 2017) and apolipoprotein E (Ye et al., 
2016) are all linked to increased risk for both depression and dementia.  Sex differences 
in prevalence rates are also observed for depression and ADRD, such that prevalence 
rates for females are significantly higher compared to males for both conditions (Green et 
al., 2002; Loy et al., 2014). However, there is limited research examining common risk 
factors in a single sample. Further, no study has examined whether these risk factors are 
differentially related to age of depression onset (early vs. late), and how depression onset 
relates to risk for ADRD.  
 The present project proposes two studies: 1) to examine risk factors related to 
early life- and late life-onset depression and 2) to examine the relationship between early 
life and late life onset depression and ADRD. Each study will use data from the Cache 
County Study on Memory in Aging (CCSMA), which included 5,092 participants who 
were studied for antecedent risk factors and followed for dementia surveillance over the 
course of 12 years. Further, participants in the CCSMA were also linked to records in the 
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Utah Population Database (UPDB), which allowed for additional demographic, vital 













Nearly 7.1% (17.3 million) of adults in the United States experienced at least one 
episode of clinically severe depression (National Institute of Mental Health; NIMH, 
2018). A clinically severe episode of depression, frequently referred to as a “major 
depressive episode” is defined by the Diagnostic and Statistical Manual of Mental Health 
Disorders, 5th edition (DSM-5) as a period of at least two weeks during which an 
individual experienced depressed mood and/or loss of interest or pleasure in daily 
activities, along with several other symptoms, nearly every day in that period (American 
Psychiatric Association [APA], 2013). The age range for those experiencing a first major 
depressive episode varies considerably. Middle aged or younger adults (aged 50 or less) 
show the highest prevalence at nearly 21%, whereas those over age 50 show prevalence 
rates between 15 and 20% (National Institute on Aging, 2007; NIMH, 2018). However, 
some studies suggest that the prevalence of major depressive disorder with late life onset 
is much higher, as depression in late life often goes undiagnosed and untreated (Mitchell 
et al., 2010; Djernes, 2006). Several epidemiological studies show that the prevalence of 
major depression symptoms across the lifespan appears to spike in early adulthood and 
again in late life (Djernes, 2006; Gatz et al., 1993). Evidence also suggests that the 
7 
 
clinical presentation (i.e., typically endorsed symptoms) of major depression in early life 
differs from that in late life (Manepalli et al., 2011). 
Studies have reported on differences in the presentation of depression symptoms 
at various ages (Manepalli et al., 2011). One study of 1,498 patients aged 18-75 found 
that younger adults (age 18-35) were more likely to report greater irritability and 
agitation, weight gain, hypersomnia, global negative beliefs and comorbid anxiety 
symptoms, whereas middle aged adults (age 36-50), were more likely to experience, 
insomnia, somatic symptoms, social isolation, problems with attention, and decreased 
motor functioning. The latter group also experienced a greater number of depressive 
episodes (Manepalli et al., 2011). Older adults (age 50 or higher) tended to report higher 
suicidality, chronic pain, and cognitive impairment, the latter two of which may be 
symptoms or contributing factors for depression (Manepalli et al., 2011). A meta-analysis 
of 11 studies examined differences in the presentation of depression in younger adults 
(age 35-45 years) and older adults (age 64-73 years). The authors reported that younger 
adults reported more feelings of chronic guilt and decreased sexual functioning, whereas 
older adults tended to report more somatic health symptoms and decreased attention 
(Hegeman et al., 2012).  
Research has also suggested sex differences in symptom presentation of 
depression across the lifespan. A meta-analysis of 32 studies and 108,260 inpatient and 
outpatient adults found that women reported a greater frequency and intensity of 
depression symptoms relative to men, including more changes in appetite, weight gain 
and sleep disruption (Cavanagh et al., 2017). A study of 170 younger depressed 
outpatients (M[SD] age in years= 32[11.29]) found that females reported a greater 
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increase in appetite and weight gain compared to males (Carter et al., 2000). Another 
study of 217 older depressed adult inpatients (M[SD] age in years= 50.3[16]) found that 
males tended to show more blunted affect, decreased sex drive and a more rigid (i.e., 
unchanging) experience of emotions. In the latter sample, females reported more emotion 
dysregulation (i.e., rapidly changing emotions) and dysphoria (Winkler et al., 2004). 
Differences in the clinical presentation of depression based on onset age and sex may 
suggest that depression is experienced differently at different stages of life and may be 
affected by unique risk factors in early and late adulthood. 
 Etiological models of depression have historically emphasized the diathesis-stress 
model (England & Sim, 2009), which posits that an interaction of risk/vulnerability 
factors (diathesis) and stressful life circumstances (stress) sets the stage for symptoms of 
depression to develop (England et al., 2009). One example of a well-researched diathesis-
stress model is the Biosocial Theory of Borderline Personality Disorder, which posits a 
biological vulnerability to experiencing intense emotions (e.g., greater sensitivity to 
emotional stimuli and a slow return to baseline emotionality) interacts with a chronically 
invalidating social environment (e.g., caregivers/social networks that punish effective 
communication of emotion) to increase an individual’s risk for developing borderline 
personality disorder (Linehan, 2018). Diathesis-stress models of depression have been 
extensively studied to identify at-risk-populations that may benefit from prevention 
strategies (See review, Fiske et al., 2009).  
Age of first onset of symptoms (often examined in diathesis-stress models) is a 
critical factor in understanding the severity and lifetime occurrence and recurrence of 
depressive episodes. As noted above, prevalence rates for major depressive disorder vary 
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considerably across the lifespan and the distribution for the age of first onset of major 
depressive disorder shows a similarly wide age range (Kessler et al., 2005). Indeed, major 
depressive symptoms in childhood are relatively rare, with an estimate of less than 5% of 
all depression cases occurring before age 12 (Kessler et al., 2005). However, 
approximately 25% of all depression cases occur before age 19 and 50% before age 32, 
suggesting that major depression is relatively common in earlier in life (Kessler et al., 
2005). Early onset major depression is associated with greater functional impairment and 
a chronic course (England & Sim, 2009; Hollon et al., 2006; Zisook et al., 2004). For 
example, research on lifetime mental health outcomes found that those with adolescent-
onset depression also had higher rates of personality disorders (Fava et al., 1996) and a 
greater overall number of psychiatric symptoms when compared to those with onsets in 
mid or late life (Zisook et al., 2004). Additionally, depression before the age of 18 is 
associated with more negative physical health outcomes, including poorer health, greater 
health care utilization and more severe functional impairment relative to physical health 
conditions (Keenan-Miller et al., 2007). 
Sex differences also emerge in early life depression. Salk and colleagues (2017) 
completed two separate meta-analyses examining gender differences in major depression 
across the lifespan. Their first meta-analysis examined 65 articles constituting 1,716,195 
individuals and found that women were more likely to be diagnosed with depression 
relative to men across the lifespan (OR=1.95, 95% confidence interval [CI]=[1.88,2.03], 
d=.37). This gender difference emerged early in life, at age 12 (OR=2.37, 95% CI=[1.68, 
3.37], d=.48) and peaked during adolescence at ages 13-15 (OR=3.02, 95% 
CI=[2.76,3.02], d=.61). Following adolescence, gender differences in the occurrence of 
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major depression declined gradually, but remained significant (OR= >1.71, d=>.30) 
throughout the lifespan (Salk et al., 2017).  
Approximately 10% of new onsets of major depressive disorder occur in 
individuals older than age 56 (Kessler et al., 2005). However, late onset major depression 
often goes undiagnosed and untreated (see review, Djernes, 2006). Similar to depression 
in early life, those who experience late life (e.g., after age 55) depression also report a 
number of mental and physical health conditions (Rodda et al., 2011). Several physical 
health comorbidities have been associated with depression in late life (Blazer, 2003), 
including neurocognitive impairment (see reviews: Alexopoulos et al., 2002; Bennett & 
Thomas, 2014) problematic weight loss (Morley & Kraenzle, 1994), cardiovascular 
disease and other chronic medical conditions (Frasure-Smith et al., 1993), lower self-
rated health (Han, 2002), disability (Alexopoulos et al., 1996; Zeis et al., 1996), and 
lower bone mineral density (Lyles, 2001; Robbins et al., 2001), all of which result in 
higher overall use of medical services (Huang et al., 2000; Luber et al., 2001). Further, a 
study examining insurance claims of 618,780 adults (age in years M=41) in the United 
States found that those with a diagnosis of depression had higher costs of overall health 
care for somatic health conditions and complaints, underscoring the associations between 
depression, physical health and overall well-being (Welch et al., 2009). Higher rates of 
non-suicide mortality (pooled OR 1.75; Geerlings et al., 2002) have also been associated 
with late life depression (Conwell et al., 2002; Shah et al., 2016). Taken together, both 
early and late onset depression are associated with a number of mental and physical 
health conditions that negatively impact quality of life. Understanding the factors that 
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increase risk for depression at early or later ages may identify targets for effective 
prevention or early intervention of depression across the lifespan. 
 Risk factors for early and late onset depression differ. In early life, family history 
of severe depression, psychiatric illness (Klein et al., 2001), criminality or psychopathy 
(Jaffee, 2002), low birth weight (i.e., birth weight of less than 5.5 pounds; Mallen et al., 
2008), early life motor skill deficits (Jaffee, 2002) and certain genes (D’Souza et al., 
2016; Haeffel et al., 2008), are associated with higher risk of depression; these factors 
however have lower associations with later onset depression  (Blazer et al., 2003). 
Additionally, specific psychosocial factors, such as stressful life events, have been 
extensively linked to risk for early life depression (see review, Mandelli et al., 2015). In 
particular, acutely stressful life events, such as death or severe illness of immediate 
family members (Riso et al., 2002), witnessing or experiencing family violence (Kessler 
& Magee, 1993), death of a parent before age 18 (Kessler & Magee, 1993) and childhood 
trauma (Mandelli et al., 2015) appear to significantly increase the risk for major 
depression in early life. Chronic stressors such as, frequent physical illness (McGonagle 
& Kessler, 1990), chronic pain (McGonagle & Kessler, 1990), financial difficulty 
(McGonagle & Kessler, 1990), marital conflict (McGonagle & Kessler, 1990), 
inadequate social support (Jaffee, 2002) and low socioeconomic status (Jaffee, 2002) 
have also been implicated as risk factors, but have been less well studied. From a 
diathesis-stress perspective, it appears that early onset depression is most likely to occur 
in individuals with inherited vulnerability factors, which interact with exposure to acute 
or chronic stressors in such a way as to decrease resilience for major depression.  
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Risk factors for late-onset depression are complex and multifaceted, and several 
of these factors include chronic health conditions. For example, certain diseases that are 
relatively common in late life are associated with significantly increased risk of late life 
depression. Diabetes (OR= 1.51, 95% Confidence Interval [CI]=[1.30,1.76], p=<.001), 
cardiovascular disease (OR=1.76, 95% CI= [1.52,2.04], p=<.001) and stroke (OR=2.11, 
95% CI=[1.61,2.62]) are all associated with higher risk (Valkanova & Ebmeier, 2013, 
p=<.001). Inherited risk factors however, appear to have an inconsistent relationship with 
late life depression. Family history, a robust predictor of depression in early life (Baldwin 
& Tomenson, 1995; Klein et al., 2001), is less common in late life depression (Fiske et 
al., 2009; Hopkinson, 1964). One study found that only 8.3% of those with depression 
onset after the age of 50 had a positive family history, compared to 20.1% for those with 
onsets before the age of 50 (Hopkinson, 1964). Genetic factors however, show some 
associations with onset of depression in late life (Blazer, 2003; Gatz et al., 1992). For 
example, one study of 306 older adults examined central serotonin neurotransmission 
dysregulation and found that a mutant allele of a single polymorphism in the rate-limiting 
enzyme of neuronal serotonin synthesis was found in nearly 10% of older depressed 
patients, but not in non-depressed individuals (Zhang et al., 2005). Psychosocial stressors 
that are traumatic, intense and short-lived, such as death of a loved one, are less robustly 
related to depression risk in late life compared to early adulthood (Fiske et al., 2009; 
Torges et al., 2008). Further, other negative life events such as death of a significant 
other, severe illness of significant other and severe illness of self, were associated with 
higher rates of depression in late life, although effect sizes were marginal (See review, 
Kraaij et al., 2002). Indeed, one meta-analysis noted that the largest associations between 
13 
 
acute negative life events and depression in late life were between the aggregated total 
number of negative life events and total number of “daily hassles” (i.e., events that 
require small behavior adjustments, such as unexpected visitors; Kraaij, et al., 2002). 
This suggests that in late life, single, acutely stressful life events, even those that are 
unexpected and/or traumatic, may represent less of a risk factor compared to an 
accumulation of frequent and chronic negative life events and daily stressors. 
Accompanying major depression (of early or late onset) are biological changes in 
the brain (Phillips, 2017). Recent studies report that major depressive episodes are 
associated with hippocampal changes including neuronal atrophy, reduced volume, and a 
decrease in neuronal regeneration (Lee & Kim, 2010; Warner et al., 2006). A possible 
contributing factor to hippocampal changes is a decrease in neurotrophin levels in the 
brain (Duman & Monteggia, 2006). Neurotrophins are a family of proteins that facilitate 
survival, function and differentiation of neurons in the brain and central nervous system, 
most notably in the hippocampus (Duman & Monteggia, 2006). In humans, neurotrophins 
include Brain Derived Neurotrophic Factor (BDNF), Nerve Growth Factor, Neurotrophin 
3 and Neurotrophin 4-5 (Phillips, 2017). Of these neurotrophins, BDNF has been 
implicated in the etiology and pathophysiology of depression in both human and animal 
studies (Lee & Kim, 2010; Phillips, 2017; Sen et al., 2008). 
 Karege and colleagues (2002) first observed that BDNF serum levels were lower 
in patients with major depression compared to healthy controls. Several studies have 
since replicated these findings (see review: Sen et al., 2008). A meta-analysis of 11 
studies that examined BDNF serum levels and major depression found strong support 
across the aggregated sample of 748 adults in the association between low BDNF serum 
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levels and patients with major depression (Sen et al., 2008). Further, the authors reported 
that in eight studies that examined the relationship between BDNF serum levels and 
patients treated with anti-depressants, BDNF levels reliably increased after a course of 
antidepressant treatment (Sen et al., 2008). Another study investigating the longitudinal 
associations of BDNF serum levels and depression among 1,751 individuals found that 
those with chronic or recently remitted depression (i.e., 1-6 months removed from a 
depressive episode) had lower levels of BDNF in serum compared to those with incident 
(acute) depression or no depression (Bus et al., 2015). Based on this finding, the authors 
suggested that BDNF serum levels may decrease after a major depressive episode and 
may contribute to preventing recovery or to increasing an individual’s vulnerability to 
future depressive episodes (Bus et al., 2015). Further, the authors found that among those 
with persistent depression, having experienced a greater number of negative life events 
was associated with a sharper decrease in serum BDNF levels (Bus et al., 2015). Indeed, 
lower BDNF serum levels in early adulthood are associated with a greater number of 
traumatic experiences in childhood (Aas et al., 2014; Mandelli et al., 2015), (Aas et al., 
2019). Thus, BDNF signaling may underlie the relationship between adverse life events 
and depression. Additional studies have reported associations between lower serum 
BDNF levels and depressive episodes among those with severe mental illness 
(Nuerenberg et al, 2016) including patients with schizophrenia or a bipolar-related 
disorder (Aas et al., 2019).  
Although research implicates BDNF as having a role in major depression, the 
method used in most human studies relies on measuring BDNF in serum or plasma, 
which reflects BDNF levels in the body and not necessarily levels present in the brain. 
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This complicates the interpretability of the findings described above, as BDNF is 
produced not only in the central nervous system, but throughout the body in various 
tissues and in multiple cell types (Karege et al., 2005). Additionally, BDNF production 
can be stimulated by food intake (Stanek et al., 2008) and physical activity (Tang et al., 
2008), both of which may further confound the relationship between BDNF and 
depression.  
A related, but independent line of research, is the examination of BDNF-related 
genes. Extant research has fully mapped the BDNF gene in humans to chromosome 11 
(Maisonpierre et al., 1991). Multiple single nucleotide polymorphisms (SNPs) have been 
implicated in the alteration of synthesis and/or functioning of BDNF and its receptors, 
including rs56164415 (BDNF C270T), rs2289656 (BDNF receptor trkB), rs2072446 
(Neurotrophic growth factor/ BDNF receptor p75NTR) and rs6265 (BDNF Val66Met; 
Hwang et al., 2006; Taylor et al., 2005; Matyi et al., 2017). The snp, rs6265 (BDNF 
Val66Met) in particular has been identified as being associated with heightened risk for 
depression in late life (Hwang et al., 2006; Taylor et al., 2007). For example, one study 
found that adults aged 65 years were two and a half times more likely to be depressed if 
they carried the met allele compared to homozygous val allele carriers (Hwang et al., 
2006). However, replication of this association has yielded inconsistent results, with one 
meta-analysis of 14 studies and over 12,000 adults (Age range= 26-70) concluding that 
BDNF Val66Met was not associated with depression in their aggregated sample, but that 
BDNF Val66Met was associated with higher odds of depression for men compared to 
women (Verhagen et al., 2010). Interestingly, another meta-analysis of 22 studies and 
14,233 individuals (Age range= 9-65) examined the relationship between recent life 
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stress, depression and BDNF Val66Met across the lifespan. The results that showed 
BDNF Val66Met moderated the relationship between life stress and depression (Hosang 
et al., 2014), such that those who were carriers of met and experienced greater life stress 
were at greater risk for depression than those with a homozygous val allele. Taken 
together, SNPs of BDN-related genes, in particular BDNF Val66Met, may represent a 
biological vulnerability factor for depression. However, no study to date has examined 
the interactive effects of BDNF-related gene polymorphisms with specific life stressors 
by the onset age of depression. 
Taken together, a large body of research has examined risk factors for major 
depression throughout the lifespan. Major depression is unique among mental health 
conditions, in that it may present at almost any point throughout the lifespan, but are most 
prevalent in early and late adulthood. The etiology of depression is complex and as such, 
a comprehensive model of risk for depression across the lifespan has eluded researchers 
to this point. The diathesis-stress model may capture the complex interaction of 
biological, psychosocial and environmental risk factors. Further, research on neurotrophic 
factors, specifically BDNF, may play a role, potentially as a vulnerability factor. 
However, few studies have examined BDNF-related gene polymorphisms and their 
relationship to major depression of early or late onset. The purpose of the present study is 
to examine risk factors for early and late onset depression, including BDNF-related 
genes, as well interactions between BDNF-related genes and psychosocial risk factors. 
The research questions and hypotheses follow: 
1) Are acutely and chronically stressful events, differentially related to early-life 
onset depression and late-life onset depression?  
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Hypotheses: I hypothesized that acutely stressful life events may show individual 
associations with both early- and late-onset depression but would be more 
strongly related to early-onset depression. Further, I hypothesized that chronic life 
stressors would be related to both early-and late-onset depression, but would show 
a stronger association with late-onset depression. 
2) Are there differences in polymorphisms of specific BDNF-related genes and 
early and late onset depression? Do these genotypes moderate the association of 
stressful life events with early and late onset depression?  
Hypothesis: I hypothesized that BDNF-related genes would be associated with 
increased risk for both early-and late-onset depression. I further hypothesized that 
BDNF-related genes will moderate the association between acutely stressful life 
events, chronic life stressors and early/late onset depression, such that those with 
at least one copy of the minor allele for each gene and exposure to stressful life 





In the present study, participants were selected from an extant dataset comprised 
of a large, population-based cohort of individuals living in semi-rural Utah. This sample 
of participants was recruited to participate in the Cache County Study on Memory in 
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Aging (CCSMA), which examined risk factors related to cognitive decline and ADRD in 
older adults. The CCSMA began collecting data from participants in 1995 and completed 
its data collection in 2007. Participants were assessed in four triennial waves during this 
12-year period (Breitner et al., 1999). In total, the CCSMA collected data on 5,092 
individuals who were over 65 years of age and resided in Cache County, Utah. Data from 
these participants were further linked to records in the Utah Population Database 
(UPDB). The UPDB includes records for over 11 million individuals residing in Utah and 
is frequently used in epidemiological and public health research (Norton et al., 2006; 
Cannon-Albright et al., 2019). Reportedly, 5,091 of 5,092 (99.99%) participants in the 
CCSMA were successfully linked to at least one record in the UPDB. The present study 
utilized data from those participants who were successfully linked from the CCSMA to 
the UPDB with non-missing data in relevant databases. 
 
Procedure 
All study procedures for the CCSMA were approved by the Institutional Review 
Boards of Utah State University, Duke University and the Johns Hopkins University. In 
1995, a cohort of 5,657 individuals were identified as being eligible for the CCSMA, of 
which 5,092 (90%) were enrolled into the study (Breitner et al., 1999). A more detailed 
description of all recruitment procedures, methods and participant selection is available 
elsewhere (see Breitner et al., 1999). To summarize these procedures briefly, participants 
completed a multi-staged screening and assessment protocol in waves 1-4 to determine 
the presence or absence of dementia, along with the presence or absence of various risk 
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factors related to dementia. Participants’ clinical data from a clinical assessment 
(physical, neurological exam, and neuropsychological assessment) and subsequent MRI 
and a panel of labs for dementia work up were reviewed by an expert clinical panel who 
categorized participants according to cognitive status, including diagnoses of dementia 
(Breitner et al., 1999). Those who were not diagnosed with dementia were subsequently 
followed in three additional waves of follow-up. 
 
 Data Sources linked with the UPDB  
The UPDB was initially created as a large multigenerational family history 
dataset for residents of Utah. Genealogy records, birth certificates, death certificates 
census records, drivers license information and hospital records are linked to the UPDB, 
resulting in over 16 million records for more than 11 million individuals (see 
https://uofuhealth.utah.edu/huntsman/utah-population-database/). Additionally, claims 
data from Medicare (which provides health care insurance coverage for qualifying 
individuals 65 years of age and over) are linked to the UPDB. Thus, via the UPDB, data 
on participants of the CCSMA were expanded greatly as described below. The 
Institutional Review Boards of Utah State University, the University of Utah and the 
Utah Resource for Genetic and Epidemiological Research approved the usage of the 




Lifetime Depression Status 
 At each wave, participants in the CCSMA were also assessed for depression 
history and current depression symptoms. At baseline and each subsequent wave, 
participants completed a depression history screener. The depression screening items 
included: “1) In your lifetime, have you ever had a period of two weeks or more when, 
nearly every day you felt sad, blue or depressed? 2) In your lifetime, have you ever had a 
period of two weeks or more when, nearly every day you lost all interest and pleasure in 
things that you usually cared about or enjoyed? 3) In your lifetime, have you ever had a 
period of two weeks or more when, nearly every day you felt unusually cross or 
irritable?” Those who endorsed at least one key symptom of depression from the screener 
were further assessed via the Diagnostic Interview Schedule (DIS; Robins et al., 1981); at 
waves 3 and 4 all participants completed the DIS (Steffens et al., 2000). Participants who 
endorsed sufficient diagnostic criteria on the DIS (i.e., 5 of 9 possible depression 
symptoms) were assigned a diagnosis of major depressive disorder (MDD; Robins et al., 
1981; American Psychiatric Association, 1987; Steffens et al., 2000). Those who did not 
meet full criteria for MDD but who reported persistent depressed mood and at least two 
other symptoms of depression were assigned a diagnosis of minor depression (Robins et 
al., 1981; American Psychiatric Association, 1987; Steffens at el., 2000). The DIS has 
been extensively validated for its diagnostic accuracy, sensitivity and ease of 
administration in large research studies (Regier et al., 1984; Robins et al., 1982). 
Additional diagnoses of major depression were assigned through examination of 
medication history, with the endorsement of an antidepressant for the indication of 
depression being considered positive for a diagnosis of MDD or minor depression, 
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regardless of self report on the DIS (Steffans et al., 2000). Finally, in the absence of data 
within the CCSMA, Medicare claims were examined for ICD codes related to depression. 
The presence of any of the following ICD-9 codes was used to designate depression 
status in Medicare claims and death certificate databases: 296.20. 296.21, 296.22, 296.23, 
296.24, 296.25, 296.26, 296.30, 296.31, 296.32, 296.33, 296.34, 296.35, 296.36, 309.00, 
309.10,309.28, 311.00, 300.40.  Those who did not report depression in the CCSMA but 
did have Medicare codes for depression were added to the late life depression group. 
Early life onset depression and late life onset depression were determined through 
self-report of the approximate date that depression symptoms (lasting at least two weeks) 
first began, or if lacking the approximate date, the date that anti-depressants were 
prescribed, or earliest Medicare claim code corresponding to major or minor depression. 
Early life onset depression was coded differently based upon sex. More specifically, for 
women early onset depression was coded for those who met criteria for MDD, a single 
major depressive episode or minor depression prior to their age at menopause. For men, 
the cut off age for early life onset depression was determined based upon previous 
literature, with those who met criteria for MDD, a single major depressive episode or 
minor depression prior to age 60 being coded as Early Life Depression (Baldwin et al., 
1995; Fiske et al., 2009; Zisook et al., 2004). Late life onset depression was coded as 
those who reported the above conditions but with first onset after menopause age for 
females and after age 59 for males.  
Data from Medicare claims were used to further ascertain any additional episodes 
of depression not otherwise reported in CCSMA (see below). Including depression 
diagnoses from Medicare claims, the present study used a multiple level variable for 
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depression, coded as 1= no reported symptoms of depression, 2=early onset depression 
(major or minor) only, 3= early and late life onset depression (major or minor) and 4= 
late life onset depression (major or minor) only. 
 
Acute Stressors 
Acutely stressful life events were conceptualized as short-term life events that 
result in significant distress but which do not occur with great frequency across the 
lifespan. The following acutely stressful life events have previously shown a relationship 
to early life and late life onset depression and were available in the UPDB. Each stressful 
life event was coded as having occurred prior to the first depressive episode in early life 
or late life, consistent with the age of onset for depression coding. 
 
Death of an Immediate Family Member 
  Data from death certificates available in the UPDB were utilized to obtain the 
number of deaths of an immediate family member (i.e., mother, father, sibling, offspring) 
for participants in the CCSMA and the age at which the death occurred. The age of the 
participant at the time of death of an immediate family member was then compared to 
their age of first depressive episode in early life and late life. Those who reported a 





Death of a Spouse 
Data from death certificates available in the UPDB were used to obtain the 
approximate date of death of spouses for participants in the CCSMA. The age of the 
participant at the time of their spouse’s death was then compared to the participant’s age 
of first depressive episode in early life and late life. Those who reported the death of a 
spouse prior to the date of their first depressive episode in early life were coded as having 
early life death of a spouse, those who experienced the death of a spouse after menopause 
(females) or after age 59 (males) were coded as having late life death of a spouse. 
 
Participant Hospitalizations 
 Data that was linked from the UPDB and Medicare claims were used to 
determine the frequency of hospitalizations of participants in the CCSMA across their 
lifespan. Dates of hospitalizations were only available for participants over 65 years of 
age (because Medicare eligibility starts at 65 years of age for the majority of individuals), 
as such the total number of participant hospitalization admit days only reflects 
hospitalizations that occurred after the late life cutoff for both males and females. 
Participants total number of days hospitalized were summed for a total value that reflects 




Immediate Family Member Hospitalizations 
 Linked data from the UPDB were used to determine the frequency of 
hospitalizations of immediate family members of participants in the CCSMA across their 
lifespan. Dates of hospitalizations were only available for participants 65 years of age and 
older, as such the total number of immediate family member hospitalization admit days 
only reflected hospitalizations that occurred after the late life cutoff for both males and 
females. Participants’ total number of immediate family member days hospitalized were 
summed for a total value that reflected the total number of days hospitalized after the 
participant reached 65 years of age. 
 
Total Acutely Stressful Life Events 
 A total score for aggregated acutely stressful life events in early life and late life 
was calculated. The total acutely stressful life events in early life was calculated by 
taking the sum total of the number of deaths of parents, siblings, spouses and offspring 
that occurred before the age of first depressive episode in early life. The total acutely 
stressful life events in late life was calculated by taking the sum total of the number of 
deaths of parents, siblings, spouses, offspring, self-hospitalizations, as well as parents, 
siblings, spouses and offspring hospitalizations that occurred before the age of first 





Several chronically stressful life events or circumstances based upon data from 
both the CCSMA and UPDB were examined. Chronic stressors were conceptualized as 
life events or circumstances that frequently cause discomfort and are present for long 
periods of time. These stressors tended to cause a lower amount of distress, but were 
present with far greater frequency compared to acute stressors. 
 
Low Socioeconomic Status (SES) 
 Data from the UPDB and CCMS were used to determine socioeconomic status 
across the lifespan. Birth certificates of participants in the CCSMA were examined for 
parents’ reported profession. These data were previously coded using an algorithm 
described by Nam & Powers (1983), which utilized census information regarding the 
relationship between education and income that is associated with individual occupations 
(Norton et al., 2011). Five discrete categories were used, with “1” reflecting the lowest 
range of socioeconomic status and “5” reflecting the highest (Norton et al., 2011). 
 
Vascular Health 
 Vascular risk factors were assessed during interviews where medical and 
medication risk factor information was collected; these were administered at each wave 
of the CCSMA. These items assessed the presence or absence of medical conditions 
and/or medications related to vascular health: 1) Congestive Heart failure 2) Diabetes 
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Mellitus 3) Myocardial Infarction 4) Cerebrovascular Accident (e.g., stroke) 5) 
Hypertension (high blood pressure) 6) Hypercholesterolemia 7) Atrial Fibrillation 8) 
Atherosclerosis 9) Obesity 10) Other Dysrhythmia (see Appendix I). An example item 
includes, “Have you ever been told by a doctor that you had hypertension or have you 
ever been treated for hypertension?” Data on cardiovascular conditions was also drawn 
from Medicare claims data. More specifically, ICD-9 codes for the above conditions were 
matched to participants in the CCSMA if endorsed. The specific ICD-9 codes for 
vascular conditions included: hypertension (401.1, 401.9), hypercholesterolemia 
(272.39),  type 2 diabetes mellitus (250, 205.12, 205.02, obesity (278, 278.01), 
myocardial infarction (410.01-410.91; 412), cerebrovascular accident (strokes of multiple 
etiologies; 433.01, 433.11, 433.21, 433.31, 433.81, 434.01, 434.11, 435.8, 435.9), atrial 
fibrillation (427.31) and other arrythmias (427, 427.1, 427.2, 427.32, 427.41, 427.42, 
427.69, 427.61, 472.81, 427.89), congestive heart failure (428), and atherosclerosis 
(440.9, 440.8, 437, 440). All vascular health conditions were coded for date of earliest 
onset or diagnosis and compared to date of onset for ADRD for those so affected. Those 
who experienced a vascular health condition prior to age of dementia onset were retained 
for the present study, those whose age of vascular condition onset was equal to or after 





Chronic Pain Condition In Late Life 
At each wave of the CCSMA and as part of the medication history, participants 
were asked if they had ever experienced any painful for inflammatory conditions as, 
"Now I have a list of ailments that can be major or minor problems to people. Almost 
everyone is bothered by some of these ailments at some time, so they are things that are 
easy to forget. However, these ailments are very important in our study, and for that 
reason I would like you to think very carefully over your past and try to remember if you 
have ever been bothered by any of these problems." The list of conditions considered as 
chronic pain conditions and their associated ICD-9 codes included arthritis (711-716), 
gout (274.9), bursitis (727.3), headaches or migraine headaches (784, 346), pain from 
injury, accidents (338.1), back pain or aches (724.5), or chronic pain from other medical 
conditions (338.2). Medicare claims data-were also used to supplement conditions that 
result in chronic pain, including fibromyalgia, arthritis, ulcer, back/neck problems, and 
multiple pains (Scott et al., 2007).  
 
 BDNF-Related Genes 
  Participants in the CCSMA provided a buccal-swab sample in Wave 1 and blood 
samples in Waves 3 and 4, from which DNA was extracted for genotyping (Breitner et 
al., 1999). Standard TaqMan® Assays (Life Technologies) was used to obtain genotyping 
for BDNF-related SNPs rs6265, rs2289656, rs2072446, and rs56164415 from the 
extracted blood samples and/or buccal samples (Matyi et al., 2017). In the present study 
we conducted exploratory analyses to determine the frequency of polymorphisms of 
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BDNF-related genes in our sample and collapsed minor allele carriers into a single 
category compared to those lacking the minor allele due to sparseness in the sample. 
 
Covariates 
 Several established covariates for depression were also included in the present 
study. These covariates included age at study enrollment (for late life depression 
analysis), education, which was collapsed into less than high school education or high 
school diploma and greater (Bjelland et al., 2008; Scarmeas et al., 2006), marital status, 
which was collapsed into married or all other statuses (Inaba et al., 2005; Steenland et al., 
2009) corticosteroid use, which was coded as having been taking a corticosteroid 
regularly for at least 2 weeks prior to first depressive episode. Each of these covariates 
were included based on extant literature that showed associations to depression. Figure 1 







Inclusion criteria for the present study were: 1) No diagnosis of dementia at wave 
1 (baseline) and 2) Outcome data of: a) no depression or b) depression in early life, early 
and late life or late life only.  Demographic characteristics of the sample were examined 
with respect to those who had a depression diagnosis compared to no depression across 
the lifespan. Differences between groups were examined using analysis of variance 
(ANOVA), Fisher’s exact tests and chi-square analyses where appropriate. For 
exploratory analysis, bivariate associations of all acutely stressful life events, chronic life 
stressors, BDNF-related genes and covariates with lifetime depression status were 
examined using ANOVA, Fisher’s exact tests, correlations, multinomial regression and 
logistic regression where appropriate. 
After examination of the bivariate associations of the above variables in separate 
models for males and females, several variables were collapsed due to sparseness. More 
specifically, due to sparseness of specific vascular health conditions (e.g., congestive 
heart failure) in late life (See Table 3), vascular health conditions were collapsed into a 
single variable that indicated the number of vascular health conditions that were present 
prior to the first depressive episode (range 0-10). Additionally, after examination of 
collinearity diagnostics (tolerance and variance inflation [VIF]), self-hospitalizations, 
spouse hospitalizations, sibling hospitalizations and offspring hospitalizations were 
collapsed into a single variable due to multi-collinearity (VIF= >4.5; Ringle et al., 2015). 
As such, the hospitalization variable that was used in all analyses that included acute 
stressors reflects the sum of total days hospitalized of the participants, their spouses, 
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siblings and offspring. The bivariate relationships and counts of specific vascular health 
conditions and total hospitalized days of self, spouse, siblings and offspring are listed in 
Appendix 1.  
To answer research question 1, which stated “Are certain types of stressful life 
events, specifically acutely stressful events and chronic life stressors, differentially 
related to early life onset depression and late life onset depression?” A multi-step 
process was utilized to reach a parsimonious, final binary logistic regression model. 
Given the number of predictors associated with acutely stressful life events and chronic 
life stressors in early and late life, multi-collinearity of predictors was a concern for these 
analyses (Daoud, 2017)). As such, we attempted to utilize Least Absolute Shrinkage and 
Selection Operator (LASSO) regularization to quantitatively account for multi-
collinearity in the model and better understand the most valuable predictors for a 
parsimonious model. However, the present study utilized SPSS v.27 to complete all 
analyses, which is the first version of SPSS with a statistical package that includes 
LASSO. Unfortunately, SPSS v.27 was unable to complete the LASSO analysis with the 
variables included for this project. More specifically, LASSO within SPSS requires all 
variables to be coded as positive integers (Numeric values greater than 0) and treats “0” 
codes as missing. Although our categorical variables were relatively simply transformed 
into categories that corresponded to positive values, this created a multitude of problems 
for both acutely stressful events and chronic life stressors that were continuous variables 
in which the value “0” had meaning. As such, LASSO was not able to be utilized in the 
analyses as originally planned.  
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 Instead, separate logistic regression models for each group of predictors (acutely 
stressful life events and chronic life stressors) were conducted, with stratified models 
developed for males and females. Models were run separately by type of life stressor, as 
either acutely stressful life events (events that cause intense distress, but occur 
infrequently) or chronic life stressors (conditions or events that occur frequently and 
incur, low level discomfort). Additionally, carriers of the minor alleles of BDNF-related 
genes were examined as biological vulnerability factors and included as chronic 
variables.  The analyses proceeded as follows: 
 Model 1 examined the impact of acutely stressful life events in early life on early 
life depression, chronic depression and late life depression using multinomial logistic 
regression. Model 1 included lifetime depression status (early life, chronic and late life) 
as the categorical outcome variable and death of mother in early life, death of father in 
early life, number of sibling deaths in early life, death of a spouse in early life, death of a 
child in early life, marital status, years of education and corticosteroid use as predictors.  
Model 2 examined acutely stressful life events that occurred in late life as 
predictors of late life depression utilizing binary logistic regression. Model 2 included 
late life depression as the binary outcome variable and death of mother in late life, death 
of father in late life, number of sibling deaths in late life, death of a spouse in late life, 
death of a child in late life, total hospitalized days of self and immediate family members 
in late life, marital status, years of education and corticosteroid use as predictors.  
Model 3 examined the same predictors as Model 2, but with chronic depression 
(early life and late life) as the binary outcome variable.  
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 Chronic life stressors and biological vulnerability factors (BDNF-related genes) 
were also examined in separate models for early and late life predictors in males and 
females. Model 4 examined the relationship of chronic life stressors on early life 
depression using binary logistic regression. Model 4 included early life depression status 
as the binary outcome variable and BDNF-related genes, early life socioeconomic status, 
corticosteroid use, marital status and education as predictors.  
Model 5 examined the relationship of chronic life stressors with late life 
depression status using binary logistic regression. Model 5 included late life depression 
as the binary outcome variable and late life chronic pain condition, number of vascular 
health conditions, BDNF-related genes, adulthood socioeconomic status, corticosteroid 
use, marital status, education and age at study enrollment as predictors.  
Model 6 examined the same predictors as model 5, but with chronic depression as 
the binary outcome variable.  
 To examine research question 2, which stated “Are there differences in the 
occurrence of specific BDNF-related genes and early and late onset depression? Do 
these genotypes moderate the association of stressful life events with early and late onset 
depression?” binary logistic regression models were built in which interactions between 
each BDNF-related gene’s genotype and all acutely stressful life events were examined in 
predicting lifetime depression status. Bivariate logistic regression analyses were 
conducted to assess the relationship of each genotype for each gene and acute stressor 
and the additive effect of their interaction in separate models for males and females. 








Demographics of The Total Sample 
 There were 5069 participants who met eligibility criteria for the present study. Of 
those eligible participants, 1818 (35.6%) were diagnosed with either major or minor 
depression in either early life, late life or in both early and late life. The majority of the 
sample with depression reported late life depression only (n=1094; 21.5%). In the overall 
sample, participants were more likely to be female, married, white and have completed a 
high school education (see Table 1). Those with depression were more likely than those 
without depression to be younger at baseline and identify their biological sex as female 









Descriptive Characteristics of the Total Sample (n=5069) of Older Adults Enrolled in the Cache County Study on 






















(%)/M(SD) f-test/Chi-square statistic 
      
Age at study 
enrollment 
76.43 (7.51) 74.08 (6.84) 74.03 (6.91) 75.18 (6.76 F (5068)=24.75, p=<.001 
Biological Sex     χ2(5069) =203.54. p=<.001 
Male 1614 (74.9%) 126 (5.8%) 97 (4.5%) 317 (14.7%)  
Female 3251 (64.1%) 331 (6.5%) 393 (7.8%) 1094 (21.6%)  
Ethnicity     χ2(5069)= 15.92, p=.60 
White 3230 (64.2%) 329 (6.5%) 391 (7.8%) 1082 (21.5%)  
Non-white 21 (<.01%) * (*%) * (*%) * (*%)  
Married 2217 (67.3%) 219 (6.7%) 220 (6.7%) 637 (19.3%) χ2(5064)= 50.08, p=<.001 
High School Education 3240 (64.1%) 331 (6.6%) 392 (7.8%) 1090 (21.6%) χ2(5053)= 3.28 p=.35 
Note. * indicates that the number was suppressed in compliance with the Health Insurance Portability and 




 Analysis of Variance (ANOVA) and chi square statistics were conducted to 
examine differences in lifetime depression status by occurrence of acutely stressful life 
events (See Table 2). Among acutely stressful life events, death of a father was more 
likely to occur in early life, and there were a higher number of participants with late life 
depression compared to early or chronic depression who experienced death of a father in 
early life (See Table 2). Similarly, death of a mother in early life occurred more 
frequently than in late life, and there were more participants who reported late life 
depression, compared to early or chronic depression, who experienced early life death of 
a mother. There were higher numbers of sibling deaths that occurred in late life compared 
to early life, and those with late life depression tended to experience a higher overall 
number of sibling deaths compared to those with chronic depression (See Table 2). 
Further, death of a spouse was most commonly experienced in late life, and among those 
who experienced it, more participants had late life depression than chronic depression. 
There were a higher number of participants who experienced death of a child in late life 
compared to early life, and of those who did, a greater number reported experiencing late 
life depression than chronic depression (See Table 2). There was a difference in the mean 
number of total hospitalized days of self and immediate family across depression status, 
such that those with chronic or late life depression tended to have more days of 
hospitalization of self and family. Finally, there was a higher mean total of acutely 
stressful life events experienced for the participants with late life depression relative to 





Means, Standard Deviations, F-Tests or Chi-Square Statistics of Lifetime Depression with Acute Life Stressors 
 
























n (%)/M(SD) F-test/Chi-square statistic 
 Father’s Death     χ2(4613) =24.13,  p = <.001 
Early Life 2292 (65.8%) 216 (6.2%) 265 (7.6%) 711 (20.4%)  
Late Life  656 (58.1%) 73 (6.5%) 102 (9.0%) 298 (26.4%)  
Mother’s Death     χ2(4623) =32.09,  p = <.001 
Early Life 1778 (67.3%) 161 (6.1%) 190 (7.2%) 512 (19.4%)  
Late Life  1178 (59.4%) 133 (6.7%) 174 (8.8%) 497 (25.1%)  
Sibling Deaths      
Early Life .78 (1.07) .69 (.99) .68 (1.02) .66 (.94) F (4918)=4.2, p=<.01 
Late Life 2.09 (1.99) - 1.96 (1.92) 2.1 (2.01) F (4918)=3.2, p= .02 
Death of Spouse      
Early Life 105 (47.7%) 33 (15.0%) 36 (16.4%) 46 (20.9%) χ2(5068) =56.95,  p = <.001 
Late Life 1553 (59.7%) - 232 (8.9%) 677 (26.0%) χ2(5068) =85.89,  p = <.001 
Death of Child      
Early Life 386 (64.4%) 37 (6.2%) 60 (10.0%) 116 (19.4%) χ2(4436) =6.78,  p = .08 
Late Life 462 (60.6%) - 55 (7.2%) 212 (27.8%) χ2(4436) =22.36,  p = <.001 
Hospitalizations-Late 9.24 (7.83) - 10.81(10.06) 10.71 (9.67) F(3920)= 10.01, p=<.001 
Total Stressful Events      
Early Life 3.52 (1.28) 3.59 (1.16) 3.95 (1.64) 3.58 (1.14) F(698)= 1.62, p=.18 




Analysis of Variance (ANOVA) and chi square statistics were conducted to 
examine differences in lifetime depression status with chronic life stressors and 
covariates (See Table 3). Among chronic life stressors, the vast majority of those with 
chronic pain reported no depression symptoms; there were also significantly more 
participants who reported chronic pain and late life depression compared to chronic pain 
and chronic depression. Of the BDNF-related genes, the vast majority of participants who 
had the minor allele of rs2289656 had no depression symptoms; however, there were also 
significantly more participants who had late life depression and carried the minor allele 
of rs2289656 compared to early life or chronic depression.  There was a significant mean 
difference in the number of vascular health conditions by depression status, such that 
those with no depression symptoms reported the highest number of vascular health 
conditions; those with late life depression reported significantly more vascular health 
conditions compared to those with chronic depression (See Table 3). Of the covariates, 
there was a difference in age at study enrollment by depression status, such that those 
who reported no depression symptoms tended to be older than those with early, chronic 
or late life depression (See Table 4). There was a difference in corticosteroid use, such 
that the majority of participants without depression symptoms reported use of 
corticosteroids; among those with depression symptoms, significantly more participants 
with late life depression reported use of corticosteroids compared to early life or chronic 
depression (see Table 4). Finally, there was a significant difference in marital status by 
depression status, such that the majority of the sample without depressive symptoms were 
married. Among participants with depression, significantly more were married and 





Means, Standard Deviations, F-Tests or Chi-Square Statistics of Lifetime Depression with Chronic Stressors 
 














Early and Late 
Life Depression 









Chronic Pain Condition 1158 (76.1%) - 42 (2.8%) 165 (10.8%) χ2(5069) =282.38 ,  p = <.001 
Childhood SES 3.04 (1.25) 3.01(1.27) 3.03 (1.22) 2.93(1.22) F(3378)=1.37 p=.25 
Adulthood SES 3.03 (1.27) 2.95 (1.29) 3.01 (1.23) 2.93 (1.26) F(4082)=1.44 p=.23 
BDNF-Related Gene      
rs6265 1053 (63.6%) 116 (7.0%) 135 (8.2%) 352 (21.3%) χ2(4757) = 1.12 ,  p = .77 
rs207244 240 (60.9%) 30 (7.6%) 39 (9.9%) 85 (21.6%) χ2(4709) =3.61 ,  p = .31 
rs2289656 953 (62.1%) 94 (6.1%) 142 (9.3%) 346 (22.5%) χ2(4685) =7.91,  p = .05 
rs561644 353 (67.1%) 29 (5.5%) 39 (7.4%) 105 (20.0%) χ2(4670) =2.89,  p = .41 







Means, Standard Deviations, t-Tests or Chi-Square Statistics of Lifetime Depression with Covariates 
 














Early and Late 
Life 
Depression 








n (%)/M(SD) F-Statistic/Chi-square statistic 
Age at study enrollment 76.43 (7.51) 74.08 (6.84) 74.03 (6.91) 75.18 (6.76) F (5068)=24.75, p=<.001 
Corticosteroid Use 673 (67.2%) 87 (8.7%) 68 (6.8%) 173 (17.3%) χ2(5057) =21.89,  p = <.001 
Marital Status  2217 (66.3%) 219 (6.7%) 220 (6.7%) 637 (19.3%) χ2(5064) = 50.09,  p = <.001 







Research Question 1: Are Certain Types of Stressful Life Events, Specifically Acutely 
Stressful Events and Chronic Life Stressors, Differentially Related to Early Life Onset 
Depression and Late Life Onset Depression? 
 
Exploratory (Bivariate) Associations between Risk Factors and Depression Outcomes 
In exploratory analyses, bivariate relationships between each risk factor and 
depression status were examined using binary logistic regression for each sex. Each 
predictor was entered in a separate model.  
 
Acutely Stressful Early Life Events and Lifetime Depression Status 
Among males, death of a spouse in early life displayed a 2.95-fold increase in the 
odds of also having early life depression. Death of a spouse in early life was also 
associated with increased odds of having late life depression (See Table 5). With chronic 
depression (both early and late life onset depression), late life hospitalizations of self, 
spouse or child all displayed increased odds of having chronic depression (See Table 5). 
Those who experienced sibling death in early life displayed reduced odds of chronic 
depression (See Table 5).  
Among females, death of a spouse in early life was associated with a 3.26-fold 
increase in the odds of having early life depression, and a 2.88-fold increase in the odds 
of having chronic depression (see Table 5). Death of a sibling in early life was associated 
with reduced odds of having late life depression. No other acute stressors that occurred in 




Acutely Stressful Late Life Events and Depression Status 
Among males, several acutely stressful late life events were associated with 
significantly increased odds of late life depression. More specifically, death of a spouse 
in late life was associated with a 1.92-fold increase in the odds of having late life 
depression; as was death of a child in late life, with a 2.28-fold increase in the odds of 
late life depression (See Table 5). Further, hospitalization of self, sibling, spouse, or child 
were all associated with increased odds of having late life depression in males. The total 
number of acutely stressful life events in late life was associated with increased odds of 
late life depression only (See Table 5), whereas the total number of stressful life events in 
early life was not associated with lifetime depression status.   
Among females, death of a father, death of a spouse, self, spouse and child 
hospitalizations were all significantly associated with increased odds of having late life 
depression. Further, hospitalizations of self, spouse, or child were all associated with 
significantly increased odds of having chronic depression (See Table 5). Finally, the total 







Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, All Acutely Stressful Life Events 
for Males and Females 
 
Variable Male Sample 
OR, (95% CI) 
Female Sample 
OR, (95% CI) 














Death of Father       
Early Life .66(.39-1.14) 1.06(.83-5.13) 1.15(.76-1.74) 1.16 (.83-
1.61) 
1.00(.77-1.30) .83(.69-1.01) 
Late Life - .49(.20-1.21) .87(.58-1.31) - .99(.77-1.29) 1.20(1.00-
1.44) 
Death of Mother       
Early Life .85 (.56-1.30) .88(.54-1.44) .83(.63-1.10) .94 (.69-1.29) 1.01(.78-1.31) .87(.73-1.04) 
Late Life - 1.09(.67-1.77) 1.18(.90-1.55)  .94(.74-1.21) 1.15(.96-1.36) 
Sibling Deaths       
Early Life .96(.81-1.14) .96(.80-1.17) .99(.89-1.11) .92(.78-1.08) .93(.82-1.07) .88(.80-.96) 
Late Life - .85(.74-.98) .99(.93-1.07) - .97(.91-1.03) .99(.95-1.03) 














Death of Child       
Early Life .96(.54-1.72) 1.40(.78-2.49) 1.15(.80-1.64) 1.03(.64-1.64) 1.38(.96-1.96) .77(.58-1.03) 




Variable Male Sample 
OR, (95% CI) 
Female Sample 
OR, (95% CI) 



























Early life 1.01(.69-1.47) 1.12(.74-1.68) 1.06(.85-1.33) 1.08(.73-1.60) 1.29(.99-1.67) 1.00(.81-1.23) 









Chronic Life Stressors in Late Life Events /BDNF Genes and Depression Status 
Among males, the bivariate relationships between chronic life stressors, 
covariates and lifetime depression were examined using multinomial logistic regression 
and binary logistic regression where appropriate. Having a chronic pain condition in late 
life was associated with reduced odds of having chronic depression and late life 
depression (see Table 6). Similarly, number of vascular health conditions was also 
associated with decreased odds of having chronic depression and late life depression. 
Childhood socioeconomic status displayed no relationship with lifetime depression status, 
nor did adulthood socioeconomic status among males. Of the BDNF-related genes, only 
rs2072446 displayed a significant relationship with lifetime depression, such that those 
with at least one copy of the minor allele of rs2072446 were at 2.28-fold increased odds 
of having early life depression (see Table 6). Among the covariates, those who were 
married were at reduced odds of having chronic depression and those who were older at 
baseline were less likely to also have chronic depression or late life depression (see Table 
6). 
 Among females, having a chronic pain condition in late life was associated with 
reduced odds of having chronic depression and late life depression (see Table 6). 
Similarly, number of vascular health conditions was also associated with decreased odds 
of having chronic depression and late life depression. Having a higher childhood 
socioeconomic status and adulthood socioeconomic status were both associated with 
having reduced risk for late life depression (See Table 6). Of the BDNF-related genes, 
those with at least one copy of the minor allele of rs2289656 were associated with 1.39-




the minor allele rs561644 were associated with reduced odds of having early life 
depression (see Table 6). Among the covariates, corticosteroid use was associated with a 
1.43-fold increased odds of having early life depression, and 33% reduced odds of having 
late life depression. Being older at study enrollment was associated with reduced odds of 








Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, All Chronically Stressful Life 
Events and covariates for Males and Females 
 




















- .30 (.16-.57) .43 (.32-.59) - .24 (.16-.35) .29 (.24-.37) 
Childhood 
SES 




.99 (.85-1.16) .99 (.88-1.13) .90(.82-.98) 
Adulthood 
SES 
 1.02(.85-1.21) 1.06(.96-1.17) - 1.03(.93-1.16) .91 (.84-.98) 
BDNF-Related 
Gene 
      











rs2289656 .95(.63-1.42) 1.09(.70-1.69) 1.16(.90-1.51) .92 (.66-1.28) 1.39(1.07-
1.81) 
1.07(.89-1.29) 






























Corticosteroids 1.30(.86-1.97) .84(.49-1.41) .92(.68-1.24) 1.43 (1.03-
2.00) 
.82 (.59-1.13) .67 (.53-.85) 
Marital Status 1.64(.87-3.1) .43(.27-.69) .76(.55-1.06) 1.02(.76-1.36) 1.01(.79-1.29) .92(.78-1.09) 
Education .83(.54-1.28) 1.13(.67-1.91) .88 (.66-1.18) 1.43(.94-2.19) 1.21(.86-1.71) 1.14(.91-1.43) 
Age at study 
enrollment 
.94(.91-.97) .93(.90-.96) .98(.96-.99) .95(.93-.97) .95 (.93-.96) .97 (.95-.98) 





Fully Adjusted Logistic Regression Models for Acute Stressors in Predicting Depression 
Outcomes 
 In the next series of logistic regression models, overall model significance/fit in 
predicting depression status was determined by examination of model fit statistics, which 
included chi-square statistics, Hosmer Lemeshow goodness of fit and Nagelkerke R2. In 
the instances where the overall prediction model performed poorly (e.g., non-significant), 
results of individual predictors were still provided in the interest of exploratory 
information.   
 
Model 1: Early Life Acute Stressful Events and Early Life Depression 
Among males, the overall binary logistic regression for Model 1, which examined 
early life acute stressors with early life depression as the binary outcome variable was not 
significant, with χ2(8)=11.03,  p = .200 (see Table 7). Despite the null model, we 
examined risk factors for significant predictors and observed that the main effect of death 
of a spouse in early life remained significant even after all other covariates were entered 
into the model, such that those who experienced death of a spouse in early life were at 
2.44 greater odds of also reporting early life depression (see Table 7). No other covariates 
were associated with early life depression in this model.  
Among females, the overall binary logistic regression for Model 1, which 
examined early life acute stressors with early life depression was significant with 
χ2(8)=23.27  p = <.001 (See Table 7). The main effects of death of spouse in early life 




depression, with a 2.77-fold and 1.89-fold increase, respectively. No other covariates 
were significantly associated with early life depression among females in model 1. 
 
Model 2: Late Life Acutely Stressful Events and Late Life Depression 
Among males, the overall binary logistic regression for Model 2, which examined 
late life acute stressors with late life depression as the binary outcome, was significant 
with χ2(10)=64.37,  p = <.001. The main effects of death of a mother, death of spouse, 
death of child and days of hospitalization of self and family all displayed significantly 
increased odds (range of ORs=1.03-2.25) for also having late life depression even after 
all other covariates were entered into the model (See Table 7). Additionally, those who 
were older at baseline displayed significantly reduced odds of having late life depression. 
Death of a father, death of a sibling in late life, corticosteroid use, marital status and 
education displayed no significant relationship with late life depression in Model 2.  
Among females, the overall binary logistic regression for Model 2, which 
examined late life acute stressors with late life depression as the binary outcome, was 
significant, with χ2(10) =55.15,  p = <.001. The main effects of death of a spouse in late 
life and days of hospitalization of self and family were associated with increased odds of 
late life depression, with a 1.40-fold and 1.02-fold increase, respectively (See Table 7). 
Additionally, the main effects of corticosteroid use in late life, marital status and age at 
study enrollment were associated with reduced odds of late life depression. No other 





Model 3: Late Life Acutely Stressful Events and Chronic Depression  
Among males, overall binary logistic regression for Model 3, which examined 
late life acute stressors with chronic depression as the binary outcome, was significant 
with χ2(10)=27.52,  p = <.001. The main effect of days of hospitalization of self and 
family displayed significantly increased odds of also having chronic depression by 3% 
(See Table 7). Additionally, the main effects of marital status and age at study enrollment 
were associated with reduced odds of having chronic depression. No other covariates 
were associated with chronic depression in Model 3.  
Among females, the overall binary logistic regression for Model 3, which 
examined late life acute stressors with chronic depression as the binary outcome variable, 
was not significant with χ2(10) =11.99,  p = .15. Only the main effects of corticosteroid 
use and age at study enrollment were associated with reduced odds of having chronic 
depression. No other covariates were associated with chronic depression among females 





Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life Events and Covariates on Lifetime 
Depression in Male and Female Models 
 
















Death of Father       
Early Life .67 (.37-1.21) - - 1.14(.79-1.65) - - 
Late Life - .44(.15-1.24) .77(.47-1.25) - 1.01(.73-1.40) 1.18(.94-1.48) 
Death of 
Mother 
      
Early Life .91(.57-1.45) - - .95(.67-1.34) - - 
Late Life - 1.08(.61-1.91) 1.56 (1.13-
2.16) 
- .86(.63-1.18) 1.02(.82-1.27) 
Sibling Deaths       
Early Life .99 (.82-1.20) - - .95(.79-1.14) - - 
Late Life - .92(.78-1.09) .97 (.89-1.06) - .97(.89-1.05) 1.05(.99-1.11) 
Death of 
Spouse 










Death of Child       
Early Life .86 (.47-1.57) - - 1.16(.72-1.86) - - 
Late Life - .60(.25-1..43) 2.25(1.57-
3.23) 
































Corticosteroids 1.09(.68-1.77) .77(.42-1.44) .86(.60-1.22) 1.89(1.30-
2.73) 
.63(.43-.96) .65(.50-.86) 
Marital Status 2.33 (.99-
5.41) 
.40(.19-.83) .90(.57-1.42) 1.11(.79-1.58) .77(.55-1.08) .70(.55-.89) 
Education .86 (.53-1.40) .81(.44-1.49) .86(.60-1.22) 1.12(.69-1.80) .93(.60-1.44) 1.12(.82-1.53) 
Age at 
enrollment 
- .92(.88-.97) .97(.94-.99) - .95(.93-.98) .95(.94-.97) 
Nagelkerke R2  .02^ .06 .07 .03 .03^ .04 





Model 4: Chronic Life Stressors, BDNF-Related Genes, Covariates and Early Life 
Depression   
Among males, the overall binary logistic regression for Model 4, which examined 
chronic life stressors with early life depression as the binary outcome, was not 
significant, with χ2(7)=9.91,  p = .19 (See Table 8). Only the main effect of rs2072446 
was significant, such that those with at least one minor allele of rs2072446 were at 2.38-
fold greater odds of also having early life depression.  
Among females, the overall binary logistic regression for Model 4, which 
examined chronic life stressors with early life depression as the binary outcome, was also 
not significant, with χ2(7) =5.18, p = .64 (See Table 8). There were no significant main 
effects in Model 4 for the female sample, although the main effect of rs2072446 trended 
towards significance.  
 
Model 5: Chronic Life Stressors, BDNF-related Genes, Covariates and Late Life 
Depression 
Among males, the overall binary logistic regression for Model 5, which examined 
chronic life stressors with late life depression as the binary outcome, was significant with 
χ2(11) =107.74,  p = <.001. The main effects of late life chronic pain conditions and 
number of vascular health conditions were associated with significantly reduced odds of 
having late life depression (See Table 8). No other main effects were associated with late 
life depression among males in Model 5.  
Among females, the overall binary logistic regression for Model 5, which 




was significant, with χ2(11) =292.45,  p = <.001. The main effects of late life chronic pain 
conditions, number of vascular health conditions, were associated with significantly 
reduced odds of also having late life depression, such that those who reported chronic 
pain or a higher number of vascular health conditions tended to be less likely to also have 
late life depression (See Table 8). Further, socioeconomic status in adulthood and age at 
study enrollment were also associated with reduced odds of late life depression, such that 
those with higher socioeconomic status and those who were older at baseline were less 
likely to also have late life depression (See Table 8). 
 
Model 6: Chronic Life Stressors, BDNF-Related Genes, Covariates and Chronic 
Depression 
Among males, the overall binary logistic regression for Model 6, which examined 
chronic life stressors with chronic depression as the binary outcome, was significant with 
χ2(11)=257.64,  p = <.001. The main effects of late life chronic pain conditions and 
number of vascular health conditions were significantly associated with reduced odds of 
also having chronic depression (see Table 8). Additionally, the main effects of marital 
status, and age at study enrollment were also associated with reduced odds of depression, 
such that those who were married or older at baseline were less likely to also have 
chronic depression (See Table 8). BDNF related genes were not associated with chronic 
depression among males. 
Among females, the overall binary logistic regression for Model 6, which 
examined chronic life stressors with chronic depression as the binary outcome, was 




conditions and number of vascular health conditions were associated with reduced odds 
of having chronic depression (See table 8). Further, those who had at least one minor 
allele of rs228956 were at 1.51-fold increased odds of having chronic depression. The 
main effect of corticosteroid use was also significant, such that those who reported 







Odds Ratios (OR) and Confidence Intervals (CI) for All Chronically Stressful Life Events and Covariates on 
Lifetime Depression in Male and Female Models 
 

















Chronic Pain  
- .42(.19-.95) .52(.36-.75) - .39(.26-.66) .39(.30-.52) 
Vascular Health 
Conditions 
- .12(.06-.21) .76(.71-.81) - .14(.09-.21) .71(.66-.75) 
BDNF-Related 
Genes  
      
rs6265 .93 (.57-1.51) .98(.55-1.74) .88(.65-1.19) 1.27(.85-1.92) .85(.59-1.22) .95(.75-1.19) 
rs2072446 2.38(1.26-
4.47) 
1.34(.50-3.56) .88(.65-1.19) .32(.09-1.01) 1.30(.70-2.42) 1.13(.76-1.67) 
rs228956 .92(.56-1.50) 1.67(.94-2.97) 1.18(.88-1.59) .82(.53-1.27) 1.51(1.06-
2.15) 
.96(.77-1.21) 
rs561644 .99(.49-1.98) .91(.38-2.18) 1.01(.66-1.55) .53(.24-1.17) 1.22(.72-2.05) .87(.61-1.24) 
Socioeconomic 
Status 
      
Early Life .96(.79-1.16) - - 1.05(.89-1.24) - - 
Adulthood - 1.03(.83-1.28) 1.10(.99-1.24) - .97(.84-1.12) .89(.81-.98) 
Corticosteroids - .83(.39-1.75) 1.15(.81-1.63) - 1.65(.99-2.74) 1.01(.74-1.38) 
Marital Status 1.80(.72-4.57) .28(.14-.57) .83(.56-1.24) .75(.50-1.13) 1.03(.71-1.49) .97(.77-1.24) 
























Age at study 
enrollment 
- .91(.87-.95) .98(.96-1.00) - .98(.95-1.00) .97(.95-.98) 
Nagelkerke R2  .02^ .47 .11 .02^ .44 .21 





Research Question 2: “Are There Differences In The Polymorphisms of Specific BDNF-
Related Genes and Early and Late Onset Depression? Do These Genotypes Moderate the 
Association of Stressful Life Events with Early and Late Onset Depression?” 
 
Exploratory Analyses of BDNF-Related Genes by Stressful Life Events Interaction and 
Depression Outcomes 
In a series of exploratory analyses, bivariate binary logistic regression models 
were developed to examine any interaction effects between each BDNF-related genes and 
each stressful life event and depression outcomes.  Separate models were run for males 
and females (See Table 9). Interaction terms were computed by taking the product of a 
BDNF-related gene (e.g., rs6265 minor allele) and an acutely stressful life event (e.g., 
death of spouse in early life). A hierarchical stepwise procedure was used to enter the 
main effects of a BDNF-related gene and an acute life stressor in step 1. In step 2 the 
interaction was entered.  
 
BDNF-Related Genes by Early Life Acutely Stressful Life Events Interaction and Early 
Onset Depression 
For males, there were no significant interactions between any of the BDNF-
related genes and the acutely stressful life events that occurred in early life with early life 
depression as the binary outcome variable (See Table 9). Similar results were obtained 





Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for interactions of BDNF-
related genes by acute life stressors in early life on Early Life Depression in Male and 
Female Models. 
 




 Early Life Depression Early Life Depression 
rs2289656xFather Death Early 2.23(.34-3.67) 1.08(.51-2.27) 
rs2289656xMother Death Early .40(.16-1.00) 1.21(.61-2.40) 
rs2289656xSibling Death Early .83(.56-1.24) 1.10(.78-1.55) 
rs2289656xSpouse Death Early .00(.0-.00) 1.24(.46-3.37) 
rs2289656xChild Death Early .38(.08-1.88) 1.34(.49-3.66) 
rs56164415xFather Death Early 1.02(.19-5.42) .70(.20-2.37) 
rs56164415xMother Death Early .57(.16-1.98) 1.21(.36-4.02) 
rs56164415xSibling Death Early 1.34(.88-2.04) 1.00(.53-1.90) 
rs56164415xSpouse Death Early 1.69(.27-10.75) .57(.07-5.00) 
rs56164415xChild Death Early .62(.07-5.47) 2.27(.53-9.85) 
rs6265xFather Death Early 2.63(.76-9.07) 1.08(.54-2.18) 
rs6265xMother Death Early 1.02(.42-2.46) .72(.37-1.37) 
rs6265xSibling Death Early 1.04(.74-1.47) 1.23(.88-1.71) 
rs6265xSpouse Death Early .76(.16-3.70) 1.92(.74-4.98) 
rs6265xChild Death Early .93(.28-3.12) 1.30(.49-3.47) 
rs2072446xFather Death Early 1.31(.24-7.05) .82(.19-3.54) 
rs2072446xMother Death Early .62(.20-1.94) 1.73(.43-6.89) 
rs2072446xSibling Death Early .65(.34-1.23) .62(.21-1.83) 
rs2072446xSpouse Death Early .42(.04-4.21) .53(.06-4.74) 
rs2072446xChild Death Early 1.91(.47-7.70) 2.78(.28-27.86) 






BDNF Genes by Acutely Stressful Events in Late life Interaction and Chronic/Late Life 
Depression 
For males, the interaction of rs2076446 by father’s death in late life was 
significant, such that those who had at least one copy of the minor allele of rs2072446 
and who experienced the death of their father in late life were at 1.67-fold increased odds 
for having chronic depression (See Table 10). Additionally, the interaction between 
rs6265 and death of a child in late life was significant, such that those who had at least 
one copy of the minor allele of rs6265 and who experienced the death of a child in late 
life were at significantly reduced odds of having late life depression (See Table 10).  
Among females, several significant interactions were observed (See table 10). 
More specifically, those with at least one minor allele of rs228965 and who experienced 
death of sibling in late life was associated with a 1.11-fold increased odds of also having 
late life depression. Further, those with at least one minor allele of rs6265 and who 
experienced mother’s death in late life were associated with significantly reduced odds of 
also having late life depression. Interactions were also observed among females with 
chronic depression as the binary outcome. In particular, those who had at least one minor 
allele of rs2289656 and who experienced mother’s death in late life had a 1.72-fold 
increase in the odds of having chronic depression compared to those who had neither risk 
factor. Further, the those with at least one minor allele of rs56164415 and had 
experienced father’s death in late life had a 2.45-fold increase in the odds of having 
chronic depression (see Table 10). The interactions between BDNF-related genes and 
each of chronic pain conditions, socioeconomic status and number of vascular health 






Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Interactions of BDNF-related Genes by Acute 
Life Stressors in Late Life on Late Life Depression and Chronic Depression in Male and Female Models. 
 












rs2289656xFather Death Late 1.22(.19-7.96) .84(.34-2.08 .91(.52-1.57) 1.27(.86-1.88) 
rs2289656xMother Death Late 1.07(.38-3.00) 1.33(.74-2.39) 1.72(1.01-2.93) .90(.62-1.32) 
rs2289656xSibling Death Late 1.10(.83-1.45) .99(.86-1.14) .91(.80-1.04) 1.11(1.01-1.21) 
rs2289656xSpouse Death Late .74(.28-1.92) .90(.53-.154) .87(.50-1.49) 1.43(.97-2.13) 
rs2289656xChild Death Late .56(.11-3.01) 1.91(.95-3.83) .99(.49-2.02) 1.11(.70-1.80) 
rs2289656xHospitalizations 1.04(.98-1.09) .98(.95-1.01) 1.00(.97-1.04) .99(.97-1.02) 
rs2289656xChronic Pain 1.17(.30-4.56) 1.14(.59-2.22) 2.01(.93-4.36) 1.24(.77-1.99) 
rs2289656xvascular health conditions 2.32(.90-6.02) 1.02(.89-1.16) .66(.30-1.44) 1.03(.93-1.14) 
rs2289656xSocioeconomic status 1.22(.84-1.77) .95).77-1.18) .95(.75-1.20) .94(.80-1.12) 
rs56164415xFather Death Late .00(.00-.00) 1.29(.38-4.40) 2.45(1.07-5.60) .91(.49-1.67) 
rs56164415xMother Death Late .00(.00-.00) 1.24(.52-2.96) 1.09(.48-2.49) 1.34(.73-2.44) 
rs56164415xSibling Death Late 1.26(.84-1.91) 1.08(.86-1.35) 1.03(.84-1.25) .97(.84-1.12) 
rs56164415xSpouse Death Late 1.11(.25-4.93) .76(.34-1.68) 1.14(.46-2.79) .61(.33-1.12) 
rs56164415xChild Death Late .00(.00-.00) 1.07(.41-2.77) .48(.13-1.72) 1.51(.74-3.09) 
rs56164415xHospitalizations .96(.86-1.07) 1.01(.96-1.06) .99(.95-1.03) 1.02(.99-1.05) 
rs56164415xChronic Pain .80(.09-7.31) 1.27(.51-3.16) 1.93(.70-5.37) 1.01(.49-2.07) 
rs56164415xvascular health 
conditions 
1.06(.26-4.31) 1.06(.88-1.27) 1.18(.39-3.53) .93(.79-1.10) 
















rs6265xFather Death Late 2.76(.42-18.01) .87(.362.13) .73(.41-1.28) .81(.55-1.20) 
rs6265xMother Death Late 1.13(.41-3.11) .95(.52-1.74) .67(.39-1.14) .56(.39-.82) 
rs6265xSibling Death Late .99(.75-1.32) .89(.77-1.04) .98(.87-1.12) 1.07(.98-1.17) 
rs6265xSpouse Death Late .70(.27-1.80) .58(.34-1.00) 1.01(.57-1.74) .89(.61-1.30) 
rs6265xChild Death Late .50(.09-2.64) .43(.20-.91) 1.13(.56-2.28) 1.09(.69-1.75) 
rs6265xHospitalizations .98(.93-1.03) 1.01(.97-1.04) .99(.96-1.02) 1.00(.98-1.02) 
rs6265xChronic Pain 1.33(.34-5.17) .71(.34-1.45) 2.16(.99-4.68) .92(.58-1.47) 
rs6265xvascular health conditions 1.03(.40-2.66) .98(.85-1.11) 1.22(.66-2.48) .97(.87-1.07) 
rs6265xSocioeconomic status 1.19(.82-1.74) .99(.80-1.23) .91(.71-1.16) .99(.84-1.16) 
rs2072446xFather Death Late 1.67(1.36-8.36) 1.01(.200-5.13) .66(.25-1.73) 1.69(.86-3.32) 
rs2072446xMother Death Late 1.33(.28-6.34) .76(.27-2.20) 2.18(.88-5.44) 1.13(.58-2.20) 
rs2072446xSibling Death Late 1.34(.88-2.07) .92(.67-1.27) 1.00(.80-1.26) .87(.72-1.04) 
rs2072446xSpouse Death Late 2.33(.55-9.85) 1.58(.61-4.05) .78(.34-1.83) .94(.48-1.81) 
rs2072446xChild Death Late .00(.00-.00) 1.14(.31-4.22) .63(.17-2.34) 1.17(.52-2.62) 
rs2072446xHospitalizations .81(.63-1.04) .99(.94-1.05) 1.02(.98-1.06) .99(.96-1.03) 
rs2072446xChronic Pain .00(.00-.00) .61(.16-2.26) 1.22(.38-3.92) .95(.43-2.14) 
rs2072446xvascular health conditions 1.77(.54-5.86) 1.22(1.00-1.48) .00(.00-.00) 1.01(.85-1.19) 
rs2072446xSocioeconomic status 1.07(.58-1.98) 1.16(.78-1.73) .95(.63-1.44) 1.19(.89-1.58) 






Fully Adjusted Logistic Regression Models for Acutely Stressful Life Events with 
Significant Interactions with BDNF-related Genes in Predicting Depression Outcomes 
In the next series of logistic regression models, significant bivariate interactions 
between BDNF-related genes and acutely stressful life events were added to the model of 
acutely stressful life events and covariates. A hierarchical stepwise procedure was used to 
enter the main effects of each BDNF-related single nucleotide polymorphism (snp) and 
the acutely stressful life event in step 1. In step 2 the interaction was entered. Overall 
model significance/fit in predicting depression status was determined by examination of 
model fit statistics, which included chi-square statistics, Hosmer Lemeshow goodness of 
fit and Nagelkerke R2 and change in R2 (in Step 2 of the analysis). 
 
Interaction of rs6265 by Child Death in Late Life and Late Life Depression in Males 
 The overall adjusted regression model of acutely stressful life events, BDNF gene 
rs6265, rs6265xChild Death in late life and covariates with late life depression was 
significant, with χ2 (12)= 62.01, p=.001. There were main effects observed for death of 
mother in late life, death of spouse in late life, death of child in late life and total 
hospitalized days of self and immediate family in late life, with positive associations to 
late life depression (odds ratios ranging from 1.03-2.54; See Table 11). The interaction of 
rs6265 by child death in late life was not significant after accounting for the effects of 






Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene Rs6265, Interaction and Covariates on Late 
Life Depression in Male Sample 
 
Variable Male Sample 
Late Life Depression 
OR, CI 
Death of Father-Late .74(.45-1.22) 
Death of Mother-Late 1.59(1.14-2.23) 
Sibling Deaths-Late .98(.90-1.08) 
Death of Spouse-Late 2.12(1.51-2.96) 
Death of Child-Late 2.54(1.65-3.91) 
Hospitalizations-Late 1.03(1.01-1.04) 
BDNF Gene rs6265 .93(.65-1.33) 
Corticosteroids .88(.61-1.26) 
Age at study enrollment .97(.94-.99) 
Marital Status .96(.60-1.55) 
Education .95(.65-1.37) 
rs6265 x Child Death-Late .58(.24-1.39) 
Nagelkerke R2 =.07 
Model χ2 (12)= 62.01, p=,.001 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 




Interaction of rs2072446 by Father Death in Late Life and Chronic Depression in Males 
 The overall adjusted regression model of acutely stressful life events, rs2072446, 
rs2072446 x father death in late life and covariates with chronic depression was 
significant, with χ2 (12)= 29.86, p=.003. Main effects were observed for age at study 
enrollment, such that those with higher ages at study enrollment had reduced odds of 
chronic depression The interaction of rs2072446 by father death in late life was 
significant after accounting for the effects of other covariates (See Table 12), such that 
those with at least one minor allele of rs2072446 and who had experienced father death 






Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene rs2072446, Interaction and Covariates on 
Chronic Depression in Male Sample 
 
Variable Male Sample 
Chronic Depression 
OR, CI 
Death of Father-Late .24(.06-1.01) 
Death of Mother-Late 1.09(.60-1.96) 
Sibling Deaths-Late .93(.79-1.10) 
Death of Spouse-Late 1.41(.79-1.10) 




Age at study enrollment .92(.88-.97) 
Marital Status .50(.24-1.05) 
Education .88(.47-1.65) 
rs2072446 x Father Death-
Late 
10.65(1.03-110.14) 
Nagelkerke R2 =.07 
Model χ2 (12)= 29.86, p=.003 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 




Interaction of rs2289656 by Mother Death in Late Life and Chronic Depression in 
Females 
 The overall adjusted regression model of acutely stressful life events, BDNF gene 
rs2289656, rs2289656 x mother death in late life and covariates with chronic life 
depression was significant, with χ2 (12)= 28.42, p=.005. There were main effects 
observed for corticosteroid use and age at study enrollment, with negative associations 
with late life depression (See Table 13). The interaction of rs2289656 with mother’s 
death in late life was not significant after accounting for the effects of other covariates 






Table 13  
Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene rs2289656, Interaction and Covariates on 
Chronic Depression in Female Sample 
 
Variable Female Sample 
Chronic Depression 
OR, CI 
Death of Father-Late 1.04(.7501.45) 
Death of Mother-Late .72(.48-1.09) 
Sibling Deaths-Late .98(.90-1.06) 
Death of Spouse-Late 1.25(.86-1.84) 
Death of Child-Late .80(.53-1.20) 
Hospitalizations-Late 1.01(.99-1.03) 
BDNF Gene rs2289656 1.02(.63-1.65) 
Corticosteroids .65(.43-.98) 
Age at study enrollment .96(.93-.98) 
Marital Status .74(.52-1.04) 
Education .93(.59-1.47) 
rs2289656 x Mother Death-
Late 
1.70(.90-3.21) 
Nagelkerke R2 =.03 
Model χ2 (12)= 28.42, p=.005 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 





Interaction of rs2289656 by sibling Death in Late Life and Late Life Depression in 
Females 
 The overall adjusted regression model of acutely stressful life events, rs2289656, 
rs2289656 x sibling death in late life and covariates with late life depression was 
significant, with Model χ2 (12)= 60.37, p=<.001. There were main effects observed for 
death of spouse in late life (OR=1.48), hospitalizations of self and family (OR=1.02) and 
marital status (.72) (See Table 14). The interaction of rs2289656 by sibling death in late 
life was significant after accounting for the effects of other covariates (See Table 14). 
More specifically, those with at least one copy of the minor allele of rs2289656 and who 
had also experienced a higher number of sibling deaths in late life were at 12% greater 







Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene rs2289656, Interaction and Covariates on Late 
Life Depression in Female Sample 
 
Variable Female Sample 
Late Life Depression 
OR, CI 
Death of Father-Late 1.15(.91-1.46) 
Death of Mother-Late 1.01(.80-1.27) 
Sibling Deaths-Late 1.00(.93-1.08) 
Death of Spouse-Late 1.48(1.13-1.95) 




Age at study enrollment .95(.93-.97) 
Marital Status .72(.56-.92) 
Education 1.14(.82-1.58) 
rs2289656 x Sibling Death 1.12(1.00-1.25) 
Nagelkerke R2 =.05 
Model χ2 (12)= 60.37, p=<.001 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 






Interaction of rs56164415 by Father Death in Late Life and Chronic Depression in 
Females 
 The overall adjusted regression model of acutely stressful life events, rs56164415, 
rs56164415 by father death in late life and covariates with chronic life depression was 
significant, with χ2 (12)= 27.83, p=.006. There were main effects observed for 
corticosteroid use and age at study enrollment, with inverse associations with late life 
depression (See Table 15). The interaction of rs56164415 by father death in late life was 






Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene Rs56164415, Interaction and Covariates on 
Chronic Depression in Female Sample 
 
Variable Female Sample 
Chronic Depression 
OR, CI 
Death of Father-Late .86(.60-1.23) 
Death of Mother-Late .89(.64-1.23) 
Sibling Deaths-Late .97(.89-1.05) 
Death of Spouse-Late 1.27(.87-1.85) 
Death of Child-Late .80(.53-1.20) 
Hospitalizations-Late 1.01(.99-1.03) 
BDNF Gene rs56164415 .75(.39-1.44) 
Corticosteroids .63(42-.95) 
Age at study enrollment .95(.93-.98) 
Marital Status .74(.53-1.05) 
Education .92(.58-1.46) 
rs561644156 x Father Death-
Late 
2.41(.94-6.19) 
Nagelkerke R2 =.03 
Model χ2 (12)= 27.83, p=.006 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 




Interaction of rs6265 by Mother Death in Late Life and Late Life Depression in Females 
 The overall adjusted regression model of acutely stressful life events, rs6265, 
rs6265 x mother death in late life and covariates with late life depression was significant, 
with χ2 (12)= 55.40, p=<.001. There were main effects observed for death of spouse in 
late life (OR=1.45), hospitalizations of self and family (OR=1.02), corticosteroid use 
(OR=.67), age at study enrollment (OR=.95) and marital status (.70) (See Table 16). The 
interaction of rs6265 by mother death in late life was significant after accounting for the 
effects of other covariates (See Table 16). More specifically, those with at least one copy 
of the minor allele of rs6265 and who experienced mother death in late life were at 







Odds Ratios (OR) and Confidence Intervals (CI) for All Acutely Stressful Life 
Events in Late Life, BDNF Gene Rs6265, Interaction and Covariates on Late 
Life Depression in Female Sample 
 
Variable Female Sample 
Late Life Depression 
OR, CI 
Death of Father-Late 1.15(.91-1.45) 
Death of Mother-Late 1.21(.91-1.61) 
Sibling Deaths-Late 1.04(.98-1.10) 
Death of Spouse-Late 1.45(1.11-1.90) 
Death of Child-Late 1.19(.91-1.55) 
Hospitalizations-Late 1.02(1.01-1.03) 
BDNF Gene rs6265 1.32(.94-1.84) 
Corticosteroids .67(.51-.89) 
Age at study enrollment .95(.93-.97) 
Marital Status .70(.55-.90) 
Education 1.11(.81—1.54) 
rs6265 x Mother Death-Late .62(.40-.98) 
Nagelkerke R2 =.05 
Model χ2 (12)= 55.40, p=<.001 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in 






Tabular Summary of Results  
In summary, a number of risk factors were differentially associated with risk of 
depression across the lifespan for males and females. Table 17 provides a summary of the 








Overall Summary of Risk Factors for Lifetime Depression for Females and Males  
 
 Males Female 
Acute Life Stressors   
Death of Mother ↑ LLD 56% (OR=1.56)  
Death of Father    
Death of Spouse ↑ EOD 144% (OR=2.44) 
↑ LLD 118% (OR=2.18) 
↑ EOD 177% (OR=2.77) 
↑ LLD 40%% (OR=1.40) 
Death of Offspring ↑ LLD 125% (OR=2.25)  
Hospitalized Days of Self and 
Family 
↑ CD 3% (OR=1.03) 
↑ LLD 3% (OR=1.03) 
↑ LLD 2% (OR=1.02) 
Chronic Life Stressors   
Chronic Pain conditions ↓ CD 58% (OR=.42) 
↓ LLD 48% (OR=.52) 
↓ CD 61% (OR=.39) 
↓ LLD 61% (OR=.39) 
Vascular Health conditions ↓ CD 88% (OR=.12) 
↓ LLD 24% (OR=.76) 
↓ CD 86% (OR=.14) 
↓ LLD 29% (OR=.71) 
Socioeconomic Status  ↓ LLD 11% (OR=.89) 
Rs6265   
Rs2289656  ↑ CD 51% (OR=1.51) 
Rs2072446 ↑ EOD 138% (OR=2.38)  
Rs56164415   
Covariates   
Age at baseline of study enrollment ↓ CD 8% (OR=.92) 
 ↓ LLD 03% (OR=.97) 
↓ CD 5% (OR=.95) 
↓ LLD 5% (OR=.95 
High school education   
Marital Status ↓ CD 60% (OR=.40) ↓ LLD 30% (OR=.70) 
Corticosteroid use  ↑ EOD 89% (OR=1.89) 
↑ CD 65% (OR=1.65) 
↓ LLD 35% (OR=.65) 
Note.  ↓=decrease in odds; ↑= increase in odds; EOD= Early Life Onset Depression; CD= 
Chronic Depression; LLD=Late Life Onset Depression; OR=Odds Ratio. 







 The goal of the present study was to examine biological factors, stressful life 
events and conditions that impact risk for depression across the lifespan. With respect to 
biological factors, we further sought to understand if the associations of stressful life 
events were altered by the presence of minor alleles of BDNF-related genes. The present 
study utilized a population-based sample of 5069 older individuals who participated in 
the Cache County Study on Memory in Aging (CCSMA) including examining 
participants’ Medicare claims data from the Utah Population Database to empirically test 
our hypotheses. In the study sample, rates of lifetime depression were comparable to the 
prevalence rates in the United States, with the overall presence of lifetime depression 
being approximately 21% (Djernes, 2006; Gatz et al., 1993; ; National Institute on Aging, 
2007; NIMH, 2018). Findings from the present study revealed that several acutely 
stressful life events were associated with increased odds of depression onset in early life, 
late life and a chronic presentation (early and late life depression). Further, there were sex 
differences observed that suggested certain life events were differentially related to the 
odds of having depression among males and females; these key results are summarized in 
Table 17. 
 In the present study, we conceptualized acutely stressful life events as events that 
occur infrequently, but which cause a great deal of stress on an individual, such as death 
of a family member or friend. Acutely stressful life events that were examined in the 
present study included death of mother, death of father, number of deaths of siblings, 




self and of immediate family members (sibling, spouse and child) as a single variable. 
Chronic life stressors were conditions or events that occurred with greater frequency and 
which contributed to a consistent but less intense state of distress, such as daily pain or 
health conditions. Chronic life stressors included in the analyses were chronic pain 
conditions, the number of vascular health conditions, childhood socioeconomic status, 
and adulthood socioeconomic status. BDNF- related genes were also included among 
chronic “life stressors,” as they represented a genetic vulnerability factor.  
Several acutely stressful life events and chronic life stressors that occurred in 
early life showed associations with early life depression in both the males and females. 
However, the overall model of early life acute stressors on early life depression was not 
significant in males, likely due to sparseness of data. For example, there were only 126 
males who reported early life depression and of those 126, only 14 experienced death of a 
child in early life. Thus, we likely did not have enough statistical power to detect the 
hypothesized relationships. Overall, the model of acute stressors in early life was a poor 
fit for predicting early life depression among males. Nonetheless, in examining the 
associations of this model of males, death of a spouse in early life was associated with 
increased odds of early life depression. These results were consistent with results in 
females, suggesting that death of a spouse in early life may be a useful predictor for early 
life depression. However, given the limitations of the male model sample size these 
results should be interpreted with caution. Another observed difference was that in 
females only, corticosteroid use was associated with increased odds of early life 
depression. Of the chronic life stressors utilized to predict early life depression in males 




with early onset depression, however the overall model failed to reach significance, again 
indicating that the sparseness of males with early life depression and chronic stressors 
may have resulted in limited statistical power. There were no significant chronic life 
stressors that were associated with early life depression in females.  
Extant research has identified several risk factors for early life depression that are 
consistent with our findings. More specifically, a meta-analysis of 26 studies examining 
depression in early adulthood observed that death of a parent or immediate family 
member was associated with greater likelihood of depression in early life (See review, 
Keller et al., 2007; Kessler & Magee, 1993; Mandelli et al., 2015; Riso et al., 2002;). Our 
results were also consistent with another study that found males and females tended to be 
more likely to report higher overall depression symptoms following the death of a spouse 
in early-to-mid adulthood (Sasson & Umberson, 2014). Additionally, another study found 
that death of a spouse in adulthood was reliably associated with chronic depression 
symptoms (Keller, Neale & Kendler, 2007). These findings may suggest that our 
analyses, though underpowered among males, were reliable in detecting death of a spouse 
in early life as an established risk factor for depression in early life. Other studies have 
linked additional stressful life events, such as abuse in childhood or adulthood (See 
review, Mandelli et al., 2015) and witnessing or being victimized by domestic violence 
(Kessler & Magee, 1993) to the onset of depression in early life; unfortunately these data 
were not available for our cohort. One novel aspect of the present study is that we were 
able in our (single) sample to separately model early/late life cutoffs of depression for 
males and females. Indeed, among studies examining acutely stressful life events, only 




males and females following a stressful life event. Taken together, our results are 
consistent with the literature on early life depression, suggesting that death of a spouse is 
an important event that reliably increases risk for depression, however our analyses were 
likely underpowered to detect associations of other acutely stressful life events with early 
life depression.   
 Several chronic life stressors and acutely stressful late life events displayed 
significant associations with lifetime depression in both males and females. Among 
males, those who lost their mother in late life, those who lost a child in late life and those 
who experienced a higher number of hospitalizations in late life were associated with 
having increased odds of late life depression, whereas those who were older at baseline 
displayed reduced odds of having late life depression. Similar associations of acutely 
stressful life events in late life emerged in females, though there were some observed 
differences. For example, death of a spouse and total days of hospitalization were 
associated with increased odds of depression in late life for females, however 
corticosteroid use, marital status and age were also associated with reduced odds of 
having late life depression.  
Several chronic life stressors were also associated with late life depression status 
in both males and females. In late life, chronic pain conditions and number of vascular 
health conditions were each associated with reduced odds of having late life depression 
in both males and females. Socioeconomic status in adulthood and age were each 
associated with decreased odds of late life depression among females, such that those 
with higher socioeconomic status or who were older at baseline were associated with 




previously established work examining chronic life stressors and depression in late life, 
though the results of several studies are inconclusive. More specifically, chronic pain has 
shown mixed associations with depression in late life, such that some studies have 
observed robust associations with chronic pain increasing or intensifying depressive 
symptoms in late life (Jeuring et al., 2018; Ohayon & Shatzberg, 2003). Still others have 
observed that chronic pain often co-occurs with depression in late life, making it difficult 
to parse whether symptoms of depression are attributed to chronic pain or are attributed 
to clinical depression (Gagliese & Melzack, 2003; Meeks et al., 2007). Our findings of 
vascular health conditions being associated with reduced odds of depression in late life 
were inconsistent with established work. For example, Valkanova & Ebmeier (2013) 
found that diabetes, cardiovascular disease and stroke were each associated with higher 
rates of depression in late life. Other studies have also observed a positive relationship 
between vascular health/conditions and late life depression as well (see review, Sheline et 
al., 2010; Taylor et al., 2013;). There are also certain medications used to treat 
cardiovascular conditions (i.e., beta blockers) that are associated with increased risk of 
depression as a side effect (Zimmerman, 1993). As our study relied primarily on self-
report data for determining the presence or absence of depression, it is possible that 
participants who experienced depression as a side effect of medication attributed 
symptoms of depression to the medication and did not separately endorse them as 
indicative of depression.  Taken together, the negative association of chronic pain and 
depression is consistent with mixed findings reported in extant studies, however the 
negative association with vascular health conditions and depression is inconsistent with 




retrospective reports to identify the onset of vascular health conditions such that the co-
occurrence of vascular health and late life depression was represented rather than 
vascular conditions antecedent to depression.  This may have been an issue with vascular 
conditions obtained from Medicare claims data or chronic conditions for which onset 
ages were less reliably obtained. 
There were also significant associations between acutely/chronically stressful life 
events in late life with chronic depression in both males and females. Indeed, those with a 
chronic pain condition in late life and those with more vascular health conditions showed 
reduced odds of having late life or chronic depression in both males and females. With 
respect to a genetic vulnerability factor, females with at least one minor allele of 
rs228956 (BDNF receptor trkB) were at significantly higher odds of having chronic 
depression. These results were inconsistent with previous research that has linked some 
BDNF- related genes to depression (Hwang et al., 2006; Taylor et al., 2007). More 
specifically, the presence of the minor allele rs6265 (BDNF Val66Met) has research 
support for increasing risk for depression, particularly in males (Hwang et al., 2006; 
Taylor et al., 2007). However, in our sample we did not observe a relationship between 
rs6265 (BDNF Val66Met) and depression status for males; in females, there was an 
interaction with stressful life events, but presence of the minor allele and stressful event 
was associated with a reduction in risk (see discussion below).  Further, corticosteroids 
were associated with increased odds of chronic depression among females but displayed 
no significant relationships with chronic depression in males. Although there is evidence 
that corticosteroids reduce serotonin levels that can increase risk for depression 




relationship between corticosteroids and depression in the context of stressful life events. 
Thus, our findings regarding the associations of corticosteroids and lifetime depression 
among males and females may be relatively novel. In particular, we observed a positive 
association between corticosteroid use and early life depression in the statistical models 
in females with acute life stressors, which was reversed when chronic depression and late 
life depression were the outcome variables. One possible explanation is the low 
frequency of women using corticosteroids in early life (n=54 women with early life 
depression and corticosteroid use), relative to late life depression (n=110). Given these 
limitations, these associations should be interpreted with caution, until replication with 
larger samples can be done.  
The findings of acutely stressful life events as risk factors for depression suggest 
that certain life events, such as death of a spouse and hospitalizations of self/family are 
relatively robust predictors of depression status. Indeed, it appears that in both males and 
females, the odds of also having depression increase significantly following the death of a 
spouse, whether that occurs in early or late life, which is consistent with previously 
established research (Keller et al., 2007; Sasson & Umberson, 2014). 
Further, although data on hospitalizations of self/family was not available in early 
life, hospitalizations of self/family remained a significant predictor of depression status in 
late life for both males and females even after other covariates were added into statistical 
models. These results are consistent with extant research on bereavement following the 
loss of a romantic partner and in depression research, which has shown robust 
associations with depression following the loss of loved ones or threats to the health of 




Interestingly, there was a difference observed between males and females such that loss 
of a child in late life and death of a mother in late life was associated with increased 
depression in males but not females. These results may reflect a gender difference in 
coping with loss, particularly in late life. Indeed, extant research on coping mechanisms 
following grief has shown that males more often cope with grief and depression, with 
increased physical activity and heavier drinking (Angst et al., 2002; Bonanno et al., 2002; 
Meléndez et al., 2018), which in turn may exacerbate symptoms of depression (Avasthi & 
Grover, 2018). 
 Our results of acutely stressful life events and depression were consistent with 
other findings in extant literature that have observed deleterious effects of stressful life 
events in increasing risk for depression (Keller et al., 2007; Mandelli et al., 2015). 
Further, our results underscore the need for examination of sex differences in considering 
risk factors for depression. Our results may also suggest that acute stressors in late life are 
just as detrimental, if not more so than acute stressors in early life. As such, clinicians 
may benefit from screening older adults for acutely stressful life events to better 
understand risk and onset for depression. Further, family members and clinicians should 
also strive to promote access to coping skills for building resilience to acutely and 
chronically stressful life events for individuals in late life. 
 The present study also examined the interactive effects of BDNF-related genes 
and stressful life events, although the interpretation and generalizability of our findings 
may be limited by sparseness and low statistical power. As noted above, the bivariate 
associations of -related genes (presence of minor alleles) BDNF genotypes were less 




present study, two main effects for BDNF-related genes were observed these were 
inconsistent with extant research. For example, extant research has primarily focused on 
one gene type: rs6265 (BDNF Val66Met) and its associations with increasing depression 
risk (Hwang et al., 2006; Taylor et al. 2007). However, in our study we did not observe 
associations between the minor allele of BDNF Val66Met and depression in either males 
or females. In the present study, among males, the minor allele of rs2072446 
(Neurotrophic growth factor/ BDNF receptor p75NTR ) was associated with increased 
odds of early life depression in the adjusted model with chronic life stressors. Further, the 
minor allele of BDNF gene rs228956 (BDNF receptor trkB ) was associated with 
increased odds of chronic depression in females. These findings are novel, considering 
that extant research has primarily focused on the BDNF gene Val66Met as a vulnerability 
factor for depression, and no work to this point has examined other genes related to 
signaling BDNF genotypes in conjunction with stressful life events.  
Another novel finding of the present study was the observation of significant 
interaction effects for BDNF-related genes by specific acutely stressful life events. At the 
bivariate level we observed six significant interactions, which were then examined in 
adjusted models with the main effects of acutely stressful life events in late life and 
covariates. Of the six significant interactions, three remained significant after accounting 
for the effects of other predictors. To the author’s knowledge, this is the first study to 
examine the interactive effects of these neurotrophin genes by acutely stressful life events 
in predicting lifetime depression.  
Our findings offer some preliminary evidence that the impact of certain life 




of a mother in late life, may vary based upon genetic factors. Indeed, in the fully adjusted 
model for acutely stressful events in late life among males, we observed risk for chronic 
depression increased when participants had the minor allele of rs2072446 (Neurotrophic 
growth factor/ BDNF receptor p75NTR) and who had also experienced their father’s death 
in late life. In the female sample, the presence of the minor allele of rs2289656 ((BDNF 
receptor trkB ) and experiencing sibling death in late life increased risk for late life 
depression in the fully adjusted model. There was also a significant interaction for rs6265 
(BDNF Val66Met) and death of mother in late life among females, such that those with 
the minor allele of rs6265 who had experienced mother death in late life displayed 
reduced risk for chronic depression. These results offer support for our hypotheses that 
BDNF-related genes may moderate the associations of stressful life events and 
depression, however given the low sample sizes and likely low statistical power, these 
results should be interpreted with caution. Future work examining the above associations 
in other samples is warranted. Additionally, the use of antidepressants have been shown 
to alter BDNF levels (Baj et al., 2012). It is unknown how the use of antidepressants (or 
other factors that influence BDNF levels) may interact with BDNF-related genes in 
modifying risk for depression.  
 
Implications of the Present Study 
The present study highlights the multi-faceted and complex nature of risk factors 
for depression and offers important findings for both clinicians and researchers. We 
examined the impact of biological and psychosocial risk factors for depression in early 




reflect the complex and inter-dependent nature of risk factors for depression; we observed 
direct associations between acutely stressful life events and lifetime depression, as well 
as biological vulnerability factors (i.e., BDNF-related genes) that displayed both direct 
associations and interactive effects with specific stressful events. We also found that the 
presence of a health condition (i.e., chronic pain), resulted in lower odds of depression, 
which may relate to co-occurrence of depression and the health condition and a possible 
tendency to attribute the symptoms of depression solely to the health condition. Indeed, 
the present study took a comprehensive approach to empirically examining risk for 
depression, such that multiple classes of risk factors were examined in conjunction with 
one another and further examined sex differences. The present study also utilized a novel 
approach to determining the early life and late life cutoff for depression in males and 
females, such that age of menopause was used to determine early life/late life in women. 
This approach reflected the biological changes associated with menopause that can 
impact risk for depression and allowed for a biologically based, rather than an arbitrary, 
age cut off for early and late life depression. 
Taken together these results have important implications for both clinicians and 
researchers. In particular, acutely stressful life events in both early and life appear to 
increase risk for depression in the time following the occurrence of the risk factor. These 
associations varied slightly by sex, but in particular the death of a spouse and death of a 
child appear to be events that reliably increase risk for developing depression in both 
males and females. Among chronically stressful life events, chronic pain conditions and 
vascular health both surprisingly displayed an inverse relationship with depression status, 




occurring risk factors, such that the overlap of deleterious functioning associated with 
these conditions might mask or create difficulties with assessing these conditions as risk 
factors for depression. For example, given the detrimental impact of both chronic pain 
and vascular health on behavior and mood, it may have been difficult for subjects and 
their health providers to accurately parse apart the behavioral sequalae that are only 
associated with depression (Gagliese & Melzack, 2003; Rethelyo et al., 2001). Further, 
given the increased mortality rates associated with depression, vascular health conditions 
and chronic pain conditions, it is also possible a portion of our sample who experienced 
these co-occurring risk factors died prior to assessment at the relative wave where 
depression was reassessed. In particular, with follow-ups every three to four years, it is 
possible that interim episodes of depression were missed. However, in examining mean 
age at death for males and females who remained free of dementia, mean ages for both 
were approximately five or more years greater than the mean age of dementia onset 
(which was the indicator for end of surveillance of depression; data not shown). Thus, 
there was no evidence of earlier mortality at least with respect to the end of surveillance 
for depression. Finally, this study also examined risk factors in separate models for males 
and females and observed some differences. Given that rates of depression among 
females are considerably higher than those in males, our results may underscore the need 
for careful attention to sex-based risk factors.  
 
Study Strengths, Limitations and Directions for Future Research 
 The present study has a number of strengths. First, the CCSMA was a large, 




generalizability to similar communities is likely to be greater than studies that rely on 
samples enrolled at medical centers or at academic universities. Further, the study 
followed participants for up to 12 years and benefitted from multiple visits to gather data 
and update risk factors. This rich dataset was further augmented with Medicare claims 
and death certificate data via linkage to study participant’s records in the Utah Population 
Database. This linkage provided greater follow-up of participant data beyond the end of 
the study for key variables of depression in late life and vascular health conditions.  
 Another study strength was the utilization of a bio-psycho-social 
conceptualization of risk factors to better empirically examine risk factors for depression 
across the lifespan. Our broad inclusion of risk factors that included genetics, physical 
health, stressful life events and established covariates allowed for an empirical model that 
matches the complex nature of risk factors that impact depression throughout life. 
Further, we utilized a novel approach to determining early and late life depression, that 
was based on both extant literature (for males) and biological changes (for females), 
which allowed for a potentially more meaningful determination of early and late life than 
that has been utilized in much of prior research. Finally, our determination of depression 
symptoms was comprised of a multi-faceted method, in which we utilized self-report 
data, medication data, and examination of Medicare claims records to determine an 
accurate diagnosis of depression across the lifespan. This approach offers a more robust 
determination of retrospective depression symptomology than other extant literature has 
utilized in examining history of depression onset (Bennett & Thomas, 2014; Jeuring et 




Like any study, ours was not without limitations. One key limitation of the 
present study is the use of retrospective data to determine onset of depression and health 
conditions. This may have been an issue for ascertainment of depression in early life 
among males. For example, only 126 (5.8%) men out of 2164 who were included in the 
sample reported depression in early life. These low self-reported depression rates may 
underscore the negative public stigma against disclosing mental health conditions, 
particularly depression, in this age cohort (Conner et al., 2010). Indeed, extant research 
has observed low rates of disclosure of mental health conditions and treatment seeking 
behavior among older adults of similar birth cohorts, particularly in men (Conner et al., 
2010). Although it is possible, given that males are approximately 63% less likely to be 
diagnosed with depression compared to females (Abate, 2013), that the low rate of early 
life depression in males accurately represents the population. Indeed, in the absence of 
the gold-standard of clinical assessment of depression and health conditions across the 
lifespan, these analyses relied on retrospective recall to determine the occurrence of 
depression, as well as onset ages for the condition, vascular health conditions, and 
chronic pain. Participants were interviewed in late life (over age 65), thus the length of 
time of recall also likely impacted our coding of these variables.  
Future research may wish to replicate and extend findings from the present study. 
In particular, researchers should consider exploring the associations of specific acutely 
stressful life events with specific depressive symptoms in early and late life and perhaps 
with more specificity with regards to age of onset (i.e., childhood/adolescent depression, 
young adult depression, mid-life depression and late life depression). Such an exploration 




conceptualization of depression, which posits that specific events and conditions are 
associated with specific symptoms of depression that lead to the activation of the network 
of symptoms clinically defined as Major Depression (Fried et al., 2016; Keller et al., 
2007). Researchers may also seek to replicate and extend the findings of BDNF-related 
gene interactions with acutely stressful life events. In particular, given the previously 
established work on BDNF gene rs6265 (BDNF Val66Met), further exploration of 
interactions of the minor allele of this gene with acutely stressful life events may be 
warranted. Finally, clinician-scientists may be interested in exploring differences in 
treatment response to various risk profiles of depression. More specifically, clinician-
scientists in particular may be interested in better understanding differences in response 
to treatment for individuals who report a high number of acutely stressful events vs those 
who report a high number of chronic stressors. Such exploration may help individually 







Early and Late Life Depression and Vascular Health Conditions as Risk Factors for 




Dementia in late life is rapidly becoming a public health crisis as the global 
population of older adults continues to increase. According to 2010 estimates, 35.6 
million people worldwide suffered from dementia, and this number was expected to 
double every two decades (Prince et al., 2013). Further, a large burden is being placed on 
caregivers of those with dementia, with an estimated 16 million caregivers providing 
approximately 18.5 billion hours of care in the United States (U.S.) alone (Gaugler et al., 
2019). According to the Diagnostic and Statistical Manual of Mental Health Disorders, 
5th edition (DSM-5), dementia (or Major Neurocognitive Disorder) is not a single disease, 
rather it reflects a constellation of symptoms related to declining cognitive functioning, 
such as changes in memory and recall, communication and language deficits, decreased 
ability to sustain attention, deterioration in executive functioning and worsening visual 
perception (American Psychiatric Association [APA], 2013). The etiology of dementia is 
complex, with symptoms developing from a variety of diseases and health conditions 
(Nowrangi, et al., 2011; Viswanathan et al., 2009). The most common cause of dementia 
in late life stems from Alzheimer’s Disease (AD), which accounts for approximately 60-




affecting over 5.8 million people which now accounts for the 6th leading cause of death 
(Gaugler et al., 2019).  
A major etiological model posits that the pathological process of AD includes the 
accumulation of beta amyloid in the brain which results in the formation of beta amyloid 
plaques; these are thought to interfere with interneuronal communication leading to 
progressive neuronal damage or death (Braak et al., 2011; National Institutes of Health, 
2018; Price et al., 1991). The pathology of the disease preferentially affects brain regions 
implicated in cognition, learning and memory, such as the hippocampus, orbitofrontal 
cortex and prefrontal cortex (Norwrangi et al., 2011). Additionally, neurofibrillary 
tangles have also been observed within neurons, which are thought to further promote 
cell death (Braak et al., 2011; Price et al., 1991). The specific cause of AD that initiates 
the "amyloid cascade" is unknown.  
Researchers studying the etiology of sporadic or late onset (after age 65) AD 
increasingly posit a number of contributing factors including a combination of risk 
factors, both modifiable and non-modifiable, rather than any single cause. Among non-
modifiable risk factors are biological factors such as age, sex, family history, and genes. 
Older age is perhaps the most well-established risk factor (Hebert et al., 2010; Hebert et 
al., 2013), with prevalence rates of AD and related dementias (ADRD) rising drastically 
with increasing age: affecting 3% of individuals aged 65-74, 17% among those aged 75-
84, and 32% in those aged 85 or above (Hebert et al., 2010). Biological sex is an 
additional factor, with the observation that nearly 3.5 million of the 5.6 million 
Americans with ADRD are women (Gaugler, et al., 2019; Hebert et al., 2013). However, 




longer, on average, than men and older age increases risk for ADRD (Chêne et al.,2015). 
Immediate (biological) family history, such as a mother, father, brother or sister with 
ADRD, increases one’s risk for ADRD (Green et al., 2002; Loy et al., 2014) and those 
with more than one relative show an even greater risk (Lautenschlager et al., 1996). 
Recently, elevated risk for AD was found for those with a positive history in extended 
family members (Cannon-Albright 2019).  
A significant genetic risk factor for AD is the inheritance of the E4 allele of the 
apolipoprotein E (APOE) gene (Saunders, et al., 1993). This gene aids in the 
transportation of cholesterol in the bloodstream (Zannis et al., 1993). Carriers of one copy 
of the E4 allele are at a three-fold risk for developing AD relative to those with the E3 
allele and further, those with two copies of the E4 allele are at an 8-to-12-fold risk for 
developing AD (Holtzman et al., 2012; Loy et al., 2014; Michaelson, 2014). 
Interestingly, this association appears to differ by ethnicity, such that inheriting a copy of 
the E4 allele increased risk for AD among individuals of Caucasian or Japanese ethnicity, 
but not among those of African American or Hispanic ethnicity (Farrer et al., 1997). This 
finding was replicated in a study of 6,158 individuals, in that inheriting an APOE E4 
allele was associated with increased odds for AD among white participants but not 
African American participants (Evans et al., 2003).   
Psychiatric risk factors for ADRD have garnered research attention as well and 
show both independent associations and indirect associations (i.e., affecting other 
conditions or systems that subsequently increase risk for ADRD). Indeed, extant research 
links several conditions, such as anxiety-related disorders (Gallagher et al., 2011) and 




ADRD. Depression has been extensively studied in relation to increasing risk for ADRD 
(see reviews, Diniz et al., 2013; Mourao et al., 2016), although the nature of the 
relationship is unclear. One review summarized the current body of longitudinal and 
cross-sectional research on the relationship between depression and ADRD and found 
that three hypotheses were frequently tested: 1) depression is a cause or risk factor for 
ADRD 2) depression is an outcome of ADRD and 3) depression is a coincidental finding 
in response to ADRD (Bennett & Thomas, 2014).  
 With respect to the hypothesis of depression being a risk factor for ADRD, 
several longitudinal studies have found evidence to support this notion (see reviews: 
Bennett & Thomas, 2014; Ownby et al., 2006). One meta-analysis of 20 studies found 
that those with a history of depression prior to the onset of dementia symptoms were over 
two times more likely to develop ADRD in late life. Further, this study also found a 
significant positive association for the interval between the first onset of depression 
symptoms and diagnosis of ADRD, such that the greatest odds for developing ADRD 
were among those with earliest onset depression symptoms (Ownby et al, 2006). These 
results suggest that the timing of depression symptom onset (i.e., in early life or late life) 
may also be an important aspect of the relationship between depression and dementia. 
Further, findings from another large study found depressive symptoms were associated 
with AD up to 25 years before the onset of AD (OR=1.71, 95% CI=1.03-2.82; Green et 
al., 2003). Underscoring the relationship between depression onset and ADRD, a study of 
503 randomly selected older adults from a longitudinal, population-based sample found 
that a history of early onset depression symptoms (i.e., before age 60) was associated 




(i.e., after age 60) showed a 2.34-fold increase in risk (Geerlings et al., 2008). A wealth 
of cross-sectional studies also have reported an association between depression and 
ADRD (see reviews: Barnes et al., 2012; Baumgart et al., 2015; Bellou et al., 2017; 
Bennet & Thomas, 2014; Diniz et al., 2013; Ownby et al., 2006; Tan et al., 2019) 
although the specific mechanism through which they are related remains unknown. 
Some studies have posited that depression is a prodrome of incipient dementia 
(i.e., a detectable symptom of dementia before the emergence of all of the symptoms). 
This hypothesis, often referred to as the ‘reverse causality hypothesis’ has proven 
difficult to confirm, as many of the symptoms of depression overlap with early signs of 
dementia (i.e., difficulties with memory or recall, decline in cognitive functioning, low 
mood and affect). To test the reverse causality hypothesis, Bennett & Thomas (2014), 
suggest that an onset of depression symptoms within 5 years of AD diagnosis may offer 
support for this hypothesis. Studies using this framework to test the reverse causality 
hypothesis, have been mixed. For example, one study found support of the hypothesis, in 
that those individuals with late life depression within 5 years of dementia onset had an 
increased risk for dementia relative to those without a history of depression or with a 
history of depression in early life (Li et al., 2011). Another study found similar results, in 
that the presence of depression symptoms one year before being diagnosed with AD was 
associated with greater risk for AD (OR=4.57, 95% CI=2.87-7.31), compared to those 
with depression symptoms that first occurred prior to the one year window of AD 
diagnosis (OR=1.38, 95% CI= 1.03-1.85; Green et al., 2003). However, another study 
examined the reverse causality hypothesis in a longitudinal sample of 917 older adults 




2008). Specifically, in this study, those who went on to develop AD did not show an 
increase in depression symptoms in the years preceding the diagnosis of AD or after AD 
diagnosis, compared to their baseline depression symptoms (Wilson et al., 2008).  
Given the difficulties associated with symptom overlap and testing the reverse 
causality hypothesis, some researchers have posited that depression occurs as a 
coincidental consequence of the functional decline associated with dementia and AD 
(Bennett & Thomas, 2014). The ‘coincidental outcome’ hypothesis regarding the 
relationship between depression and dementia posits that depression occurs in response to 
a decline in cognitive abilities. More specifically, when an individual is diagnosed or 
becomes aware of significant cognitive decline, they may experience symptoms of 
depression as a response to the realization that they may have a progressive and terminal 
condition (Bennett & Thomas, 2014). Similar to the reverse causality hypothesis, the 
coincidental hypothesis has been difficult to empirically test. This is further compounded 
by the overlap in symptoms of dementia and depression, particularly apathy, which is a 
key feature of dementia and is also commonly associated with depression (Bennett & 
Thomas, 2014; Landes, Sperry & Strauss, 2005). 
Notwithstanding the complexities described above, there are theoretical 
explanations and empirical findings that support both early and late onset depression as 
risk factors for ADRD.  In particular, several studies have observed that depression 
appears to negatively impact brain structures that are heavily involved in the 
pathophysiology of ADRD (Ding et al., 2015; Lee & Kim, 2010; Rapp et al., 2006; 
Warner et al., 2006). For example, reduced hippocampal volume was observed in patients 




hippocampal volume are associated with dementia of all types (Vijayakumar & 
Vijayakumar, 2012), with the greatest reduction in those with AD-dementia (Schuff et al., 
2009; Vijayakumar & Vijayakumar, 2012;). Further, a post-mortem study observed that 
certain key pathological signs of AD (i.e., neurofibrillary tangles and neuritic plaques) 
were found in significantly higher levels in the hippocampus of those with AD and a 
history of lifetime depression compared to those with AD and no depression history 
(Rapp et al., 2006). Other brain changes that are considered biomarkers for signs of AD 
(i.e., decreased volume, reduced neuron density and impaired cellular health) have been 
reported in the orbitofrontal cortex (Cotter et al., 2005) and prefrontal cortex (Cotter et 
al., 2002) in those with depression. Further, depression across the lifespan has been 
linked to decreased production of neurotrophic factors, such as brain derived 
neurotrophic factor (BDNF), a substance which promotes neuronal health, synthesis and 
functionality. Higher levels of BDNF have been inversely related to the occurrence of 
AD (see reviews: Lee & Kim, 2010; Phillips, 2017; Sen et al., 2008). 
Risk factors for early life depression may relate to risk for ADRD through 
physiological response to stress that lead to changes in the hippocampus. In early life 
onset depression, risk factors include family history of psychiatric illness (Klein et al., 
2001) and psychosocial variables, such as adverse life events (Mandelli et al., 2015) and 
low socioeconomic status (Jafee, 2002). Limited research exists examining the direct 
pathway from early life stress to risk for AD, however one meta-analysis found that 
chronic stress in early life negatively impacted neuroplasticity in the hippocampus and 
was associated with increased risk for cognitive impairment and AD in late life (Rothman 




to ADRD risk through chronic activation of the body's response to stress that results in 
detrimental effects to the hippocampus and other brain regions (Aznar & Knudsen, 2011).  
Another avenue through which both early and late life onset depression may be 
related to increased risk for AD-related dementia is through vascular health (Lewis, 2002; 
Treadway et al., 2015). Poor cardiovascular health has been extensively linked to 
increased risk for AD (see reviews, Barnes & Yaffe, 2011; Newman et al., 2005; Sparks 
et al., 2000; Stampfer, 2006) and may be a potential consequence of depressive 
symptomology. Indeed, neuroimaging studies have found that vascular damage is 
common among patients with major depression in both early life and late life compared 
to healthy controls (Lewis, 2002; Treadway et al., 2015). Further, the microvascular 
damage observed in individuals in these studies closely mirrors damage observed in 
neurodegenerative diseases, including AD (Kim, et al., 2016; Lewis, 2002; Treadway et 
al., 2015;). This might suggest that one sequalae of depression is poor cardiovascular and 
cerebrovascular health, which may subsequently increase AD risk. Thus, the timing of 
depression onset (i.e., early life or late life) and its chronicity would become important 
factors, as earlier onset depression (along with more chronic or recurrent episodes) would 
likely result in poorer cardio- and cerebrovascular health over time and subsequently 
affect risk for depression (Almeida et al., 2007) as well as ADRD (Barnes & Yaffe, 
2011). 
To date, no study has examined the direct and indirect relationships between early 
onset depression, late onset depression (and their risk factors) and ADRD in a single 




determine if they are modified by the presence of vascular risk factors stratified by sex. 
The research questions and hypotheses follow. 
1. Is a history of early- or late-onset depression (and chronicity) associated with 
risk for ADRD?  
Hypothesis: I hypothesize that both early- and late-onset depression will be 
related to greater risk for ADRD, but that the greatest risk will be for those with 
an early-onset of depression. 
2. Do vascular risk factors modify the relationship between early- and late-onset 
depression and risk for ADRD?  
Hypothesis: I hypothesize that vascular risk factors and conditions will moderate 
the relationship between both early life onset depression and late life onset 
depression and ADRD.  
The present study addresses a gap in the literature by furthering the knowledge on 
specific risk factors associated with early life and late life onset depression and their 





In the present study, participants were selected from an extant dataset comprised 
of a large, population-based cohort of individuals living in semi-rural Utah. This sample 
of participants was recruited to participate in the Cache County Study on Memory in 




older adults. The CCSMA began collecting data from participants in 1995 and completed 
its data collection in 2007. Participants were assessed in four triennial waves during this 
12-year period (Breitner et al., 1999). In total, the CCSMA collected data on 5,092 
individuals who were over 64 years of age and resided in Cache County, Utah. Data from 
these participants was further linked to records in the Utah Population Database (UPDB). 
The UPDB includes records for over 11million individuals and is frequently used in 
epidemiological and public health research (Norton et al., 2006; Cannon-Albright et al., 
2019). Reportedly, 5,091 of 5,092 (99.99%) participants in the CCSMA were 
successfully linked to at least one record in the UPDB. The present study utilized data 
from those participants who were successfully linked from the CCSMA to the UPDB 
with non-missing data in relevant databases. 
 
Procedure 
All study procedures for the CCSMA were approved by the Institutional Review 
Boards of Utah State University, Duke University and the Johns Hopkins University. In 
1995, a cohort of 5,657 individuals were identified as being eligible for the CCSMA, of 
which 5,092 (90%) were enrolled into the study (Breitner et al., 1999). A more detailed 
description of all recruitment procedures, methods and participant selection is available 
elsewhere (see Breitner et al., 1999). To summarize these procedures briefly, participants 
completed a multi-staged screening and assessment protocol in waves 1-4 to determine 
the presence or absence of dementia, along with the presence or absence of various risk 
factors related to dementia. Each wave began with a cognitive screening process that 




(3MS; Tschanz et al., 2002). Those who were unable to complete the 3MS, or scored 
below 60, or scored below 15 on the orientation section of the 3MS, or were otherwise 
deemed unreliable were referred for a proxy interview. This interview, The Informant 
Questionnaire for Cognitive Decline in the Elderly (IQCODE; Jorm and Jacomb, 1989), 
is a structured clinical interview for informants/caregivers to assesses the symptoms of 
dementia (Jorm & Jacomb, 1989).  
Individuals who scored below 87 on the 3MS or above 3.27 on the IQCODE were 
administered another informant interview, which utilized the Dementia Questionnaire. 
The Dementia Questionnaire targets information regarding specific symptoms of 
cognitive impairment, limitations in daily activities, and medical and health conditions. 
Following this screening process, participant responses were reviewed by the study 
neuropsychologists and geropsychiatrists, who referred those who were rated with 
significant cognitive impairment or dementia for a clinical assessment. Additionally, 
participants who matched in age, gender and APOE genotype to those with AD 
(regardless of screening scores) were selected to constitute a designated subpanel of 
participants to also complete the clinical assessment (Breitner et al., 1999). 
 
 Data Sources Linked with the UPDB  
The UPDB was initially created as a large multigenerational family history 
dataset for residents of Utah. Genealogy records, birth certificates, death certificates 
census records, drivers license information and hospital records are linked to the UPDB, 
resulting in over 16 million records for more than 11 million individuals (see 




data from Medicare, which provides health care coverage for qualifying individuals 65 
years of age and over, are linked to the UPDB. The Institutional Review Boards of Utah 
State University, the University of Utah and the Utah Resource for Genetic and 
Epidemiological Research approved the usage of the UPDB in conjunction with data 
from the CCSMA. 
 
Dementia Diagnoses 
The clinical procedures used to assess persons for dementia were designed based 
on procedures of AD Research Centers at the time (Breitner et al., 1999), and included a 
clinical assessment, neuroimaging and laboratory studies, and a physician visit. The 
clinical assessment consisted of a nurse interview of health history (with a reliable 
informant) and a physical and neurological examination with the participant. The health 
history included an assessment of neuropsychiatric symptoms, cognitive status and daily 
functional ability of the participant with a knowledgeable informant. A battery of 
neuropsychological tests (approximately one hour in duration) was also completed with 
the participant. Following completion of the clinical assessment, a geropsychiatrist and 
neuropsychologist reviewed the entirety of the data with the assessment team and 
assigned preliminary diagnosis of dementia (i.e., vascular dementia, Alzheimer’s 
dementia, or other causes of dementia). Those with dementia were invited to complete 
neuroimaging and laboratory studies to rule out other causes of cognitive impairment 
(Breitner et al., 1999). Those with dementia or its prodrome were invited to complete a 
physician exam and a follow-up clinical assessment approximately 18 months after the 




The final assignment of dementia was determined by an expert panel of clinicians 
consisting of geropsychiatrists, neurologists, neuropsychologists, and a cognitive 
neuroscientist (Breitner et al., 1999) according to DSM-III-R criteria (American 
Psychiatric Association, 1987). Diagnoses of AD, vascular dementia and other forms of 
dementia followed standard research criteria at the time. For example, a diagnosis of AD 
followed National Institute of Neurological and Communicative Diseases and 
Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) and 
a diagnosis vascular dementia followed National Institute of Neurological Disorders and 
Stroke-Association Internationale pour la Recherche et l’Enseignement en 
Neurosciences(NINDS-AIREN; Roman et al., 1993). All those who were not diagnosed 
with dementia at each wave were followed until they subsequently developed dementia, 
refused further participation in the study, or died. Thus, at the end of the CCSMA, 
individuals were classified as having dementia, with other cognitive disorders or non-
case. Additionally, data from Medicare claims from 1992 – 2012 and death certificates 
(through 2014) via linkage with UPDB were further examined for additional sources to 
identify development of dementia. For Medicare claims, criteria from Nair and 
colleagues (Nair, et al., 2018) were applied, requiring a minimum of two claims with 
dementia diagnoses separated by a minimum period of 18 months. The presence of the 
following ICD-9 codes were used to designate dementia status in Medicare claims and 
death certificate databases: 294.20, 294.21, 291.20, 290.40, 290.41, 290.42, 290.43, 
290.12, 290.90, 294.11, 294.10, 331.0, 331.9, 290.10. 331.20, 742.40. In the present 
study, we used a binary code for dementia, such that those with any dementia diagnosis 




free at the end of all study waves (i.e., evaluated or screen negative) were coded as a non-
case and served as the comparison group. The following numbers of individuals were 
classified with dementia from the above sources: 942 (CCSMA), 174 (Medicare claims), 
and 238 (death certificates) for a total of 1354 individuals. 
 
Lifetime Depression Status 
 At each wave, participants in the CCSMA were also assessed for depression 
history and current depression symptoms. At baseline and each subsequent wave, 
participants completed a depression history screener. The depression screening items 
included: “1) In your lifetime, have you ever had a period of two weeks or more when, 
nearly every day you felt sad, blue or depressed? 2) In your lifetime, have you ever had a 
period of two weeks or more when, nearly every day you lost all interest and pleasure in 
things that you usually cared about or enjoyed? 3) In your lifetime, have you ever had a 
period of two weeks or more when, nearly every day you felt unusually cross or 
irritable?” Those who endorsed at least one key symptom of depression from the screener 
were further assessed via the Diagnostic Interview Schedule (DIS; Robins et al., 1981); at 
waves 3 and 4 all participants completed the DIS (Steffens et al., 2000). Participants who 
endorsed sufficient diagnostic criteria on the DIS (i.e., 5 of 9 possible depression 
symptoms) were assigned a diagnosis of major depressive disorder (MDD; American 
Psychiatric Association, 1987; Robins et al., 1981; Steffens et al., 2000). Those who did 
not meet full criteria for MDD but who reported persistent depressed mood and at least 
two other symptoms of depression were assigned a diagnosis of minor depression 




DIS has been extensively validated for its diagnostic accuracy, sensitivity and ease of 
administration in large research studies (Regier et al., 1984; Robins et al., 1982). 
Additional diagnoses of major depression were assigned through examination of 
medication history, with the endorsement of an antidepressant for the indication of 
depression being considered positive for a diagnosis of MDD or minor depression 
(Steffans et al., 2000). Finally, in the absence of data within the CCSMA, Medicare 
claims were examined for ICD codes related to depression. The presence of the following 
ICD-9 codes were used to designate depression status in Medicare claims and death 
certificate databases: 296.20. 296.21, 296.22, 296.23, 296.24, 296.25, 296.26, 296.30, 
296.31, 296.32, 296.33, 296.34, 296.35, 296.36, 309.00, 309.10,309.28, 311.00, 300.40.  
Those who did not report depression in the CCSMA but did have Medicare codes for 
depression were added to the late life depression group. 
Early life onset depression and late life onset depression were determined through 
self-report of the approximate date that depression symptoms (lasting at least two weeks) 
first began, or if lacking the approximate date, the date that anti-depressants were 
prescribed or earliest Medicare claim of Major/Minor depression. Early life onset 
depression was coded differently based upon sex. More specifically, for women early 
onset depression was coded for those who met criteria for MDD, a single major 
depressive episode or minor depression prior to their age at menopause. For men, the cut 
off age for early life onset depression was determined based upon previous literature, 
with those who met criteria for MDD, a single major depressive episode or minor 
depression prior to age 60 being coded as Early Life Depression (Baldwin et al., 1995; 




who reported the above conditions but with first onset after menopause age for females 
and after age 59 for males.  
Data from Medicare claims was used to further ascertain any additional episodes 
of depression not otherwise reported in CCSMA (see below). Including depression 
diagnoses from Medicare claims, the present study used a multiple level variable for 
depression, coded as 1= no reported symptoms of depression, 2=early onset depression 
(major or minor) only, 3=Early and Late Life Depression (major or Minor) and 4= Late 
Life Depression (major or minor) only. 
 
Vascular Health 
Vascular risk factors were assessed during interviews where medical and 
medication information regarding risk factors was collected; these were administered at 
each wave of the CCSMA. These items assessed the presence or absence of medical 
conditions and/or medications related to vascular health: 1) Congestive Heart failure 2) 
Diabetes Mellitus 3) Myocardial Infarction 4) Cerebrovascular Accident (e.g., stroke) 5) 
Hypertension (high blood pressure) 6) Hypercholesterolemia 7) Atrial Fibrillation 8) 
Atherosclerosis 9) Obesity 10) Other Dysrhythmia (see Appendix I). An example item 
reads, “Have you ever been told by a doctor that you had hypertension or have you ever 
been treated for hypertension?” Data on cardiovascular conditions was also drawn from 
Medicare claims data. More specifically, ICD-9 codes for the above conditions were 
matched to participants in the CCSMA if endorsed. The specific ICD-9 codes for 
vascular conditions included: hypertension (401.1, 401.9), hypercholesterolemia 




myocardial infarction (410.01-410.91; 412), Cerebrovascular accident (stroke; 433.01, 
433.11, 433.21, 433.31, 433.81, 434.01, 434.11, 435.8, 435.9), atrial fibrillation (427.31) 
and other arrythmias (427, 427.1, 427.2, 427.32, 427.41, 427.42, 427.69, 427.61, 472.81, 
427.89), congestive heart failure (428), and atherosclerosis (440.9, 440.8, 437, 440). All 
vascular health conditions were coded for date of earliest onset or diagnosis and 
compared to date of onset for ADRD. Those who experienced a vascular health condition 
prior to age of dementia onset were retained for the present study, those whose age of 




 Several established covariates for depression and ADRD were also included in 
the present study. These were age at study enrollment, education, which was collapsed 
into less than high school education or high school diploma and greater (Bjelland et al., 
2008; Scarmeas et al., 2006), marital status, which was collapsed into married and all 
other statuses (Inaba et al., 2005; Steenland et al., 2009) and presence or absence of 
APOE E4 allele (Saunders et al., 1993). Each of these covariates were included based on 
extant literature that showed associations to depression and ADRD. 
 
Analytic Plan 
Inclusion criteria for the present study included: 1) Participant data successfully 
linked to the UPDB 2) outcome data of non-case or all-cause dementia diagnosis. 




dementia diagnosis compared to non-cases. Differences between groups were examined 
using Independent Sample t-tests or Fisher’s Exact tests where appropriate. For 
exploratory analyses, bivariate associations of lifetime depression status, ADRD and 
covariates were examined using, independent samples t-tests or Fisher’s Exact tests, 
correlations and logistic regression where appropriate.  
 To examine research question 1, which stated “Is a history of early- or late-onset 
depression associated with risk for ADRD?” binary logistic regression models were built. 
Each regression model was built separately for each sex. In each model, the association 
of each covariate with cognitive status (dementia vs non-case) was examined as a main 
effect with no other covariate in the model. Covariates that were deemed theoretically 
important or that demonstrated a significant association (p=<.05) with cognitive status 
(dementia vs. non-case) were retained in the final model. Additionally, interactions 
between APOE4 gene status and all covariates were explored. As no interactions were 
significant at the bivariate level, these were not included in further analyses. Covariates 
in all models included lifetime depression status, age at study enrollment, education, 
marital status and APOE 4 gene status, with cognitive status as the binary outcome 
variable. The final model included all of the above covariates after completing the 
variable selection process described above.  
To examine research question 2, which stated “Do vascular risk factors and 
conditions modify the relationship between early and late onset depression and risk for 
ADRD?” binary logistic regression models were built in which interactions between 
lifetime depression status and vascular variables were examined in predicting cognitive 




used to guide decisions for variable inclusion. First, frequencies, correlations (phi) and 
2x2 Fisher’s exact tests between all vascular health conditions were determined and 
assessed for multicollinearity between conditions and to guide whether collapsing highly 
correlated conditions into a single variable was warranted. There were no conditions that 
exceeded a correlation of r=.4, thus each vascular health condition was retained as an 
independent condition. Next, the Least Absolute Shrinkage and Selection Operator 
(LASSO) regularization procedure was used to quantitatively examine which amongst all 
of the predictor variables were the most salient variables associated with the outcome 
(cognitive status) to guide variable selection for the binary logistic regression model. 
LASSO regression is a regularization technique that utilizes shrinkage to an absolute 
value (lambda) that produces the lowest mean squared error possible. Predictors that 
survive a penalty are retained to minimize variance and encourage sparse/parsimonious 
models (Tibshirani, 1996). Thus, a LASSO regression model (run separately for each 
sex) was built with cognitive status as the outcome and predictors including lifetime 
depression status, age at study enrollment, APOE E4 status, marital status, education, 
each vascular health condition and interaction terms between lifetime depression with 
APOE E4 status and lifetime depression with each vascular condition.  
Following the LASSO analysis, logistic regression analyses were conducted to 
further explore relationships/interactions between lifetime depression status, each 
vascular variable and the APOE gene. Each interaction was first examined in a bivariate 
logistic regression model (separate models for each sex) which included only the main 




with the interaction (lifetime depression x atrial fibrillation) being entered in step 2 of the 
model.  
Following each of the above steps, variables to be tested in the final logistic 
regression model were those that were either retained in the LASSO regression model or 
those that were significantly associated with cognitive status in the exploratory logistic 
regression analyses described above. Note that covariates of age at study enrollment, 
education, and APOE E4 status were retained in the final model regardless of statistical 
association with cognitive status as they are theoretically important factors in the 




There were 4214 participants who met eligibility criteria for the present study. Of 
those 4214, 1354 were diagnosed with some form of dementia, with the majority (n=787; 
58%) of those diagnoses being dementia due to Alzheimer’s Disease (AD). Those with 
dementia were more likely to report depression in late life than non- case participants (see 
Table 1). Further, those with dementia were more likely to be female and be older at 
baseline than non-cases. In the overall sample, the majority of participants were more 
likely to be female, white, married, have completed at least a high school education and 
be over age 75 (See Table 1). Approximately 26% of the total sample were diagnosed 
with dementia at the time of their death or at study completion (see Table 1). Further, 
approximately 36% of the sample reported clinically significant depression in their 






Descriptive Characteristics of the Total Sample. 
Variable 
Dementia  
n= 1354  
n (%)/M(SD) 
Non-case  
n= 2860  
      n 
(%)/M(SD) 
 
All Cause Dementia    
Alzheimer’s Disease 787 (15.5%)   
Lifetime Depression 
Status 
  χ2(4196) = 12.12, 
p=<.01 
No depression  879 (65.5%) 1861 (65.2%)  
Early Life 
Depression 
88 (6.6%) 209 (7.3%)  
Early Life 
Depression and Late 
Life Depression 
77 (5.7%) 233(8.2%)  
Late Life Depression  299 (22.3%) 550 (19.3%)  
Age at study enrollment 77.76 (7.42) 74.41 (6.86) T(4212) = -14.42, 
p=<.001 
Biological Sex   χ2(4214) = 13.04, 
p=<.001 
Male 515 (38.0%) 1256 (43.9%)  
Female 839 (62.0%) 1604 (56.1%)  
Ethnicity   χ2(4214) = 6.05, p=.42 
White 1344 (99.3%) 2839 (99.3%)  
Non-white * (*%) 18 (.07%)  
Married 816 (60.3%) 1964 (68.7%) χ2(4211) = 29.43, 
p=<.001 
High School Education 1087 (80.5%) 2349 (82.2%) χ2(4206) = 1.83, p=.18 
Note. * indicates number suppressed in compliance with Health Care Insurance 





 Independent sample t tests and chi square statistics were conducted to examine 
sex differences in cognitive status, lifetime depression, age at study enrollment, APOE 
E4 gene status, marital status, education and vascular conditions where onset preceded 
dementia onset. Males were more likely to be married, report no history of depression, 
and have a history of diabetes, myocardial infarction, atrial fibrillation and other 
dysrhythmias (See Table 2). However, females were more likely to report a history of 
depression, particularly in late life, be older at baseline, have completed high school and 






Means, Standard Deviations, t-Tests or Chi-Square Statistics of Cognitive Status, 
Lifetime Depression, Age at baseline of study enrollment, Education, Marital Status, 
APOE E4 status and Vascular Conditions Prior to Dementia, Stratified by Sex. 
 
 Sex  
Variable 
Males 




(SD)/n (%) t-test/Chi-square statistic 
All Cause Dementia 515 (29.1%) 839(28.7%) χ2(4214) =13.04,  p = <.001 
Lifetime Depression 
Status 
  χ2(4196) =181.14, p = <.001 
No depression  1349 (76.5%) 1391 (57.2%) - 
Early Life Depression 112 (6.35%) 185 (7.6%) - 
Chronic Depression 76 (4.3%) 234 (9.6%) - 
Late Life Depression  227 (12.9%) 622 (25.6%) - 
Age at study enrollment 74.64 (6.87) 76.09 (7.40) T (4212) = -6.46, p = <.001 
APOE E4 Status 536 (31.0%) 771 (32.2%) χ2(4121) = .67, p = .41 
Married 1531 (86.5%) 1249 (51.2%) χ2(4211) = 570.85, p = <.001 
High School Education 1395 (78.9%) 2041 (83.7%) χ2(4206) = 15.88,  p = <.001 
Vascular Health Factors     
Congestive Heart 
Failure 
742 (45.3%) 1038 (46.4%) χ2(3875) = .50, p = .48 
Diabetes Mellitus 604 (35.7%) 744 (31.7%) χ2(4036) = 6.92, p = <.01 
Myocardial Infarction 627 (36.3%) 549 (23.0%) χ2(4121) = 87.21, p = <.001 
Cerebrovascular 
Accident 
390 (23.0%) 593 (25.5%) χ2(4021) = 3.28, p= .07 
Hypertension 1378 (81.0%) 2019 (87.0%) χ2(4023) = 26.36, p = <.001 
Hypercholesterolemia 980 (56.3%) 1310 (55.0%) χ2(4122) = .60, p = .44 
Atrial Fibrillation 664 (39.7%) 780 (33.6%) χ2(3994) = 15.39,  p = <.001 
Atherosclerosis 352 (20.7%) 469 (20.0%) χ2(4046) = .33, p = .56 
Obesity 115 (6.5%) 230 (9.5%) χ2(4187) = 11.81,  p = <.001 
Other dysrhythmia 711 (42.0%) 849 (36.5%) χ2(4017) = 12.12, p = <.001 







Among males, correlations between risk factors, covariates and cognitive 
outcomes revealed that a cognitive status of dementia was positively associated with 
lifetime depression status, age at study enrollment and APOE E4 status, all with small 
effect sizes. Cognitive status of dementia was negatively associated with congestive heart 
failure, myocardial infarction, hypertension, hypercholesterolemia, atrial fibrillation, 
obesity and other dysrhythmia, also with small effect sizes (see Table 3). Among females, 
cognitive status of dementia was positively associated only with age at study enrollment 
and APOE E4 status, all with small effect sizes. Cognitive status of dementia was 
negatively associated with lifetime depression status, married status, high school 
education, and all vascular conditions with the exception of cerebrovascular accident, 
which displayed no significant association with the other variables (see Table 4). As 
expected, many of the vascular health conditions were positively associated with one 
another for both males and females. However, none of these associations were larger than 






Correlations for All Cause Dementia with Lifetime Depression, APOE E4 status, Married, High School Education and Vascular 
Risk Factors for Male Sample 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Cognitive Status -                
2. Lifetime Depression Status .08 -               
3. Age at baseline of study 
enrollment 
.18 -.08 -              
4. APOE4 Gene Status .17 -.01 -.06 -             
5. Married -.02 -.05 -.27 .01 -            
6. High School Education -.00 -.02 -.17 .04 .07 -           
7. Congestive Heart Failure -.18 -.06 .12 -.05 -.02 -.07 -          
8. Diabetes Mellitus -.05 .05 -.12 -06 .05 .03 .18 -         
9. Myocardial Infarction -.07 .05 .00 -.02 .02 -.01 .33 .12 -        
10. Cerebrovascular Accident -.01 .06 .01 -.04 .02 .02 .11 .06 .10 -       
11. Hypertension -.06 .07 -.16 -.01 .07 .05 .20 .22 .14 .13 -      
12. Hyper-cholesterolemia -.11 .07 -.37 .03 .20 .12 .07 .19 .20 .07 .27 -     
13. Atrial Fibrillation -.12 .01 .02 -.05 .01 .01 .38 .07 .21 .13 .18 .11 -    
14. Atherosclerosis -.04 .08 -.05 -.01 .04 .02 .14 .09 .11 .13 .13 .15 .12 -   
15. Obesity -.09 .08 -.14 -.04 -.01 .02 .14 .16 .05 .00 .10 .09 .05 .04 -  
16. Other dysrhythmia -.11 .04 -.01 .03 .07 .04 .28 .08 .26 .09 .16 .18 .33 .12 .06 - 






Correlations, for All Cause Dementia with Lifetime Depression, APOE E4 status, Married, High School Education,  
and Vascular Risk Factors for Female Sample 
 
Variable .4 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1. Cognitive Status -                
2. Lifetime Depression 
Status 
-.04 -               
3. Age at baseline of study 
enrollment 
.23 -.13 -              
4. APOE E4 Status .20 -.03 -.05 -             
5. Married -.09 -.02 -.44 .04 -            
6. High School Education -.04 .02 -.23 .03 .12 -           
7. Congestive Heart Failure -.14 .04 .12 -.08 -.08 -.12 -          
8. Diabetes Mellitus -.10 .04 -.14 -.07 .06 -.02 .18 -         
9. Myocardial Infarction -.14 .05 -.01 -.03 -.01 -.05 .26 .15 -        
10. Cerebrovascular 
Accident 
-.02 .03 .02 -.05 -.03 -.01 .15 .09 .13 -       
11. Hypertension -.08 .08 -.10 -.04 .03 -.02 .21 .16 .15 .15 -      
12. Hypercholesterolemia -.17 .11 -.43 .03 .22 .12 .03 .18 .14 .07 .21 -     
13. Atrial Fibrillation -.17 .01 .03 -.05 -.03 -.01 .42 .13 .19 .14 .15 .06 -    
14. Atherosclerosis -.06 .06 -.11 -.02 .05 .01 .14 .14 .12 .16 .11 .16 .11 -   
15. Obesity -.08 .10 -.21 -.05 .09 .02 .10 .18 .05 -.00 .08 .12 .06 .0 -  
16. Other dysrhythmia -.11 .05 -.08 -.02 .07 .03 .27 .11 .21 .14 .19 .17 .37 .15 .04 - 




 Bivariate relationships between cognitive status and all study variables were 
further examined using binary logistic regression. Among males, lifetime depression 
status, age at study enrollment, APOE E4 gene status, and vascular health conditions with 
the exception of cerebrovascular accident, hypertension and atherosclerosis displayed a 
significant relationship with cognitive status (see Table 5). Among females, lifetime 
depression status, age at study enrollment, APOE E4 status, marital status, high school 
education, and vascular conditions with the exception of cerebrovascular accident 






Bivariate Odds Ratios (OR) and Confidence Intervals (CI) for Lifetime Depression, Age, Marital Status, 
Education, APOE E4 Status and Vascular Health Conditions on Cognitive Status in Male and Female 
Models. 
 
Variable Nagelkerke R2 Male Sample 
OR, 95% CI 
Nagelkerke R2 Female Sample 
OR, 95% CI 
Lifetime Depression Status .01  .01  
Early Life Depression - 1.06 (.69-1.62) - .75 (.54-1.05) 
Chronic Depression - .95 (.56-1.60) - .56 (.41-.77) 
Late Life Depression  - 1.77 (1.32-2.37) - .87 (.71-1.06) 
Age at study enrollment .04 1.06 (1.04-1.07) .07 1.07 (1.06-1.08) 
APOE E4 Status .04 2.19 (1.76-2.72) .05 2.40 (2.01-2.87) 
Married <.01 .86 (.64-1.16) .01 .68 (.58-.81) 
High School Education <.01 .99 (.88-1.13) <.01 .89 (.80-.99) 
Vascular Health Factors      
Congestive Heart Failure .05 .41 (.32-.52) .03 .54 (.44-.65) 
Diabetes Mellitus <.01 .77 (.61-.98) .02 .61 (.50-.74) 
Myocardial Infarction <.01 .71 (.57-.89) .03 .47 (.37-.58) 
Cerebrovascular 
Accident 
<.01 .97 (.75-1.25) <.01 .91 (.74-1.11) 
Hypertension <.01 .73 (.56-.95) .04 .47 (.40-.56) 
Hypercholesterolemia .02 .62 (.50-.77) .04 .47 (.40-.56) 
Atrial Fibrillation .02 .54 (.43-.69) .04 .42 (.34-.52) 
Atherosclerosis <.01 .80 (.60-1.05) <.01 .71 (.57-.89) 
Obesity .01 .35 (.20-.61) .01 .53 (.38-.73) 
Other dysrhythmia .02 .60 (.48-.76) .02 .62 (.51-.74) 




Research Question 1: Are Early Life Depression and Late Life Depression associated 
with increased risk for Dementia? 
 Among males, the overall binary logistic regression of cognitive status regressed 
on lifetime depression status, age at study enrollment, APOE4 E4 status, marital status 
and high school education was significant (χ2[7]=130.99, p=<.001; see Table 6). The 
main effect of lifetime depression status remained significant after adding all covariates 
into the model, such that those with late life depression were at 1.98 increased odds to 
also be diagnosed with all-cause dementia (See Table 6). Two covariates, age at study 
enrollment and APOE E4 status were also significant in the model after all other 
covariates were entered into the model. More specifically, those who were older at 
baseline were 7% more likely to be diagnosed with dementia and those with at least one 
copy of the APOE E4 allele were 2.4 times more likely to be diagnosed with all cause 
dementia (See Table 6). 
 Among females, the overall binary logistic regression of cognitive status 
regressed on lifetime depression status, study enrollment, APOE E4 status, marital status 
and high school education was significant (χ2[7]=246.02, p=<.001; see Table 6). The 
main effect of lifetime depression status trended towards significance (p=.06) after 
adding all covariates into the model, with those who reported early and late life 
depression being less likely to also be diagnosed with all cause dementia (see Table 6). 
Two covariates, age at study enrollment and APOE E4 status were also significant in the 
model after the inclusion of all other covariates into the model. More specifically, those 




those with at least one copy of the APOE E4 allele were at 2.68 increased odds to be 
diagnosed with dementia (See Table 6). 
Table 6 
Odds Ratios (OR) and Confidence Intervals (CI) of Lifetime Depression Status, Age 
at baseline of study enrollment, APOE E4 Gene Status, Marital Status and 
Education for Cognitive Status in Male and Female Samples 
 
Variable 
Male Sample (n=1717) 
OR, 95% CI 
Female Sample (n=2375) 
OR, 95% CI 
Lifetime Depression Status p=<.001 p=.06 
Early Life Depression 1.23 (.79-1.92) .87 (.61-1.23) 
Chronic Depression 1.17 (.68-2.03) .65 (.47-.91) 
Late Life Depression 1.98 (1.45-2.70) 1.04 (.84-1.29) 
Age at study enrollment 1.07 (1.05-1.09) 1.08 (1.06-1.09) 
APOE4 Status 2.42 (1.93-3.03) 2.68 (2.22-3.23) 
Married 1.24 (.89-1.72) 1.05 (.86-1.28) 
High School Education 1.18 (.90-1.55) 1.08 (.84-1.38) 
Nagelkerke R2 .11 .14 
Note. CI = 95% confidence interval; OR’s and CI’s with p = <.05 are in boldface. 
 
 
Research Question 2: Do Vascular Risk Factors Modify the Relationship between 
Lifetime Depression Status and All Cause Dementia? 
 Exploratory bivariate binary logistic regression analyses were conducted to 
examine any interaction effects between lifetime depression status and each vascular 
health condition on cognitive status. Interaction terms were computed by taking the 
product of lifetime depression and a vascular health condition (e.g., Congestive Heart 
Failure). A hierarchical stepwise procedure was used to enter the main effects of lifetime 




For males, there were no significant interactions between lifetime depression and any of 
the vascular health conditions included in the present analyses. Similar results were 
obtained for females, except for two interactions that trended towards significance: the 
interaction of lifetime depression by hypercholesterolemia and the interaction of lifetime 
depression by obesity. More specifically, those who had late life depression and 
hypercholesterolemia displayed 69% greater odds of also having a diagnosis of dementia. 
Further, those with a history of late life depression and obesity displayed approximately 
1.32 greater odds of also having a diagnosis of dementia. Taken together there were no 
significant interactions between lifetime depression and vascular variables for men, 
however two interactions trended towards significance in the female sample and thus may 
be important to consider in the final model. 
 LASSO Regularized Regression analysis was utilized to better understand the 
most important predictors in the context of the most parsimonious model and to avoid 
overfitting to the data. In both male and female samples, the LASSO regression included 
cognitive status as the outcome variable with lifetime depression status, age at study 
enrollment, APOE4 gene status, marital status, high school education, vascular health 
conditions and the interactions of lifetime depression with APOE E4 status as well as 
lifetime depression with each vascular health condition (e.g., lifetime depression x 
congestive heart failure, etc.). A conventional 10-fold cross-validation level was used for 
the LASSO analysis, with the first cross validation serving to optimize the regularization 
parameters and the second evaluating predictive performance of the variables within the 
optimal model. In both the male and female models a λ=.02 was selected as a 




model that included only one predictor: the interaction of lifetime depression and 
congestive heart failure with a penalty of .38. The optimal model was also selected as the 
most parsimonious model, accounting for approximately 3% of the variance in predicting 
the outcome (Adjusted R2; See Table 7). In the selected model the interaction of lifetime 
depression by congestive heart failure was not a significant predictor (see Table 7).  
For females, LASSO regression revealed an optimal model that included age at 
study enrollment, the interaction of lifetime depression by congestive heart failure, the 
interaction of lifetime depression by APOE E4 status and the interaction of lifetime 
depression by atrial fibrillation. The optimal model was selected as the most 
parsimonious model and accounted for 5% of the total variance associated with 
predicting the outcome (See Table 7). In the selected model only the interaction of 
lifetime depression by APOE E4 status and the interaction of lifetime depression by atrial 





LASSO Regression Optimal Models; Lambda Penalty, Prediction Error, Adjusted R2 








(df), p value 
Optimal Model for Male 
Sample 
.38 .88 .03  
Lifetime Depression x 
Congestive Heart Failure 
   .01 (7), p=.99 
Optimal Model for Female 
Sample 
.22 .98 .05  
Age at baseline of study 
enrollment 
   -.02 (1), p=.23 
Lifetime Depression x 
Congestive Heart Failure 
   <.01 (7),p =1.0 
Lifetime Depression x APOE 
E4 
   .05 (7), 
p=<.001 
Lifetime Depression x Atrial 
Fibrillation 
   .05 (7), 
p=<.001 
Nagelkerke R2  .11   






 The final binary logistic regression models to examine research question 2 were 
determined through examination of theory, bivariate associations and LASSO regression 
results. More specifically, in both the male and female models theoretical considerations, 
dictated the inclusion of lifetime depression status and at least some vascular health 
conditions as they were central to the research aims. Additionally, inclusion of APOE E4 
status, age at study enrollment and educational status were warranted as established 
predictors of dementia in the extant literature (Saunders et al., 1993; Bjelland et al., 
2006). After examining bivariate logistic regression analyses and correlations, marital 
status was excluded from final analyses due to lack of theoretical importance and 
association with cognitive status. The LASSO regularization was not used in the final 
model due to restrictiveness of theoretically important variables. Among males, the final 
model included 1465 participants with cognitive status as the binary outcome variable 
being regressed onto lifetime depression status, age at study enrollment, APOE E4 status, 
high school education, congestive heart failure, myocardial infarction, 
hypercholesterolemia, atrial fibrillation, obesity and other-dysrhythmia (See Table 8). 
Three vascular health conditions, diabetes, cerebrovascular accident and atherosclerosis, 
as well as all interaction terms, were excluded from the final model due to non-significant 






Odds Ratios and Confidence Intervals (CI) of Lifetime Depression Status, 
age at study enrollment, APOE4 Gene, Education and Vascular Conditions 
with Cognitive Status in the Male and Female Sample  
Variable Male Model 
b, 95% CI 
Female Model 
b, 95% CI 
Lifetime Depression Status P=<.001 P=<.01 
Early Life Depression 1.51 (.86-2.65) .70 (.43-1.14) 
Chronic Depression .71 (.29-1.72) .44 (.27-.74) 
Late Life Depression 2.68 (1.81-3.95) 1.06 (.81-1.41) 
Age at study enrollment 1.06 (1.03-1.08) 1.06 (1.04-1.08) 
APOE E4 Gene Status 2.37 (1.75-3.19) 2.41 (1.89-3.08) 
High School Education 1.30 (.89-1.90) .97 (.70-1.34) 
Congestive Heart Failure .43 (.30-.62) .68 (.51-.90) 
Diabetes < > .98 (.75-1.29) 
Myocardial Infarction .93 (.66-1.31) .64 (.46-.87) 
Cerebrovascular Accident < > < > 
Hypercholesterolemia  .79 (.57-1.08) .94 (.72-1.23) 
Atrial Fibrillation .74 (.52-1.04) .52 (.38-.71) 
Atherosclerosis < > 1.30 (.97-1.74) 
Obesity .56 (.26-1.21) 1.12 (.73-1.72) 
Other Dysrhythmia  .81 (.58-1.13) 1.13 (.86-1.48) 
R2 .15 .13 
Note: OR=Odds Ratio CI = 95% confidence interval; OR’s and CI’s with p 
= <.05 are in boldface.  < >: Indicates variable was not included in analysis 





For males, the overall binary logistic regression model was significant 
(χ2[13]=135.04, R2=.15; p=<.001; See Table 8) and several main effects were observed. 
Lifetime depression status was associated with increased odds of dementia, with those 
who reported late life depression being approximately 2.68 times more likely to also 
report dementia (see Table 8). Further, age at study enrollment and APOE E4 status were 
associated with increased odds of dementia, such that those with higher ages were 6% 
more likely to also be diagnosed with dementia and those with at least one copy of APOE 
E4 were 2.37 times more likely to be diagnosed with dementia (See Table 8). Of the 
vascular health conditions included in the final model, only congestive heart failure 
demonstrated a significant relationship with cognitive status, after accounting for the 
other covariates. In particular, those with congestive heart failure were 57% less likely to 
also be diagnosed with all cause dementia.  No other vascular health conditions 
demonstrated a significant relationship with dementia, although atrial fibrillation and 
hypercholesterolemia trended towards significance displaying a negative association with 
cognitive status (see Table 8.)  
 The final binary logistic regression model for females included 1939 participants 
with cognitive status as the binary outcome variable. Predictors in the female model 
included lifetime depression status, age at study enrollment, APOE E4 status, high school 
education, congestive heart failure, diabetes mellitus, myocardial infarction, 
hypocholesterolemia, atrial fibrillation, atherosclerosis, obesity and other dysrhythmias 
(See Table 8). Marital status and cerebrovascular accident were excluded from the final 
model due non-significant bivariate associations and elimination from the LASSO 




lifetime depression x atrial fibrillation were retained and significant in the LASSO 
analysis, they were excluded due to a lack of bivariate association and poor model fit 
when included in the model with other covariates.  
 For females, the overall binary logistic regression model was significant 
(χ2[8]=20.32, R2=.13; p=<.001; See Table 8) and several main effects were observed. 
Lifetime depression status was significantly associated with cognitive status, with those 
who reported early and late life depression displaying significantly reduced odds of also 
having dementia (see Table 8). Further, age at study enrollment and APOE E4 gene were 
associated with increased odds of dementia, such that those with higher ages were 6% 
more likely to also be diagnosed with dementia and those with at least one copy of APOE 
E4 allele were 2.41 times more likely to be diagnosed with dementia (see Table 8). Of the 
vascular health conditions included in the final model, congestive heart failure, 
cerebrovascular accident and atrial fibrillation were each negatively associated with 




 The goal of the present study was to examine if the onset of depression in early 
life, late life or a chronic presentation (both early and late), increased risk for dementia. 
In our study, we also sought to examine if vascular health conditions modified the 
relationship between depression and dementia. The present study utilized a population-
based sample of 4214 older individuals who participated in the Cache County Study on 




data to empirically test these hypotheses. Rates of lifetime depression and dementia in 
our sample were comparable to the prevalence rates in the United States (Djernes, 2006; 
Gatz et al., 1993; National Institute of Mental Health [NIMH], 2018; World Health 
Organization [WHO], 2017). Findings from the present study indicated that lifetime 
depression status was associated with increased odds of dementia in males, particularly 
for those with late life onset depression. Conversely, in females depression was a less 
robust predictor and in fact only displayed an inverse relationship with dementia, such 
that those with chronic depression (early and late life) were less likely to later be 
diagnosed with dementia. It is possible that these results were influenced by our use of 
self-report data in the determination of depression in older adults. More specifically, 
older generations experience greater stigma for disclosing mental health conditions, and 
are significantly less likely to seek treatment relative to younger generations, particularly 
among older men (Conner et al ., 2010). Thus, our data may have only captured a subset 
of the total sample who experienced depression symptoms, which may have contributed 
to the low rates of depression in males and may serve to explain the lack of consistent 
association between depression and dementia across sex.   
Further, vascular health conditions did not modify the relationship between 
depression and dementia in either the male or female samples and relatively few 
conditions overall showed robust associations with dementia after accounting for other 
established risk factors. These findings have several important implications for clinicians 
assessing depression and dementia as well as future research investigating depression and 
dementia. In particular, our results underscore the importance of open discussion of 




depression and encouraging treatment for depression. Given that depression is largely 
treatable (APA, 2013), such discussions may serve to increase treatment seeking 
behaviors among older adults that could result in decreasing risk for dementia. 
 Extant literature has established an association between depression and dementia, 
however few studies have thoroughly examined the onset age of depression and its 
relationship with dementia (Manepalli et al., 2011). Indeed, the few studies that have 
specified the onset age of depression in relation to dementia diagnosis have examined 
either only early life onset depression or late life onset depression (Hegeman et al., 2012; 
Manepalli et al., 2011). The present study utilized multiple sources of data to identify the 
earliest onset of depression for participants in the sample. We determined the cutoff ages 
for early and late life based upon biological factors (i.e., menopause) in the female 
sample and extant literature (i.e., age 60) in the male sample. To our knowledge, this is 
the first study to utilize this approach for defining onset ages in depression.  
Our results confirm previous work that observed a relationship between late life 
depression and dementia diagnosis in males (see review, Mourao et al., 2016;) and 
underscore the need to examine males and females separately with regard to risk for 
dementia as their onset and type of risk factors differed. Indeed, even after accounting for 
established covariates associated with dementia and depression, males who reported late 
life depression were at over a 1.5-fold risk for also having a dementia diagnosis. These 
findings are consistent with previous work that found associations between depression in 
late life and a cognitive status of dementia (Lewis, 2002; Treadway et al., 2015). 
Inconsistent with previous findings, we did not observe any significant interactions 




findings may be partially due to limitations associated with the measurement of vascular 
health conditions in the present study. More specifically, the present study relied heavily 
on self-report data and data from Medicare claims to determine the presence and onset 
age of a vascular health condition, which is likely less reliable than medical assessment 
and diagnosis.  Further, early onset depression was not associated with a dementia 
diagnosis in males, which might suggest that depression onset in late life is a more 
problematic risk factor for males.   
 Older adults are frequently underassessed for mental health conditions, in 
particular depression (Avasthi & Grover, 2018). Further, older adults tend to less 
frequently seek treatment for mental health conditions than younger adults, which can 
result in more severe symptoms and a chronic course of condition (Avasthi & Grover, 
2018; Geerlings et al., 2008). Our findings underscore the importance of frequent and 
accurate assessment of depression symptoms for males in late life and may suggest that 
those who experience depression in late life should further be assessed for other warning 
signs of dementia. Interestingly and in contrast to other extant literature, late life onset 
depression was not associated with dementia diagnosis in females. 
In the present study depression was only marginally significant in the female sample 
and the direction of the association was the reverse of what was hypothesized. Indeed, 
among females only those who reported chronic depression had a significant association 
with dementia, with our results revealing that females with chronic depression showed 
reduced odds of having dementia diagnosis. These findings may suggest a resilience 
effect, such that those who have struggled with depression throughout their life may have 




et al., 2002; Bonanno et al., 2002; Southwick et al., 2005). Although this study did not 
evaluate treatments for depression and their associations with cognitive status, extant 
research has linked the use of selective serotonin reuptake inhibitors (SSRI) 
antidepressants for the treatment of depression to reduced odds of developing dementia 
(Bartels et al., 2018; Kessing et al., 2009). Further, some extant research has observed 
that consistent use of antidepressants for the treatment of depression increases the 
production of Brain Derived Neurotrophic Factor (BDNF) and may have epigenetic 
effects on BDNF genotypes (Baj et al., 2012). Thus, those participants in our sample who 
were regularly taking antidepressants may have higher levels of BDNF production than 
those not on medication.  Given the higher rates of depression among females and the 
frequent use of prescription medications to treat depression (Steffens et al., 2000), it is 
possible that those with a more chronic course of depression were regularly taking 
medication that reduced their odds of developing dementia (Bartels et al., 2018; Kessing 
et al., 2009). However, other studies have observed that use of anti-depressants are 
associated with increased odds of dementia (See review, Chan et al., 2019), thus further 
research is likely needed to clarify this issue. 
Also contrary to our hypotheses, vascular health factors did not modify the 
relationship between depression and dementia and were less robustly associated with 
dementia diagnoses than expected. Indeed, there were no significant interaction effects of 
depression by vascular health conditions for either males or females. Even after removing 
vascular health conditions that were not associated with dementia at the bivariate level, 
only congestive heart failure was significantly associated with dementia for both males 




associated with dementia. However, the direction of these relationships was also 
unexpected, in that congestive heart failure in males and females was associated with a 
57% and 32% reduced odds of dementia, respectively. Further, among females, 
myocardial infarction and atrial fibrillation were associated with 36% and 48% reduced 
odds of dementia, respectively.  
These findings offer support for the hypothesis that there are sex differences present 
in the onset of depression as a risk factor for dementia. In the present study late life 
depression increased the odds of having a dementia diagnosis for males, with no 
significant associations observed between early life onset or a chronic presentation of 
depression, which was contrary to hypotheses. In contrast, late life depression was not 
associated with dementia in females and in fact only chronic depression showed a 
significant relationship with dementia onset, though in the opposite direction 
hypothesized. One possible explanation for these findings is a gender difference in 
coping mechanisms for depression that may serve to increase resilience to dementia. 
Indeed, one longitudinal study of 561 men and 1321 women who were diagnosed with 
depression found that men often coped with depression via increased alcohol 
consumption, which can increase risk for dementia (see review, Xu et al., 2017), whereas 
women tended to cope via emotional processing and religious activities that can promote 
resilience against dementia (Angst et al., 2002; Meléndez et al., 2018;).  
Taken together, the results of this study may lend support to the hypothesis that 
depression, particularly late life onset depression, is a risk factor for dementia that should 
be carefully assessed in men. Given the limitations of the present study in accurately 




better understand the role of cardiovascular conditions in conjunction with late life 
depression and dementia in men. Among females, it is possible that other factors 
associated with treatment of depression and resiliency impacted the association with 
dementia. As prior literature has clearly documented a relationship that confers risk from 
depression to dementia in both males and females these results should be interpreted with 
caution and further explored to better understand the reduced risk for dementia among 
those with chronic depression. Finally, the present study examined only all-cause 
dementia; as such it is possible that these associations may vary by type of dementia (i.e., 
Alzheimer’s Disease vs vascular dementia) and may shed light on the direction of the 
relationships observed. 
 
Study Strengths, Limitations and Future Research Directions 
 The present study had a number of strengths. First, the CCSMA was a large, 
community-based sample that retained 90% enrollment of the base population. Thus, 
generalizability to similar communities is likely to be greater than studies that rely on 
samples enrolled at medical centers or at academic universities. Further, the study 
followed participants for up to 12 years and benefited from multiple visits to gather data 
and update risk factors. This rich dataset was further augmented with Medicare claims 
and death certificate data via linkage to study participants’ records in the Utah Population 
Database. This linkage provided increased follow-up participants beyond the end of the 





Limitations of the present study included a reliance upon self-report data and 
Medicare claims data to determine the age of onset for key study variables, depression 
and vascular health conditions most notably. As retrospective self-report data can be 
unreliable as more time passes, it is possible that determining ages of onset for these 
variables was negatively impacted by inaccurate recall. In our study, we observed 
relatively few males and females who reported early life depression and chronic 
depression when compared to late life depression, which may have limited the statistical 
power needed to understand the complex relationships that were hypothesized. Further, 
given the limited available data on vascular health conditions in early life our analysis 
was limited to examining the impact of cardiovascular health conditions with late life 
onset, rather than across the lifespan and in conjunction with early life depression. As the 
behavioral sequelae of depression have shown robust associations with worse vascular 
health in extant research (Kim et al., 2016; Lewis, 2002; Treadway et al., 2015) this 
limitation is notable for the present study. Another limitation of the present study is a lack 
of generalizability to more ethnically diverse samples, as our sample was over 97% 
White. 
 Future research might consider examining lifetime depression status with other 
underlying dementia types, such as Alzheimer’s disease or vascular dementia. Utilizing 
study methods that allow for clinical diagnosis of depression and vascular health 
conditions across the lifespan would yield more precise incident diagnoses particularly 
regarding mental health and cardiovascular, vascular conditions at younger ages, rather 




interested in better understanding treatment of depression and any potential underlying 






 Depression and dementia are two conditions that result in significant functional 
impairment, which are both widespread in the global population, affecting millions of 
people worldwide (WHO, 2017).  With the aging of large birth cohorts and medical 
advancements that prolong life, the number of people affected by dementia globally is 
likely to rise significantly in the coming years (Prince et al., 2013), highlighting the 
importance of a comprehensive understanding of risk factors related to dementia onset. 
The present study sought to examine multi-faceted risk factors related to the onset of 
depression in early and late life, and further to understand depression onset as a risk 
factor for dementia. The findings from this study offer support for examining multiple 
bio-psycho-social risk factors in conjunction with depression onset throughout the 
lifespan. Further, our results indicate that late life depression is a risk factor for dementia, 
particularly for males. These results have several important implications for clinicians 
and researchers. In particular, our results highlight the importance of discussing and 
normalizing depression symptoms with older adults, particularly as a means of 
counteracting negative stigma for disclosing and seeking treatment of depression in this 
age group. Early intervention for depression symptoms is critical for this population, as 
depression is largely treatable and may result in increased quality of life and subsequently 
decrease risk for dementia. 
 Extant research has established that there are high prevalence rates of depression 
in early life and late life (Djernes, 2006; Gatz et al., 1993; National Institute on Aging, 




depression may suggest that vulnerability to depression changes at different points 
throughout the lifespan and thus that specific events and circumstances in early and late 
life increase risk for depression (Baldwin & Tomenson, 1995). The present study sought 
to elucidate these risk factors for early life, late life and chronic depression. We found 
that certain life events, such as death of a spouse, death of a child, were reliably 
associated with depression in both early and late life, which was consistent with extant 
literature (Mandelli et al., 2015; Sasson & Umberson, 2014). We also observed that 
corticosteroid use was associated with alterations in risk for females, but not males, and 
that the direction of this relationship varied for early life onset, late life onset and chronic 
onset, which was a novel finding relative to previous work on corticosteroids and 
depression (McCAllister-Williams, 1998). Further, chronic pain conditions in late life 
and number of vascular health conditions in late life were associated with reduced odds 
of depression in our model, which was unexpected and somewhat consistent with the 
mixed findings observed in extant literature (Gagliese & Melzack 2003; Sheline et al., 
2010; Taylor et al., 2013). Indeed, it is possible that the unexpected direction of these 
relationships in our study may be due to data reflecting the co-occurrence of problematic 
conditions (i.e., depression and chronic pain), rather than chronic pain being a risk factor 
that leads to depression in late life. Our study also revealed novel findings regarding the 
impact of genes BDNF genotypes in the presence of acute life stressors, which suggests 
that the presence of a minor allele of certain genes associated with BDNF signaling may 
act as a vulnerability factor for depression after the occurrence of specific stressful life 
events. Finally, our study findings underscored the importance of examining multiple 




differences in the associations of acutely stressful and chronic life stressors with 
depression onset over the lifespan. 
 Extant research has linked dementia and depression in several longitudinal 
studies, such that a history of depression is often associated with increased risk for 
dementia (see review: Bennett & Thomas, 2014; Geerlings et al., 2008). Typically, three 
hypotheses have emerged from the extant literature: 1) Depression is an independent risk 
factor for ADRD, 2) Depression is a prodromal feature of ADRD and 3) Depression is a 
coincidental finding resulting from the loss of functioning associated with ADRD 
(Bennett & Thomas, 2014). Our findings from the present study are consistent with the 
majority of research featuring longitudinal samples, which support depression as an 
independent risk factor for ADRD (Blazer, 2003; Ownby et al., 2006; Wilson et al., 
2008). Indeed, we found evidence that depression, particularly in late life, was associated 
with increased odds of dementia in males, but not females, possibly revealing a sex 
difference in resilience or co-occurrence of conditions. Biological explanations of 
depression being a risk factor for dementia onset have posited that there are biological 
changes that occur in key brain structures following a depressive episode that may confer 
risk for dementia (Ding et al., 2015; Lee & Kim, 2010; Rapp et al., 2006; Warner et al., 
2006). Specifically, several studies have found evidence of reduced neuronal health and 
functioning, as well as reduced hippocampal volumes in individuals following a 
depressive episode (Lee & Kim, 2010; Warner et al., 2006), which are also key markers 
for dementia onset (Vijayakumar & Vijayakumar, 2012; Schuff et al., 2009). 
 Taken together, this study utilized a robust and rich dataset comprised of multiple 




related to depression onset and subsequent risk for dementia in late life. The findings of 
this study highlight the complex nature and relationships of risk factors for depression 
across the lifespan. We examined broad classes of risk factors: acutely stressful life 
events, chronic life stressors and BDNF-related genes and genotypes and discovered 
unique pathways in which risk for depression is increased, with differences observed for 
males and females. Subsequently, we also added to the literature that supports depression 
in late life as an independent risk factor for dementia, particularly in males. These results 
underscore the importance of accurate assessment and effective treatment of depression 
throughout the lifespan, but in particular in late life, which may alter the trajectory of risk 
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Now I’m going to ask you some specific 
questions about your medical history, 
your medications and some other related 
things. 
  
D5. Has a doctor or nurse told 
you that you have 
Parkinson’s Disease?  
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 2 
D6. Have you taken L-DOPA 
or Sinemet? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 2 
D7. Has a doctor or nurse told 
you that you had a stroke? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 1 NO (GO TO D11) . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . 2 RF (GO TO D11) . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . 7 DK (GO TO 
D11) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
D8.  How many strokes have you had in that interval? 
NUMBER  OF STROKES . . . . . . . . . . . . . . . . . 
. . . . .  
D9. When did the (last) stroke 
take place? 
  
   MM      YY 
 a. Did one side of 
your body, or one 
arm or leg, become 
weaker than the 
other? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 2 
 b. Did you lose the 
ability to speak or 
understand what was 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 




said to you, for a day 
or more? 
 c. Did you see a doctor or go 
to a hospital? 
SAW DOCTOR (RECORD) . . . . . . . . . . . . . . . 
. . . . . . . . 1 WENT TO HOSPITAL (RECORD) 
. . . . . . . . . . . . . . . . . 2 NO DOCTOR OR 
HOSPITAL . . . . . . . . . . . . . . . . . . . . . 3 RF . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . 7 DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 










Have you had a TIA, mini-
stroke, or funny spell 
suggestive of a stroke? 
a. When did this first take place? 
Has a doctor or nurse told you 
that you have had a transient 
ischemic attack, TIA or mini-
stroke? 
a. When did this first take 
place? 
b. Did you see a doctor or go 
to a hospital? 
RECORD NAME AND 




Have you had a head injury 
so severe that you lost 
consciousness, lost your 
memory for a period of time, 
or had to see a doctor? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 NO (GO TO D12) . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO 
D12) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. 7 
DK (GO TO D12) . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 8 
  
MM   YY 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 NO (GO TO D13) . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO 
D13) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. 7 
DK (GO TO D13) . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 8 
  
MM   YY 
SAW DOCTOR (RECORD) . . . . . . . . . . . . 
. . . . . . . . . . . 1 WENT TO HOSPITAL 
(RECORD) . . . . . . . . . . . . . . . . . 2 NO 
DOCTOR OR HOSPITAL . . . . . . . . . . . . . . 
. . . . . . . 3 RF . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . 7 DK . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 NO (GO TO D17) . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO 




 #1 INTERVIEWER CHECKPOINT: IF D8=1 STROKE, GO TO D11 
D10.When was the stroke before the last one?  
a. Did one side of your body, 
or one arm or leg, become weaker 
than the other? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 2 
D14. How many times did this happen? 





D20. Now I’d like you to tell me 
how well you’re doing with 
several routine daily 
activities.  Do you need 
assistance with bathing or 
grooming (for example, 
running bath water, getting 
into or out of the tub, or 
washing body and hair)? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . 7 
D21. Can you walk long distance 
(>1 BLOCK) without any 
sort of assistance? 
YES (GO TO D22) . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . 7 DK . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . 8 
 a. Do you use a cane, a 
walker, or some other 
form of assistance? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 2 
D22. Do you need help traveling 
beyond walking distance 
(such as using the bus 
system or driving yourself)? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 






YES (SPECIFY) . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 NO (GO TO D18) . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO 
TO D18) . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . 7 DK (GO TO D18) . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . 8 
D23.Do you need help getting into or out of a bed or a chair? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
 
 
D24. Do you need help using the restroom (including adjusting clothing or getting onto 
or off of the toilet)? 
D25.Do you need reminders to use the restroom? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
D26
. 
Do you need help preparing meals for yourself 
(for example a hot meal, a sandwich, a TV dinner 
or microwaving food)? 
YES . . . . . .. . 1 
NO . . . . .. . . . . 2 
D27
. 
Do you need assistance with eating (for example, 
serving your food, using utensils, or drinking from 
a glass or cup)? 
YES . . . .. . . . . 1 
NO . . . .. . . . . . 2 
D28
. 
Do you need assistance doing the laundry? This 
includes putting clothes into the washer and dryer, 
starting the machines, and unloading them when 
they’re finished. 
YES . . . .. . . . . . 1 
NO . . . . .. . . . . . 2 
D29
. 
Do you need help doing light housework such as 
dusting, washing dishes, or sweeping? 
YES . . . . .. . . . . 1 
NO . . . . .. . . . . . 2 
D30
. 
Do you need help doing heavier chores such as 
vacuuming, yard work, moving furniture, or 
scrubbing? 
YES . . . . .. . . . 1 
NO . . . . . .. . . . . 2 
D31
. 
Do you need any kind of assistance using the 
telephone, either answering the phone or placing 
calls? (This would include an amplifier, larger 
push button numbers, or preprogrammed phone 
numbers.) 
YES . . . . .. . . . . 1 NO 
(GO TO D32) . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . 
 2 RF (GO TO D32) . . . . . 
. . . . . . . . . . . . . . . . . . . . . 
. . . . . . 
 7 DK (GO TO D32)  
 









Do you need assistance with any kind of shopping 
(not including help with transportation)? 
YES . . . . .1  
NO (GO TO D33) . . 2 
 RF (GO TO D33)  
7 DK (GO TO D33) . 
 8 
 a. Do you need assistance with shopping for 
groceries and prescriptions? 
YES . . 1 
NO .. . 2 
 b. Do you need assistance with shopping for 
things other than groceries and 
prescriptions? 
YES . . . 1 
NO . . . 2 
D33
. 
Do you need assistance or reminders to take your 
medications? 
YES . . . 1 
NO . . . 2 
D34
. 
Do you need help managing your finances, such 
as paying the bills or balancing your checkbook? 
YES . . . .1 
NO . . . .2 
D35
. 
Do you feel that you have enough contacts with 
other people or do you wish that you had more? 
ENOUGH . . . . 1  
WANTS MORE 
CONTACTS . . . 2 
D36. This next group of questions is 
about cardiovascular or heart 
problems. Have you had a severe 
pain across the front of your chest 
lasting for a half an hour or more? 
RF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . 7 DK . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 NO . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 2 RF . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
7 DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . 8 
D37.Have you been told you had angina? 
D38. Have you been troubled by shortness of breath 
when walking up a slight hill or when hurrying 
on level ground? 
YES . . . . . 
1 NO . . . . 
 
 
c. Who was the doctor who evaluated your 




2 RF . . . .  
7 DK . . .  
8 
D39. Have you ever had high blood pressure or 
been told that you had hypertension? 
YES . . . .  
1 NO(GO TO D40) . . . 
2 RF (GO TO D40) . . . . 
7 DK (GO TO D40) . . . 
8 
 a. How old were you when you first learned 
you had high blood pressure? 
AGE . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . 
 b. Did a doctor evaluate your high blood 
pressure or prescribe treatment? 
YES, EVALUATED . . . . 
1 YES, EVALUATED 
AND TREATED . . . . . . . . 
. . . . . . . 2 NO (GO TO 
D40) . . . .  
3 RF (GO TO D40) . . .  
7 DK (GO TO D40) . . . 
8 
 d. Do you have high blood pressure now or 
are you under current treatment for high 
blood pressure? 
YES . . . 1  
NO . . . 2  
RF . . .  7 




g. Who was the doctor who 
evaluated your high 




            
h. Do you have high 
cholesterol or blood lipids 
now or are you currently 
under treatment for this 
condition? 
RF . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 7 
DK . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 8 
D40. Have you been told you had high blood 
cholesterol triglycerides (lipids)? 
YES . . . 1 
 NO . . .. 2  
RF . . . . 7 
DK . . . .8 
 e. How old were you when you first learned 
you had high cholesterol or blood lipids? 
AGE . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . 
 f. Did a doctor evaluate your high cholesterol 
or blood lipids, or prescribe treatment? 
YES, EVALUATED . . .  
1 
 YES, EVALUATED 
AND TREATED . . . . .. 2  
NO (GO TO D41) . . . 3 
 RF (GO TO D41) . . . 7  
DK (GO TO D41) . .. . 8 
 
 
D41. Have you had coronary bypass surgery)? YES . . . . . 1 
 NO (GO TO D42) . . . 2  
RF (GO TO D42) . . 7 
 DK (GO TO D42) . . . 8 
a. How old were you when you first had a coronary AGE . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . 
b. Who performed the (last) bypass surgery? 
            
D42. Have you ever had a heart attack, a myocardial infarction, YES . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 or a coronary thrombosis? NO (GO TO 
D43) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
RF (GO TO D43) . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 7 
DK (GO TO D43) . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 8 
a. How old were you when you first had a heart attack AGE . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . (coronary)? 
b. How many heart attacks have you had? # HEART ATTACKS . . . . . . . . . 




            
D43 Have you ever had diabetes, high blood 
sugar or sugar in your urine? 
YES . . . . . 1 
NO (GO INT. 
CHECKPOINT) . . 2 
 a. Did a doctor diagnose this condition? YES . . .. 1 
NO . . 2 
        
 
 
D44. What sort of treatment was prescribed for 
your diabetes? 
DIET ONLY . . . 1  
ORAL TREATMENT 
(PILLS) .. 2 INSULIN . . . 3 
 NONE . . . . 4  
RF . . . 7  
DK . . . . . 8 
YES (CONTINUE) . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 1 INTERVIEWER CHECKPOINT: IS R. FEMALE? 
 
 
D45. Have you ever taken calcium 
supplements? 
YES . . . . 1  
NO . . . . 2  
RF . . . . 7  
DK . . . . 8 
 a. For how many years? YEARS (ROUND TO 
NEAREST INTEGER) . . . . 
RF . . . 97 
D46. Have you ever taken estrogen 
supplements? 
YES . . . 1 
 NO (GO TO E1) . . . 2 
 RF (GO TO E1) . . . . 7 
 DK (GO TO E1) . . . . 8 
 a. For how many years? YEARS (ROUND TO 
NEAREST INTEGER) . . . . 
RF . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . 97 
 
 




SECTION F:  DEPRESSION 
 
Now I am going to ask you a few more questions about your mood. 
F1. In your lifetime, have you ever had a period 
of two weeks or more when, nearly every 
day, you felt sad, blue or depressed? 
YES . . . . . . . . . . . . . . . . . . . . . 
. . . 1 NO . . . . . . . . . 2  
RF . . . . . . . . . . 7  
DK . . . . . . . . . 8 
F2. In your lifetime,  have you ever had a period 
of two weeks or more when, nearly every 
day, you lost all interest and pleasure in 
things that you usually cared about or 
enjoyed? 
YES . . . . . . . . 1  
NO . . . . . . . . 2  
RF . . . . . . . .. 7  
DK . . . . . . . . 8 
F3. 
In your lifetime, have you ever had a period 
of two weeks or more when, nearly every 
day, you felt unusually cross or irritable? 
YES . . . . . . 1  
NO . . . . . . 2  
RF . . . . . . 7  
DK . . . . . . 8 
INTERVIEWER CHECKPOINT: DOES F1, F2 OR F3=YES?  
NO (GO TO SECTION G) . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 
a. How old were you when this 
(last) episode AGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . began? 
F4.   How many episodes of two weeks or more of 
this sort of 
 
 sadness, loss of interest, or irritability have 
you had in your life? 
COMMENT:  
EPISODES . . . . . . . . . . . . . . 
. . . . . . . . . . 








b. How long did this episode last? WEEKS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . 
IF ONLY 1 EPISODE, GO TO F7. 
 
F5. When was the first time that, nearly every day 
for two weeks or more, you felt sad, blue, or 
depressed, lost all interest and pleasure in 
things, or felt irritable? 
AGE . . . . . . . . . . . . . . . . . . .        
. . . . . . . . . . . 
 
a. How long did this episode last? WEEKS . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . F6. When was your most severe spell when, nearly every AGE . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
day for two weeks or more, you felt 
sad, lue, or depressed, lost all 
interest and pleasure in things, or 
felt irritable? (IF MORE THAN 1 
YEAR AGO) How old were you 
then? 
 
a. How long did this episode last? WEEKS . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . 
 
F7. At present, are you still 
experiencing this sort of 
sadness, loss of interest, 
or irritability? 
YES . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 1 
NO (GO TO F19) . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . 2 
RF (GO TO F19) . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . 7 
DK (GO TO F19) . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . 8 
F8.   Have people told you 
recently that you look sad or 
down? 
YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 1 
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . 2 
 
 
F18. Have you told a doctor about your current depression, loss of interest and pleasure, 
or irritability? 
RF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 DK . . . . . . . . . . . . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
YES (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 NO (GO TO F30) . . . . . . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 RF (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . . . . . . 7 DK (GO TO F30) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 F19. During 
your (most recent) episode when you felt sad, lost interest and pleasure, or felt irritable, 





During your (most recent) episode, was your 
appetite recently decreased or increased? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
F21
. 
During your (most recent) episode, did you 
lose or gain weight? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO (GO TOF22) . .                
. . . . . . . . . . . . . . . . . . 2 RF (GO          
. . . . . . . . . . . . . . . . . . . . . . . . . .       
F22) . . . . . . . . . . . . . . . . . . . . . .               
 a. How much? LBS. . . . . . . . . . . . . . . . . . . . . .                 
F22
. 
During your (most recent) episode, did you 
have difficulty sleeping, or did you sleep  too 
much? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
F23
. 
During your (most recent) episode, did you feel 
either slowed down, or restless and fidgety? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
F24
. 
During your (most recent) episode, did you 
have low energy, feel tired out, or fatigued? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
F25
. 
During your (most recent) episode, did you 
feel worthless or guilty? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
F26
. 
During your (most recent) episode, did you 
have trouble concentrating, thinking, or making 
decisions? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             





During your (most recent) episode, did you 
have thoughts about death or suicide? 
YES . . . . . . . . . . . . . . . . . . . . . .                
. . . . . . . . 1 NO . . . . . . . . . . . . .                
. . . . . . . . . . . . . . . . . . 2 RF . . .                 
. . . . . . . . . . . . . . . . . . . . . . . . . .             
. . . . . . . . . . . . . . . . . . . . . . . . . .              
DK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 
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Member of a large, interdisciplinary consultation team focused on providing 
evidence-based treatment for PTSD. Conducted comprehensive diagnostic 
PTSD assessments. Completed VA trainings for Prolonged Exposure (PE), 
Cognitive Processing Therapy (CPT; standard and intensive) and Safety 
Behaviors for PTSD (SBP). Maintained a caseload of 4-6 weekly individual 
patients via telehealth. Interventions utilized included PE, CPT, and SBP. 
Presenting Problems: Posttraumatic Stress Disorder, Acute Stress Disorder, 
Other Specified Trauma-and Stressor-Related Disorder, Insomnia and 
Adjustment Disorder. 
 
Leadership and Telehealth (August 2020-November 2020):  
4-month outpatient psychotherapy rotation that focused on developing 
leadership skills for consultation teams in psychology and general outpatient 
treatment via telehealth. Developed a training presentation to increase 
inclusivity and awareness of diversity for consultation teams in VA and 
community mental health settings. Maintained a caseload of 4-7 individual 
clients via telehealth. Interventions utilized: Acceptance and Commitment 
Therapy, Cognitive Behavioral Therapy for Insomnia, Motivational 
Interviewing, Prolonged Exposure 
Presenting Problems: Major depressive disorder, generalized anxiety 
disorder, insomnia, adjustment disorder and alcohol dependence.  
 
Outpatient Trauma and Addiction (November 2020-March 2021): 
2013 Undergraduate Creative Activities and Research Experiences Funding Award, 
University of Nebraska-Lincoln 
2013 Psi Chi Outstanding Member Award, University of Nebraska-Lincoln 




4-month outpatient psychotherapy rotation focusing on the unique 
challenges of treating Veterans with PTSD and co-occurring addictive 
behaviors. Emphasis on learning how to integrate Evidence-Based 
Treatments for PTSD and addiction. Co-facilitated two groups, Relapse 
prevention skills and Relapse prevention Processing. Received training on 
integrating evidence based approaches with substance use as a presenting 
problem. 
 
Whole Health Mindfulness Center (March 2021-July 2021) 
The Center aims to provide and to support front-line staff who are providing 
mindfulness-based interventions (MBIs) throughout the facility, to expand 
the availability of MBIs for Veterans and staff, to conduct research regarding 
the effectiveness of new and existing MBIs, and to train staff to provide 
mindfulness interventions. The majority of the caseload is group-based, with 
possible groups including Mindfulness-Based Stress Reduction, Mindfulness-
Based Cognitive Therapy, Mindful Self-Compassion, and Foundations of 
Mindfulness. 
 
VITAL Program (February 2021-July 2021) 
The VITAL program is focused on outreach to student Veterans and is 
designed to connect them to campus resources, assist with the transition to 
higher education and provide mental health service. VITAL is a collaborative 
effort between Veterans Health Administration (VHA), Veterans Benefits 
Administration (VBA), state and local governments, and the schools to get 
student Veterans the tools they need to succeed.  
 
Anticipated Direct Hours (July 2021): 500-700 
Anticipated Supervision Hours (July 2021): 120-170 
Anticipated Assessment Hours (July 2021): 70-100 






Utah Center for Evidence Based Treatment (UCEBT): 
UCEBT is a private practice that employs 10 licensed psychologists. UCEBT 
serves adults, adolescents and children in Salt Lake City, UT and surrounding 
communities and specializes in the treatment of complex psychiatric 
conditions and behaviors.   
Supervisors: Sheila Crowell, Ph.D., Robin Lange Ph.D., Karli Merideth, Ph.D. 
 
Clinical Training Rotations:  
Dialectical Behavior Therapy Consultation Team (May 2018-June 2020): 
Participated in a comprehensive DBT team: active participation in weekly 
DBT-consultation team, co-led two weekly adult DBT skills groups, developed 
 
 
a DBT skills for addictive behaviors group, provided individual therapy and 
phone coaching for a caseload of 2-5 DBT clients (Stage 1 and 2). 
Presenting problems: Borderline Personality Disorder, Posttraumatic Stress 
Disorder (PTSD), Avoidant Personality Disorder, Major Depressive Disorder, 
recurrent, severe without psychotic features. 
Assessment and Testing Team (January 2019-June 2020):  
Participated in a bi-weekly assessment-focused consultation team: wrote 
integrative psychodiagnostic reports, conducted personality and cognitive 
assessments. Typical assessment batteries included: an objective measure of 
personality (PAI or MMPI), a standardized measure of cognitive ability (e.g., 
WAIS IV), a structured clinical interview (e.g., SCID-5 and/or DIB-R), records 
review and self-report measures based upon the referral question (e.g., PCL-
5, PHQ-9, Mood DQ, ASRS etc.).  
Presenting problems: Major Neurocognitive Disorder, Attention Deficit and 
Hyperactivity Disorder, Major Depressive Disorder, Borderline Personality 
Disorder and Posttraumatic Stress Disorder.  
Trauma Stress and Resilience Consultation Team (August 2018-June 2020): 
Participated in a weekly trauma treatment-focused consultation team: 
Conducted individual therapy for a caseload of 1-3 individuals with PTSD and 
stress-related disorders. Interventions utilized: Cognitive Processing Therapy, 
Trauma-Focused Cognitive Behavior Therapy and Acceptance and 
Commitment Therapy. Developed and led a Cognitive Behavior Therapy for 
Insomnia group (August 2019) for individuals with history of trauma. 
Presenting Problems: Posttraumatic Stress Disorder, Acute Stress Disorder, 
Other Specified Trauma-and Stressor-Related Disorder, Insomnia and 
Adjustment Disorder. 
Intake and Professional Development Team (May 2018-June 2020): 
Participated in a weekly consultation team focused on development of case 
conceptualization skills, report writing, diagnostic knowledge and evaluation. 
Conducted brief diagnostic assessments with treatment recommendations 
for new clients at UCEBT. 
Presenting Problems: Generalized Anxiety Disorder, Major Depressive 
Disorder, Acute Stress Disorder, PTSD, Borderline Personality Disorder, 
Persistent Depressive Disorder, Social Anxiety Disorder and Complex 
Bereavement.  
Direct Hours: 582 
Assessment Hours: 105 
Supervision Hours: 378.5 






Utah State University Counseling and Psychological Services (CAPS):  
CAPS is a university counseling center that employs 9 licensed psychologists 
and serves students attending Utah State University (mostly young adults).  
Supervisors: Mark Nafziger, Ph.D., Alberto Varela M.S. (psychology intern), 
Charley Bentley Ph.D. 
 
Clinical Training Rotations  
Student Therapy Clinic (September 2017-May 2018): Conducted brief intake 
assessments and individual therapy for students attending Utah State 
University. Interventions utilized: Acceptance and Commitment Therapy, 
Dialectical Behavior Therapy (skills only) Motivational Interviewing and 
Cognitive Behavioral Therapy. Co-led an emotion regulation skills group 
(January 2018-May 2018). Developed and led psychoeducational workshops 
for test anxiety and interpersonal communication.  
Presenting problems:  Major Depressive Disorder, Generalized Anxiety 
Disorder, Anxiety Disorder (NOS) and Adjustment disorder. 
Direct Hours: 98 
Assessment Hours: 0 
Supervision Hours: 46 




Utah State Community Psychology Clinic (CPC): 
The CPC is a training clinic for graduate students in the clinical/counseling 
doctoral program at Utah State University that serves children, adolescents 
and adults in Cache County, UT and surrounding communities.  
Supervisors: Susan Crowley Ph.D. and Sara Boghosian Ph.D. 
 
Clinical Training Rotations 
Student Therapy Clinic (September 2016-June 2017):  
Conducted brief intakes and individual therapy for children, adolescents and 
adults. Interventions utilized: Acceptance and Commitment Therapy, 
Cognitive Behavioral Therapy, Motivational Interviewing, Dialectical Behavior 
Therapy (skills only). Conducted comprehensive cognitive and personality 
assessments for adults and children. Assessment batteries included an 
objective measure of cognitive ability (e.g., WAIS-IV or WISC V), an objective 
measure of achievement (e.g., Woodcock Johnson) a review of records and 
self-report measures based upon the referral question (e.g., PHQ-9, 
Childhood Behaviors Scale etc.).  
Presenting problems: Adjustment Disorder, Major Depressive Disorder, 
Generalized Anxiety Disorder, Unspecified Personality Disorder, Childhood 
trauma and child behavior problems.  
 
Direct Hours: 113 
 
 
Assessment Hours: 11 
Supervision Hours: 72 
Support Hours: 235 
 
Peer Reviewed Publications 
Kugler J., Andresen F. J., Bean R.C., & Blais R.K. (2019). Couple-based 
interventions for PTSD among military veterans: an empirical review. Journal of 
Clinical Psychology, 75, 1737-1755. https://doi.org/10.1002/jclp.22822   
Andresen, F.J., Monteith, L. L., Kugler, J., Cruz R. A., & Blais, R. K., (2018). 
Institutional betrayal following military sexual trauma is associated with more severe 
depression and specific PTSD symptom clusters. Journal of Clinical Psychology, 75, 
1305-1319. DOI:10.1002/jclp.22773 
Blais R. K., Monteith L. L., & Kugler J. (2018). Sexual dysfunction is associated 
with suicidal ideation in female service members and veterans. Journal of Affective 
Disorders, 226, 52-67 
Manuscripts in Progress 
Sanders C. L., Wengreen H., Rattinger G. B., Kugler J., DeBerard S.M., Kauwe J. S., 
Buhusi M., & Tschanz J. T., (2019). Interaction of brain derived neurotrophic factor 
(BDNF) and lifestyle factors in late life depression: The Cache County Study. 
Manuscript accepted pending revision (resubmitted January 2021). 
Vernon E. K., Kugler J., Rattinger G.B., DeBerard S.M., & Tschanz J.T., (2020). Sex 
Differences in the Association between Pharmacological Agents to Treat Insomnia 
and Risk of Alzheimer’s Disease: The Cache County Study (USA). Manuscript in 




June 2021 Building a Life Worth Living: Components of Dialectical Behavior Therapy 
Oral presentation to clinicians and community members at the Utah 
Addictions Conference (upcoming). Developed and Conducted by Jordan 
Kugler and the Utah Center for Evidence Based Treatment. 
November 2020 Increasing Inclusivity in Consultation Teams 
Oral presentation to Interdisciplinary team leaders at the Salt Lake City VA. 




Obtaining Commitment in DBT: A Guide to Pre-treatment 




Developed and conducted by Jordan Kugler and Robin Lange, Ph.D. 
May 2019 Working with Personality Disorders 
Oral Presentation to Salt Lake City Police Department Crisis Intervention 
Trainees. 
Developed and conducted by Jordan Kugler and Sheila Crowell Ph.D. 
April 2019 Acceptance and Commitment Therapy for Recurrent Major Depression: A 
Comprehensive Case Presentation. 
Oral presentation and written manuscript presented by Jordan Kugler to 
Utah State faculty. 
March 2019 Introduction to Dialectical Behavior Therapy: Distress Tolerance and Emotion 
Regulation Skills 
Seminar for University of Utah Psychiatry Medical Residents 
Conducted by Jordan Kugler and Karli Merideth, Ph.D. 
January 2019 Working with Personality Disorders 
Oral Presentation to Salt Lake City Police Department Crisis Intervention 
Trainees. 
Developed and conducted by Jordan Kugler and Sheila Crowell Ph.D. 
April 2018 Test Anxiety Workshop 
Psychoeducation workshop conducted at Utah State Counseling and 
Psychological Services.  
Developed and Conducted by Jordan Kugler 
Poster Presentations 
Kugler J., (2019, May) Posttraumatic Stress Disorder from Institutional Betrayal: Treatment 
Response to Cognitive Processing Therapy. Poster presented at the Utah Center for Evidence 
Based Treatment Clinical Psychology Ph.D. Programs Open House, Salt Lake City, UT. 
Kugler J., Andresen F. J., Bean R.C., & Blais R.K. (2018, November) Couples-Based Interventions 
for PTSD and Relationship Satisfaction Among Military Veterans and Their Romantic Partners: 
An Empirical Review. Poster presented at the Association for Behavioral and Cognitive 
Therapies, Washington, D.C. 
Kugler J., & Blais R.K. (2018, November) Frequency and Perception of Positive and Negative 
Social Exchanges are Related to Heightened Suicide Risk in Male Service Members/Veterans. 
Poster presented at the Association for Behavioral and Cognitive Therapies. Washington, D.C. 
Kugler J., Livingston W. S., Andresen F. J., & Blais R. K. (2017, August) MST-Based PTSD Is 
Related to Higher Disordered Eating Behavior in Female Veterans. Poster presented at the 
American Psychological Association, Washington, D.C. 
Kugler J. & Blais R. K. (2016, November) Perceived combat threat relates to higher PTSD stigma 
from family in OEF/OIF military Veterans. Poster presented at the International Society for 
Traumatic Stress Studies, Dallas, Texas. 
 
 
Morton, A., Kugler, J., Brungardt, K. L., West, T., & Hansen, D. J. (2014, 
November). Internalizing symptom presentation of sexually abused youth: Examination of 
interpersonal predictors. Poster presented at the Association for Behavioral and Cognitive 
Therapies Convention, Philadelphia, PA.  
Huit T., Grandgenett H., Kugler J., Vanderheiden S., B.A., Morton A., B.A., Pittenger S., M.A., 
Hansen D., (2014 November) The ole of peer and parental Support in Presentation of 
Internalizing Symptoms Following Child Sexual Abuse. Poster presented at the Association for 
Behavioral and Cognitive Therapies Convention, Philadelphia, PA. 
Kugler, J., Grandgenett, H., Morton, A., Brungardt, K. Predictors of residential treatment 
outcomes (2014, April) Poster presented at the University of Nebraska-Lincoln Undergraduate 
Research Fair. 
Kugler, J., Grandgenett, H., Brungardt, K. L., & Morton, A. (2013, November). Loneliness, 
gender, marital status and their interaction with depression and stress. Oral Presentation 
presented at Nebraska Psychological Society Conference, Wayne, NE. 
Morton, A., Kugler, J., Brungardt, K. L., West, T., & Hansen, D.J. (2014, April). Interpersonal 
predictors of internalizing symptoms of sexually abused youth. Poster presented at the 
Undergraduate Research Fair at the University of Nebraska-Lincoln. 
Grandgenett, H., Kugler, J., Morton, A., & Brungardt, K. L. (2013, November). Social anxiety 
levels and negative thoughts during a positive or negative conversation interact with self-
focused attention and general anxiety among college students. Oral Presentation presented at 
Nebraska Psychological Society Conference, Wayne, NE. 
 
Clinical Trainings Completed 
November 2020 Cognitive Processing Therapy for PTSD  
2-day comprehensive VA training covering standard and intensive CPT with 
supervision provided through core rotations. Ongoing CPT consultation 
provided with 3 completed cases. 
October 2020 Safety Behaviors for PTSD 
1-day comprehensive VA training with supervision provided through core 
rotation  
September 2020 Prolonged Exposure for PTSD 
2-day comprehensive VA training with supervision provided through core 
rotation. 
August 2020 Cognitive Behavior Therapy for Insomnia 
Self-paced online VA training. Supervision in CBT-I cases completed through 
rotations. 
May 2019 Dialectical Behavioral Therapy Foundational Training  
16 week intensive online foundational training course via Behavioral Tech; 
see https://app.psychwire.com/courses/3vnl9i/about 
April 2019 Diagnosis and Treatment of Dissociative Identity Disorder 
 
 
Didactic training at Utah Center for Evidence Based Treatment conducted by 
Donna Hunter, MA, CMHC 
January 2019 Using Crisis Response Plans and Reducing Access to Means of Suicide 
Attempts 
Didactic training at Utah Center for Evidence Based Treatment conducted by 
Craig Bryan, Ph.D. 
October 2018 Introduction to Prolonged Exposure Protocols 
Didactic training at Utah Center for Evidence Based Treatment conducted by 
Michelle Ertl, Ph.D. 
September 2017 Acceptance & Commitment Therapy-Intermediate/Advanced 2-day 
Workshop 




Implementing LGBT-Affirmative CBT: A Transdiagnostic Minority Stress 
Treatment Approach 
Webinar conducted by John Pachankis, Ph.D. 
March 2017 Conducting Asylum Evaluations 
Webinar conducted by the APA Refugee Mental Health Resource Network 
August 2016 Introduction to Acceptance & Commitment Therapy 2-day Workshop  




Summer 2017 Instructor 
Abnormal Psychology (Psych 3210) 
Class Size: 17 
Responsibilities: Designed a curriculum, led weekly lectures, developed 
exams and assignments, held weekly office hours. 
Spring 2017 Teaching Assistant 
General Psychology (Psych 1010) 
Instructor: Rebecca Blais Ph.D. 
Class Size: 212 
Responsibilities: Held office hours, graded weekly assignments and 
conducted pre-exam review sessions for students. Delivered two guest 
lectures on PTSD and Childhood Behavior Disorders 
Fall 2016 Teaching Assistant 
General Psychology (Psych 1010) 
Instructor: Kathryn Sperry, Ph.D. 
Class Size: 280 
Responsibilities: Held office hours and graded weekly class assignments. 
Delivered two guest lectures on PTSD and Therapy Interventions. 
 
 
Spring 2016 Teaching Assistant 
General Psychology (Psych 1010) 
Instructor: Rebecca Blais, Ph.D. 
Class Size: 204 
Responsibilities: Held office hours, conducted pre-exam review sessions for 
students and graded weekly class assignments. 
Fall 2015 Teaching Assistant 
Abnormal Psychology (Psych 3210) 
Instructor: Rebecca Blais, Ph.D. 
Class Size: 121 
Responsibilities:  Held office hours, conducted pre-exam review sessions for 
students and managed student emails for the course. Delivered two guest 





Clinical/Counseling Psychology Doctoral Program Graduate Assistant (20 hours 
weekly assistantship) 
Supervisors: JoAnn Tschanz, Ph.D. and Michael Levin, Ph.D. 
Responsibilities: Worked directly with the director and associate director of 
clinical training (Dr. Tschanz and Dr. Levin) in collecting data for accreditation, 
maintaining quality of clinical training and developing data collection 
instruments for the Combined psychology PhD program. 
Fall 2015- 
Spring 2017 
Research Assistantship (10 hours weekly) 
Supervisor: Dr. Rebecca Blais 
Responsibilities: Supervised data collection for a study on academic 
functioning of Veterans in college. Collaborated on a study involving 
institutional betrayal and PTSD symptom clusters. Collaborated on a study 
involving suicidal ideation and sexual dysfunction. Collaborated on a study 
involving military sexual trauma and eating disorders. Presented a poster for 
the International Society for Traumatic Stress Studies.  
May 2014-  
May 2015 
Undergraduate Research Coordinator 
Study: Project S.A.F.E. 
Lab: Child Maltreatment Lab, UNL 
Supervisor: Dr. David J. Hansen, Director Clinical Training  
 Responsibilities: Project SAFE (Sexually Abused Family Education) is a 12- 
week standardized group intervention program for sexually abused youth and 
their non-offending caregivers. Tasks included: a) coding empirically 
supported assessment measures (SCL 90, MASC, CDI, YSR, CBCL, CSBI), b) 
entering pre-treatment, and post-treatment data into SPSS and c) data 
cleaning and updating the database d) conducting statistical analyses e) 
assisting with the management of the research team and the training and 
supervising of new research assistants to code and review the various 
measures associated with Project S.A.F.E. 
January 2014-  
May 2015 
Research Assistant 
Study: Sleep and Psychopathology in Youth Project 
 
 
Lab: Pediatric Health Lab, UNL 
Supervisor: Dr. Timothy Nelson 
 Responsibilities: The purpose of this study was to examine the daily 
bidirectional relationship between sleep and psychopathology in youth. Tasks 
included: a) participation in recruitment from a treatment seeking sample, b) 
performing a formal literature review of current research in the field and c) 
administering questionnaires and collecting actigraphy data from subjects 
participating in the study. 
 
 
August 2014-  
May 2015 
Research Assistant 
Study: Stimulant and Sleep Behavior Meta-Analysis 
Lab: Pediatric Health Lab, UNL 
Supervisor: Dr. Timothy Nelson 
 Responsibilities: The purpose of this project was to examine past literature on 
the effects of stimulant medication on the sleep patterns of children and 
adolescents with ADHD. My responsibilities included: a) conducting a literature 
review through specific search engines and b) analyzing the relevance of each 
article to the project.  
 
August 2014-  
May 2015 
Research Assistant 
Study: Pediatric Dentistry and Obesity Project 
Lab: Pediatric Health Lab, UNL 
Supervisor: Dr. Timothy Nelson 
 Responsibilities: This project examined the correlates of oral health in relation 
to physical health in children, ages 3-5 years. Primary responsibilities: a) subject 
recruitment at local pediatric dentist offices and b) administering questionnaires 
associated with the study.  
 
October 2013-  
May 2015 
Research Assistant 
Study: Growing Great Beginnings Project 
Lab: Pediatric Health Lab, UNL 
Supervisor: Dr. Timothy Nelson 
 Responsibilities: This project involved collecting parent-report data on children 
aged infancy through 3 years. Data were collected through home visits in 
collaboration with a community outreach program. Primary responsibilities 
included: a) administering questionnaires, answering questions that arose 
during the home-visit session b) assembling questionnaire packets, c) 






Study: Acute Alcohol Intoxication and Neurocognitive Processing on Intimate 
Partner Aggression during Anger Arousal 
Lab: Trauma, Violence and Abuse Lab, UNL 
Supervisor: Dr. David Dilillo 
Responsibilities: This project involved data collection for a study investigating 
the effects of alcohol intoxication on intimate partner violence and 
 
 
neurocognitive processing. Primary responsibilities included: a) running 
participants through an established experimental protocol approximately 8 
hours per week b) transcribing participant responses c) coding participant 
responses for qualitative themes. 
 
Professional Development 
November 2018 Association for Behavioral and Cognitive Therapies National Conference 
National conference in Washington D.C.  
August 2017 American Psychological Association National Conference 
National conference in Washington, D.C. 
November 2016 International Society for Traumatic Stress Studies National Conference 
National conference in Dallas, TX 
November 2015 Association for Behavioral and Cognitive Therapies National Conference 
National conference in Philadelphia, PA 
Membership in Professional Organizations 
March 2018-
December 2019 




















Association for Behavioral and Cognitive Therapies; Child Maltreatment and 







Jason Goodson Ph.D. Harrison Weinstein Ph.D. 
Clinical Supervisor Assistant Clinical Training Director  
Salt Lake City VA Healthcare System Salt Lake City VA Healthcare System 
Email: Jason.Goodson@va.gov Email: Harrison.Weinstein@va.gov 
  
  
Ben Swanson Ph.D. Sheila Crowell Ph.D. 
Clinical Supervisor Clinical Supervisor 
Salt Lake City VA Healthcare System Utah Center for Evidence Based Treatment 
Email: Leland.swanson@va.gov Email: Sheila.crowell@ucebt.com 
